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Abstract
Neoplastic overgrowth depends on the cooperation of several mutations ulti-
mately leading to major rearrangements in cellular behaviour. The molecular cross-
talk occurring between precancerous and normal cells strongly influences the early
steps of the tumourigenic process as well as later stages of the disease. Precancer-
ous cells are often removed by cell death from normal tissues but the mechanisms
responsible for such fundamental safeguard processes remain in part elusive.
To gain insight into these phenomena I took advantage of the clonal analysis
methods available in Drosophila for studying the phenotypes due to loss of function
of the neoplastic tumour suppressor lethal giant larvae (lgl). I found that lgl mutant
cells growing in wild-type imaginal wing discs are subject to the phenomenon of cell
competition and are eliminated by JNK-dependent cell death because they express
very low levels of dMyc oncoprotein compared to those in the surrounding tissue.
Indeed, in non-competitive backgrounds lgl mutant clones are able to overgrow and
upregulate dMyc, overwhelming the neighbouring tissue and forming tumourous
masses that display several cancer hallmarks. These phenotypes are completely
abolished by reducing dMyc abundance within mutant cells while increasing it in lgl
clones growing in a competitive context re-establishes their tumourigenic potential.
Similarly, the neoplastic growth observed upon the oncogenic cooperation be-
tween lgl mutation and activated Ras/Raf/MAPK signalling was found to be char-
acterised by and dependent on the ability of cancerous cells to upregulate dMyc
with respect to the adjacent normal tissue, through both transcriptional and post-
transcriptional mechanisms, thereby confirming its key role in lgl -induced tumouri-
genesis. These results provide first evidence that the dMyc oncoprotein is required
in lgl mutant tissue to promote invasive overgrowth in developing and adult epithe-
lial tissues and that dMyc abundance inside versus outside lgl mutant clones plays
a key role in driving neoplastic overgrowth.
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Chapter 1
Introduction
Multicellularity has originated in many instances since life has appeared on
Earth leading to the evolution of increasingly complex organisms, capable of self-
replication, in which different cell types perform specialised functions integrated by
sophisticated and finely tuned regulatory circuits [1]. As complexity increased, a
plethora of strategies have evolved to keep proliferation, differentiation, adhesion
and migration of each and every cell of the organism under strict control to ensure
the correct and harmonious development of multicellular beings, their ability to
adapt to the environment and thus increase their chances of survival. Nevertheless,
along with undeniable advantages, evolution of multicellularity has its downside:
breakdown of regulatory circuits can lead to escape from developmental constraints,
uncontrolled proliferation and altered behaviour of cells, a disease known as cancer.
Cancer is the leading cause of death in developed countries and the second lead-
ing cause of death in developing countries [2]. Despite the huge effort in terms of
biomedical and pharmacological research, it has been estimated that about 12.7
million cancer cases and 7.6 million cancer death have occurred in 2008 worldwide
[2]. The reason for this lies in the complexity and heterogeneity of this disease. It is
now widely accepted that it results from the clonal accumulation and cooperation of
various genetic and epigenetic lesions which cause the progressive transformation of
normal somatic cells into malignant derivatives which can grow, invade and migrate
uncontrollably [3].
Two general classes of genes are typically affected in cancer cells: oncogenes
and tumour suppressor genes (TGS). The first are aberrantly activated and thus
represent dominant gain of function mutations of genes (proto-oncogenes) generally
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involved in growth and division promotion and protection against programmed cell
death. On the other hand, tumour suppressor genes are inactivated in cancer cells
(commonly in the form of recessive loss of function mutations), resulting in the loss
of normal cellular functions, such as accurate DNA damage repair, control over the
cell cycle, cell polarity and adhesion within tissues [3].
Cancer can arise in virtually any organ but those of epithelial origin, namely
carcinomas, are the most frequent form, representing about 90% of all human ma-
lignant tumours. The first carcinogenic events generally lead to local hyperpro-
liferation/metaplasia or dysplasia that then evolves into in situ carcinoma, which
already exhibit strong alterations in cell physiology and behaviour, such as loss of
differentiation, apical-basal cell polarity and tissue organisation, but the lesion is still
confined within the basement membrane (BM), a specialised sheet of extracellular
matrix that underlies epithelial tissues. At this stage, tumour-induced angiogene-
sis and vascularisation of the cancerous mass is also observed. Finally the tumour
becomes invasive when basement membrane degradation occurs and cells dissem-
inate to neighbouring tissues. These cells can eventually intravasate into lymph
or blood vessels, allowing their passive transport to distant organs. At secondary
sites, carcinoma cells can extravasate seeding micrometastases that in some cases
will form secondary lesions, the final step of this sequence of events often termed
invasion-metastasis cascade (Fig. 1.1) [3].
Figure 1.1: Main stages of epithelial tumour progression from dysplasia to metastasis [4]. A
detailed description is given in the text.
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1.1 The Hallmarks of Cancer
The heterogeneity and complexity of cancer led to the widely accepted notion
that it represents a large group of different diseases with a common outcome rather
than a single pathological condition [5]. Tumourigenesis can indeed be seen as a
Darwinian evolutionary process: it founds itself on random genetic variation and
evolves by means of natural selection within the organism. Mutant cancerous cells
compete for space and resources and are under a strong selective pressure to evolve
strategies which will allow them to evade the organism defensive mechanisms and to
be able to proliferate, migrate and colonise. All those acquired features, leading to
an increased fitness of the cancerous cell, will result in an enhanced “reproductive”
success, a growth advantage, and thus will be favourably selected [5, 6].
There are more than 100 distinct types of cancers and a myriad of organ- and
tissue-specific subtypes, everyone characterised by a set of genetic and epigenetic
lesions that may differ even within each subtype. But, despite this remarkable di-
versity, it is still possible to identify a handful of essential physiologic alterations that
cells need to acquire in order to progress towards malignancy. A huge effort in this
sense has been made by Hanahn and Weinberg to provide a conceptual framework
for understanding the complex biology of cancer [5, 7]; the authors have identified
six hallmarks that are shared by most if not all human tumours: sustaining pro-
liferative signals, evading growth suppressors, resisting cell death, enabling replica-
tive immortality, inducing angiogenesis and activating invasion and metastasis (Fig.
1.2). Two emerging hallmarks have been added in the more up to date review [7]:
reprogramming energy metabolism and evading immune destruction (Fig. 1.3).
Self-Sufficiency in Growth Signals Abnormal proliferation is probably the
most striking feature of cancer. Cell proliferation in a healthy tissue is carefully
controlled and depends on the release of growth-promoting factors which activate
membrane receptors and their downstream signalling pathways stimulating growth,
cell cycle entry and cell division. There are several ways cancerous cells can gain
independence from physiological mitogenic signals and paroxystically activate prolif-
erative programs. These cells may be able to produce growth factors and thus induce
proliferation in an autocrine fashion or stimulate the tumour-associated stroma to
release them. Alternatively growth signal receptors can be overexpressed resulting
in higher sensitivity towards the ligands. Nevertheless, the most common way in
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Figure 1.2: The six hallmarks of cancer proposed by Hanahan and Weinberg in 2000 [5].
which cancer cells become independent of mitogenic factors is the constitutive ac-
tivation of components of proliferation-promoting pathways (or the loss of negative
regulators) [5, 7]. This is probably best exemplified by the Ras/MAPK (Mitogen
Activated Protein Kinase) signalling cascade as activating mutations of its mem-
bers are found in a significant percentage of human cancers [8]. This key signalling
pathway and its relevance to cancer will be discussed in greater detail in Section 1.3.
Insensitivity to Anti-Growth Signals Tissue homeostasis is also main-
tained by means of powerful antiproliferative programs that cancer cells need to
circumvent for unrestrained proliferation to occur. In physiological conditions pro-
liferation is inhibited by two distinct mechanisms: cells may enter a quiescent state
(the so-called G0 phase), a reversible condition that allows re-entry into the cell cy-
cle upon mitogenic signalling, alternatively cells can permanently block proliferative
programs by committing them-selves to a specific cell fate and entering the post-
mitotic state. Relief of proliferation inhibition is generally achieved through loss of
function of tumour suppressor genes, the key players in these processes, and inac-
tivating mutations of these genes are indeed a common feature of all tumours. At
the same time some oncogenes are known to inhibit terminal differentiation allowing
mutant cells to switch back to a fully proliferative phenotype [5, 7].
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Cell Death Evasion Programmed cell death is a major safe-guard mechanism
employed in the control of the balance between cell proliferation, differentiation and
death. Besides ensuring the correct patterning and development of the organism
it also serves the elimination of damaged and potentially harmful cells. Apopto-
sis, arguably the best characterised form of programmed cell death, is known to be
triggered in response to many stresses cancerous cells face in the course of tumour
development, including hyperproliferation, elevated levels of oncogene signalling and
DNA damage. In normal conditions both intra- and extracellular stresses are per-
ceived by molecular sensors which can elicit adequate responses or, if the damage
is not reversible, trigger cell death. Unsurprisingly many of these sensors belong to
the tumour suppressor genes category and are found inactivated in human cancers,
being p53 a well-known example. Increased expression of antiapoptotic regulators or
pro-survival signals or downregulation of proapoptotic molecules are also strategies
cancer cells may use to prevent cell death [5, 7].
Limitless Replicative Potential It has been established that normal cells
are able to undergo only a limited number of growth and division cycles before ir-
reversibly entering a non-proliferative status named senescence. This phenomenon
is particularly evident when cells are propagated in culture: they pass through a
certain number of cell divisions and then become senescent. Senescence seems to
be linked to the telomere ends. Each cell division telomeres undergo progressive
shortening untill they reach a critical length and proliferation is inhibited. Inducing
cells to circumvent this barrier by forcing cell proliferation leads to telomere loss
and thus genomic instability; as a consequence cells enter a crisis phase charac-
terised by high levels of cell death; rare variants may emerge from this crisis and
acquire limitless replicative potential, a status termed immortalisation. Senescence
and crisis, much like programmed cell death, are self-defence mechanism against
uncontrolled proliferation that cancer cells need to overcome to acquire limitless
replicative potential and give rise to a tumour. Immortalisation of cells which will
eventually proceed towards malignancy seems to depend on their ability to maintain
telomeric DNA at a length sufficient to avoid triggering of senescence or apoptosis.
This is generally achieved by upregulating the activity of telomerase, a specialised
DNA polymerase that adds telomere repeat units to the chromosomal ends, usually
absent in nonimmortalised cells [5, 7].
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Sustained Angiogenesis Beyond a critical tumour volume, diffusion of oxy-
gen and nutrients becomes insufficient to sustain the metabolic requirements of the
growing mass and cells suffer from hypoxia. This hypoxic condition triggers the
so-called angiogenic switch: the normally quiescent vasculature is induced to prolif-
erate, expand and sprout new vessels which penetrate into the tumour supplying it
with oxygen and nutrients as well as evacuating its metabolic waste. A sustained
angiogenesis is thus an essential step in tumour progression and also provides cancer
cells with an access to the blood stream allowing them to spread and metastasise
to distant sites. Angiogenesis is generally activated by cancer cells upon the secre-
tion of proangiogenic factors such as VEGF (Vascular Endothelial Growth Factor)
and FGF (Fibroblast Growth Factor) which are normally responsible for regulating
blood vessel growth during development as well as in physiologic conditions in the
adult (i.e. wound healing) [5, 7].
Recent findings seem to prove that angiogenesis can start very early in tumour
development, before hypoxia occurs. This “early angiogenesis” is triggered by the
cancer-initiating cells or cancer stem cells (CSC), which have potent pro-angiogenic
capabilities. CSC are characterised by high plasticity and multipotency of differenti-
ation; interestingly, they are able to transdifferentiate into several cell types, includ-
ing endothelial cells, and to form a vascular-like structure which supplies blood to
the tumour in the early stages of cancer development, called vasculogenic mimicry
(VM). It was proposed that only later VM is replaced by endothelium-dependent
vasculature via a transition phase where vessels are a mosaic of cancer and en-
dothelial cells. Indeed, a significant proportion of the tumour-associated vascular
endothelium has been proved to be of neoplastic origin [9].
Invasion and Metastasis More than 90% of cancer mortality is not at-
tributable to the growth of the primary tumour, often successfully removable by
surgical resection, but to the development of metastases which, due to their sys-
temic nature and resistance to therapeutic agents, are still largely incurable. In
the last decade of research substantial progress has been made towards the under-
standing of the molecular mechanisms behind the invasion-metastasis cascade, in
particular regarding carcinomas, but a lot still needs to be achieved to fully address
this pivotal hallmark.
It is now clear that epithelial cells acquire the ability to invade, migrate and
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disseminate by activating the epithelial-mesenchymal transition (EMT), a develop-
mental regulatory program involved, in physiologic conditions, in various aspects
of embryonic morphogenesis and wound healing, which consists in loss of cell ad-
hesion, acquisition of a fibroblastic-like morphology, secretion of matrix-degrading
enzymes, increased motility and resistance to apoptosis. Secretion of proteases, such
as matrix-metalloproteinases (MMPs), able to degrade matrix components, allows
carcinoma cells freed from cell-adhesive ties to branch the basement membrane and
directly invade the stroma. Besides the mesenchymal-like invasion characteristic of
EMT, two other mechanisms of invasion have been identified: collective invasion,
where cells migrate in clusters, and ameboid invasion in which individual cells slide
through existing interstices. Once in the stroma, by virtue of their motility, can-
cer cells can directly access the systemic circulation by entering either lymphatic or
blood vessels, being these latter the most common option. Intravasation is facilitated
by the abnormal leakiness which characterises the tumour-associated neovasculature.
When in the blood stream cancer cells need to resist multiple stresses as anchorage
loss, hemodynamic shear forces and immune system attacks and they seem to be
able to overcome these threats by interacting with platelets and forming emboli, a
process akin to normal blood coagulation.
Robust clinical evidence proved that individual types of carcinomas form metas-
tasis in only a limited subset of target organs, a phenomenon called tissue tropism.
It is still unclear what the reasons for this selectivity are and two main hypotheses
have been proposed. The first envisions a passive mechanical explanation according
to which circulating cancer cells arrest within the capillary beds of certain organs
due to vessel diameter restrictions and are thus unable to reach more distant terri-
tories. The alternative hypothesis is that cancer cells posses intrinsic characteristics
that determine their ability to interact with specific microenvironments. Extrava-
sation may also play a role in organ tropism: microvessels in normal tissues, distant
from the primary tumour, are functional and posses an extremely low permeability,
moreover while some organs result relatively accessible, some other are protected by
additional physical obstacles (i.e. the blood-brain barrier). Nevertheless circulating
cancer cells are known to be able to secrete specific factors able to perturb physical
barriers and increase vascular permeability.
In order to form micrometastases tumour cells must survive in a new environ-
ment and may adapt to new conditions via the establishment of a “premetastatic
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niche” induced by systemic signals released by the primary tumour, but more gen-
erally, disseminating cancer cells seem to employ very complex local strategies to
modify their new microenvironment as well as trigger cell-autonomous mechanisms
to adapt to it.
It has been estimated that less then 0,01% of cancer cells that enter into the
systemic circulation develop into clinically detectable metastases. Micrometastasis
formation is certainly a rate-limiting step but the most prominent one appears to
be colonisation. In fact, the vast majority of the carcinoma cells that do manage
to land in distant sites are probably either poorly adapted to the new environment,
experience high levels of cell death that counterbalance possible high levels of cell
proliferation or enter a quiescent state that may persist for years after seeding. Nev-
ertheless, certain organs seem to offer a more hospitable environment to certain
types of cancer cells (the well-known seed-and-soil model of metastatic dissemina-
tion) giving yet another explanation for the phenomenon of tissue tropism.
Substantial progress is currently being made to define a metastatic signature
of gene expression changes which correlates with the establishment of macroscopic
metastases in specific tissues. This will also help clarify how metastasis-promoting
genetic alterations are selected within the primary tumour: whether these mutations
are also beneficial to primary growth and thus are fixed before cells start to dissem-
inate or whether they are stochastically accumulated as “passenger” mutations that
will only subsequently give an advantage and be fixed. Alternatively, cells may leave
the tumour in a partially metastatic-competent condition and further evolve once
they experience the new environment-associated pressure. Indeed, an increasing
body of evidence seems to point towards a parallel progression model for certain
types of carcinomas, according to which mutant cells disseminate relatively early,
from pre-neoplastic lesions, and undergo genetic diversification and selection within
the distant target organs thus showing a rather different genetic profile with respect
to the primary tumour [7, 10].
Enabling Characteristics Acquisition of the hallmarks described above re-
lies on the recurrence of genetic alterations that may, by chance, provide cells with
novel advantageous capabilities and thus be favourably selected and fixed. In nor-
mal conditions spontaneous mutation rate is extremely low thanks to very efficient
genome maintenance systems capable of detecting and repairing DNA damages and
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Figure 1.3: The emerging hallmarks and enabling characteristics Hanahan and Weinberg added
to their conceptual framework of cancer biology in 2011 [7].
defects. Mutation rate must therefore somehow be increased to explain how cancer
cells are able to accumulate a sufficient number of lesions to develop a malignant
behaviour. A higher mutability can be achieved by precancerous cells through im-
pairment of the genome maintenance systems them-selves or of those circuits which
monitor genome integrity and force damaged and potentially dangerous cells into
apoptotic cell death. Indeed, many genes belonging to these two categories can be
classified as tumour suppressor genes and are often found inactivated in most, if
not all, human cancers. In addition, a certain degree of genomic instability initially
generated upon telomeric ends loss (before telomerase activity is restored) in the
process of immortalisation may further promote accumulation of genetic lesions. It
is therefore clear that high genomic instability is to be considered an enabling char-
acteristic as it endows the row material on which natural selection can act and, as
a consequence, drive tumour progression.
Another distinctive trait that all neoplastic lesions share is the presence, at
various degrees, of immune system cells. Counterintuitively, a large body of com-
pelling evidence has unquestionably led in recent years to the conclusion that the
tumour-associated inflammatory response has tumour-promoting rather than anti-
cancer effects. Immune cells have been proved to contribute to the acquisition of
multiple hallmarks by releasing a wide range of molecules among which growth and
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prosurvival factors thus sustaining growth and limiting cell death, by producing ma-
trix metalloproteinases and pro-angiogenic molecules facilitating angiogenesis and
stimulating cancer cells to undergo EMT, invasion and metastasis. Moreover inflam-
matory cells can also contribute to genomic instability by releasing reactive oxygen
species (ROS), potent mutagenic agents [7].
The Emerging Hallmarks It has been known for long time that cancer cells
have peculiar metabolic charcteristics, despite their higher energetic requirements,
even in presence of oxygen these cells switch to a much less efficient glycolytic
metabolism, the well-known Warburg effect. Glycolysis can be upregulated both by
certain oncogenes such as Myc and Ras and by hypoxic condition but the biological
significance of this metabolic reprogramming remains elusive. According to some
interpretations glycolytic intermediates can be redirected into various biosynthetic
pathways, including those of aminoacids and nucleotides, contributing to sustain the
high proliferation rate. Nevertheless, it still needs to be clearly established whether
deregulation of energy metabolism belongs to the core hallmarks or it merely is a sec-
ondary effect of proliferation-inducing oncogenes activity and/or excessive growth.
A second still disputed issue again involves the immune system. There is some
evidence that an actual anti-tumoral immune response exists that cancer cells need
to avoid to survive and be able to expand. This immune surveillance seems to be
mediated mainly by T and B lymphocytes and macrophages but further work needs
to be done to ascertain whether or not antitumour immunity plays a significant role
in contrasting cancer development [7].
The tumour-promoting role played by immune system cells is paradigmatic of the
fundamental concept that cancer must not be considered as a cell-autonomous dis-
ease, instead progression towards malignancy is unavoidably based on the crosstalk
between cancer cells and their microenvironment. Besides those belonging to the
immune system, many other cell types contribute to the emergence of neoplastic
traits in mutant cells: a notable example of the importance of these interactions
is given by carcinomas where neoplastic epithelial cells coexist with a variety of
cell types such as fibroblasts and endothelial cells which, together with the immune
system cells, form the tumour stroma. Indeed stromal cells are leading players
in cancer initiation and progression and contribute to the acquisition of nearly all
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the hallmarks described above. To take an example, tumour associated fibroblasts
can stimulate cell proliferation through release of growth factors, hormones and cy-
tokines; they can convey survival signals and proangiogenic factors and promote
invasion and metastasis by inducing EMT of tumour epithelial cells as well as se-
creting BM-remodelling factors [7, 11].
Further to this, it is becoming clear that tumour development also depends on
systemic interactions between cancer cells and distant tissues and organs [12]. An
increasingly large body of evidence is thus contributing to the understanding of the
tumour-enhancing abilities of the tumour microenvironment, nevertheless very little
is known about its tumour-suppressing ones. For earlier stages of cancer develop-
ment, the probability of progression is lower than for more advanced stages of disease
[13] and this clearly suggests the existence of safeguard mechanisms able to avoid
the expansion of precancerous lesions.
1.2 Modelling Cancer in Drosophila
Most aspects of human carcinogenesis can be profitably investigated employing
Drosophila as an in vivo model. The first tumour-causing mutation was indeed
described in the fruit fly by Elizabeth Gateff in the 60’s [14]; this mutation affected
a locus named lethal giant larvae, lgl, that acted in a recessive manner and was
thus the first tumour suppressor gene to be identified, even before the first human
transforming oncogenes were described [15]. In subsequent years, also thanks to the
possibility to easily conduct wide genetic screens, several other tumour suppressor
genes were identified in Drosophila that caused uncontrolled proliferation leading
to tumorous growth and proved not only to be functionally conserved in mammals
but also were found to be altered in human cancers. Thanks to the high degree
of conservation of most signalling pathways, analyses of the fly tumour suppressors
and proto-oncogenes have produced substantial contribution towards understanding
the basic cell biology of tumourigenesis [16]. Nowadays Drosophila represents an
invaluable model in cancer research as the fine genetic tools available allow to study
the clonal effects of multiple genetic manipulations on populations of cells which
are embedded in and interact with the surrounding normal tissue; these effects can
be examined in the context of a whole organ or even the whole animal and with
remarkable resolution [17].
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1.2.1 lethal giant larvae Tumour Suppressor Gene
Although almost all human tumour suppressors have a fly homologue, conven-
tionally only those genes that cause overproliferation in Drosophila can be defined
as fly tumour suppressor genes (TGS). They are classified into two main categories:
hyperplastic and neoplastic [15].
Hyperplastic Tumour Suppressor Genes Belong to this category those
genes that when mutated display extensive overproliferation of imaginal epithelia,
but overall tissue monolayer organisation and cell shape are not affected and mutant
tissue is able to differentiate into adult organs. Examples are given by loss of func-
tion of the Hippo (Hpo) pathway genes, involved in organ size control (see Section
1.2.1.2).
Neoplastic Tumour Suppressor Genes On the other hand, are classified
as neoplastic those TGS that, when mutated, cause excessive proliferation accom-
panied by loss of apical-basal cell polarity and organ structure and in mutant tissues
differentiation never occurs. Furthermore, when transplanted into adult hosts, tis-
sues mutant for neoplastic TSG are able to overgrow, spread metastases and kill the
host.
Among the neoplastic tumour suppressors so far identified, lethal giant larvae,
discs large (dlg) and scribble (scrib) are of particular interest as they encode con-
served proteins involved in the establishment and maintenance of epithelial apical-
basal polarity as well as in proliferation control [15]. The regulation of epithelial cell
polarity is a crucial issue in cancer biology as its loss is a key feature of carcinomas.
As reported in Section 1.1, it well correlates with invasive and metastatic abilities
of cancer cells and is strongly associated to a negative prognosis [18, 19].
1.2.1.1 lgl in Epithelial Cell Polarity
The plasma membrane of epithelial cells is subdivided into two functionally dis-
tinct domains: apical and basolateral domains, by means of epithelial cell junctions
(Fig. 1.4). The basolateral domain interconnects neighbouring cells while the apical
domain forms a specialised surface usually not in permanent contact with other cells.
This distinct polarisation along the apical-basal axis is essential for the adhesion,
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communication, vectorial transport, permeability and morphogenetic properties of
epithelia [18, 20].
Apical and basolateral domains are separated by an adhesive belt that encircles
the cell just below the apical surface, which is called the zonula adherens (ZA),
made of adherens junctions (AJs). At the core of AJs, E-cadherins mediate cell-cell
adhesion through homophilic interactions between their extracellular domains; the
cadherin cytoplasmic portion binds β-catenin, (Armadillo in Drosophila), that links
to α-catenin which in turn binds to F-actin connecting ZA to the cytoskeleton. Ver-
tebrate epithelial cells develop tight junctions (TJs) apical to the ZA. In Drosophila
epithelial cells no TJs are observed; instead the septate junctions (SJs) lie basal
to the ZA and form a region of close membrane contacts that extends over large
parts of the lateral plasma membrane domain. SJs and TJs share however some
functions in establishing solute barrier as well as regulating paracrine transport.
Vertebrates also posses a third epithelial junction, absent from invertebrate tissues,
the desmosomes, which mediate adhesion by linking intermediate filament network
to the plasma membrane. At cell basement, both in vertebrates and invertebrates,
Intergrins and Dystroglycan provide attachment to the basement membrane mainly
contacting one of its major components, Laminin [20, 21].
Extensive genetic analysis in Drosophila has led to the notion that establishment
and maintenance of cell polarity is mediated by the antagonising activity of three
main protein complexes: the Crumbs/Stardust/PatJ (apical), the Bazooka/Par6/
aPKC (sub-apical) and the Scribble/Dlg/Lgl (basolateral) complexes (Fig. 1.5).
Given the pivotal importance of epithelial cell polarity in animal development and
homeostasis, it is not surprising that the vast majority of the proteins involved in
its regulation are extremely conserved through evolution.
The Crumbs/Stardust/PATJ Complex This complex establishes the api-
cal identity of polarised cells and is required for AJs formation both in Drosophila
and mammalian epithelial cell lines. It consists of three main components: a trans-
membrane protein, Crumbs (Crb), and two adaptor proteins Stardust (Sdt) and
PATJ. Drosophila Crb is characterised by a large extracellular portion with thirty
epithelial growth factor (EGF)-like and four laminin A G-domain-like repeats and a
small conserved cytoplasmic region. In mammals three homologous genes have been
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Figure 1.4: Basic epithelial cell structure in invertebrates and vertebrates. The apical and
basolateral domains are marked in red and yellow respectively. Schematics of the lateral cell
junctions are also shown [20].
identified (CRB 1-3); they show tissue specific expression patterns (CRB3 is the
most widely expressed in epithelial tissues) and high levels of sequence identity with
Drosophila Crumbs are observed in the cytoplasmic domain. std encodes a MAGUK
(Membrane-Associated with GUanylate Kinase domain) protein with a PDZ (PSD-
95/Dlg/ZO-1), a SH3 (Src homology region 3) and a GUK (GUanylate Kinase-like)
domain which binds Crb intracellular domain. Similarly, CRB3 complexes with the
PDZ domain of Std mammalian homologue Pals1 (protein associated with lin seven
1). The third component is encoded by dpatj gene in Drosophila and two mammalian
homologues, PATJ (Pals-associated tight junction protein) and MUPP1 (multi-PDZ
domain protein) are also known to interact with Crb intracellular portion [18, 21].
The Bazooka/Par6/aPKC Complex In Drosophila, below the Crumbs/
Stardust/PATJ Complex at the sub-apical region, lies a complex composed of two
scaffold proteins, Bazooka (Baz) and Par6, both containing PDZ domains as well as
other protein-protein interaction motifs and an atypical protein kinase C, aPKC. Ge-
netic analysis has revealed that they are mutually dependent for proper localisation
and ZA formation. In mammals one Baz homologue (Par3), three Par6 homologues
(Par6α, β and γ) and two aPKC homologues (aPKcλ/ι and aPKCζ) have been
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found with differential expression patterns but mostly redundant functions.
In mammalian cells this complex localises to tight junctions and is required for
AJs formation as it is in Drosophila [18, 21].
The Scribble/Discs Large/Lethal Giant Larvae Complex In Drosophila
the three neoplastic TSG show identical loss of function (LOF) phenotypes as well
as a strong genetic interaction. Indeed, genetic analysis demonstrated that they act
in a common pathway linking cell polarity and cell proliferation control in epithelial
cells [22]. They all encode scaffolds rich in protein-protein interaction domains.
Scribble belongs to the LAP (Leucine-rich repeats And PDZ domain) family and
has four PDZ domains at the C-terminus and sixteen LRR (Leucine-Rich Repeats)
at the N-terminus; it is encoded by a single gene both in Drosophila and mammals.
Dlg is a MAGUK protein and contains three PDZ an SH3 and a GUK domain.
Four mammalian homologues of Drosophila Dlg have been identified so far (Dlg 1-
4). lethal giant larvae encodes a protein, Lgl, rich in WD40 repeats predicted to fold
into two β-propeller domains at the N-terminus. The mammalian genome encodes
two Drosophila Lgl homologues: Lgl-1 and Lgl-2 (also known as Hugl-1 and Hugl-2)
which also contain WD40 repeats and have distinct expression patterns [18, 21].
Fly and human proteins show the significant global sequence similarity of 62.5% if
conservative aminoacid changes are taken into account and conclusive evidence of
the functional conservation between the two proteins is found in the full rescue of
the null lgl mutant by the human Lgl-1 cDNA [23]. Analogous rescuing ability has
been demonstrated also for rat Dlg [24] and human Scrib [25].
In Drosophila it has been demonstrated that the three proteins are mutually
dependent for correct localisation [22] although direct physical interactions have
never been proved. Dlg and Scrib localise at the membrane cortex, at Drosophila
septate junctions. Lgl colocalises with Dlg and Scrib at septate junctions but its
localisation is not restricted to the cortex but it is also found in the cytoplasm.
In neuronal synapses Scrib has been shown to bind Dlg via a protein named GUK
Holder. In mammalian epithelial cells they are also localised in the basolateral
domain of the plasma membrane and, similarly to the fly counterparts, the exact
nature of their physical interaction has yet to be established; so far direct binding
has only be proven for Scrib and Lgl-2 [18, 21].
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Figure 1.5: Schematic representation of Drosophila polarity complexes. The Crumbs/Stardust
complex identifies the apical domain of the plasma membrane; the Bazooka(Par3)/Par6/aPKC
localises at the subapical region while the Scribble/Dlg (Discs Large)/Lgl (Lethal Giant Larvae)
complex lies in the basolateral domain. Details on how apical-basal cell polarity is regulated by
these complexes are given in the text. Apical and basal sides as well as cell junctions are indicated
[26].
Regulation of Cell Polarity The Scrib/Dlg/Lgl complex functions in es-
tablishing basolateral domain identity antagonising the activity of the other two
polarity complexes. Their mutually exclusive activity is required for the correct for-
mation and positioning of cell junctions, which in turn provide cells with a correct
apical-basal and cytoskeletal structure [18] (Fig. 1.5).
The mechanism through which these complexes regulate each other was initially
investigated in Drosophila neuroblasts, the larval neuronal progenitors [27]. These
cells do not have cell junctions but require a compartimentalisation of membrane
domains in order to perform asymmetric cell division. These membrane complexes
are required for proper positioning of cell fate determinants that will differentially
segregate into the daughter cells giving origin to a new stem cell (self-renewal) and
to a ganglion mother cell (GMC), the neuron/glia precursor. Failure to segregate
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cell fate determinants due to lgl LOF results in excessive self-renewal and thus ab-
normal expansion of the neuroblast population [28]. It was demonstrated that Lgl
localisation at the plasma membrane depends on its phosphorylation in conserved
residues by aPKC of the Baz complex [27]. Phosphorylated Lgl assumes an autoin-
hibited conformation in which protein interaction domains are masked and is thus
excluded from the cortex. Lgl in turn counteracts aPKC activity by sequestering it
in an inactive Lgl/aPKC/Par6 complex from which Bazooka is excluded [29]. The
phenotype observed in lgl -/- tissues can indeed be reproduced by expanding aPKC
activity domain in neuroblasts. The expression of a prenylated form, which is tar-
geted to the entire cell cortex, results in impairment of asymmetric cell division
leading to an excess of self-renewal and abnormal increase in neuroblast population
similarly to what happens in lgl -/- individuals [30].
The same is true for epithelial tissues. The lateral spreading of aPKC activity
causes cytoplasmic release of Lgl from the basolateral membrane leading to hy-
perproliferation and massive overgrowth in the wing disc and deep morphogenetic
alterations in the adult wing [31]. Moreover, reduced aPKC levels can suppress
lgl -/- phenotype in the imaginal discs [32] and a non-phosphorylatable form of Lgl
completely fails to rescue mutant phenotype in embryos lacking both maternal and
zygotic lgl [33]. The Crb complex is recruited by the Baz complex to the apical
domain and seems to further antagonise the activity of the lgl complex by blocking
its spreading along the lateral membrane domain. Crb is phosphorylated by aPKC
and this event is required for its correct apical localisation [18].
As expected from the high level of functional conservation, mammalian Lgl-1
and Lgl-2 are also excluded from the apical domain due to aPKC phosphorylation
and bind Par6 and aPKC preventing their association with Par3 and thus the ba-
solateral spreading of apical complexes [18].
Lgl is also part of the actin cytoskeleton network, linking it to the cell cortex, as
it interacts with non-muscle myosin II heavy chain both in Drosophila and human
cells [29, 34]. Furthermore, it was observed in fly neuroblasts a negative genetic
interaction between lgl and zipper (Drosophila myosin II gene): delocalisation of
basal determinants in lgl -/- cell can be rescued reducing the dosage of zipper [35].
Nevertheless, the importance of Lgl in Myosin regulation and the effects of Lgl loss
in cytoskeletal architecture in epithelial cells have yet to be elucidated.
Lgl yeast homologues SRO7 and SRO77 have been shown to bind the t-SNARE
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protein Sec9p, involved in the fusion of transport vesicles at plasma membrane and
SRO7/SRO77 double mutants show accumulation of post-Golgi vesicles within the
cytoplasm [36]. An intriguing possibility is that Lgl may contribute to generation
and maintenance of basolateral domain identity regulating polarised exocytosis of
vesicles containing specific proteins. There is evidence of Lgl being involved in De-
capentaplegic (Dpp) signal exocytosis, the fly TGF-β (Transforming Growth Factor
β) homologue, as lgl activity seems to be required in those cells producing Dpp
and not in those which respond to the morphogen, and to function downstream dpp
transcription and upstream Dpp receptor, Thickveins [37]. Direct demonstration of
Lgl involvement in vesicle trafficking has however yet to be found in Drosophila and
mammalian cells.
1.2.1.2 lgl in Tumourigenesis
lethal giant larvae was the first Drosophila tumour suppressor described in liter-
ature: it was identified by Hadorn in 1938 and its neoplastic phenotype was charac-
terised in depth by Elizabeth Gateff following the isolation of a spontaneous locus
deletion named lgl4 [14] and the gene, located in the sub-telomeric region of the
second chromosome’s left arm, cytologic position 21A, was cloned and characterised
by Mechler in 1985 [38].
lgl loss of function causes neoplastic overproliferation of both imaginal epithe-
lia and neuroblasts of the larval brain. These structures not only show excessive
growth but also loss of apical-basal polarity and tissue architecture which result in
an extended larval period and pre-pupal lethality. Cell growth appears to be slow
in lgl mutants; 5 days-old lgl -/- wing discs indeed contain about one third cells with
respect to the wild-type counterpart [15]; despite this, since lgl -/- cells are unable to
exit cell cycle, after many additional days of proliferation, discs reach an enormous
cell number and eventually form large amorphous masses which fail to form proper
cellular contacts and do not differentiate (Fig. 1.6). lgl mutants also show loss of
positional clues since, in lgl defective discs, cells straddle the anterior-posterior com-
partment boundary [39], which separates two independent developmental units that
never intermix. Moreover they are able to fuse with nearby tissues, i.e. haltere and
third leg discs, so displaying local invasiveness [14]. lgl -/- larval brains are twice as
big as wild-type ones and overproliferating neuroblasts spread to all regions causing
a disorganised brain structure and never differentiate into neurons [30].
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Figure 1.6: A wild-type (left) and a lgl4 (right) imaginal wing disc. Overgrowth and loss of
monolayered organisation and tissue architecture are evident in lgl mutant epithelium.
lgl and Proliferation Understanding how loss of cell polarity and control of
cell proliferation are linked would represent a relevant advance in the comprehension
of the molecular bases of cancer development. Overgrowth might be hypothesised
to be a direct consequence of loss of cell polarity in lgl mutant tissues. Loss of mem-
brane compartimentalisation could indeed alter distribution of diffusible signals that
regulate proliferation and their receptors, delocalisation of signalling molecules both
on cell surface and within the cytoplasm could result in simultaneous deregulation
of several different pathways so triggering changes in cell metabolism and prolifera-
tion rate. Moreover, disruption of the adherens junctions could impinge on contact
inhibition, known to restrict cell division. Nevertheless, several lines of evidence
exist that demonstrate a specific signalling function of the Dlg/Lgl/Scrib module
in proliferation control. First of all, disruption of polarity by other means does not
induce overproliferation in imaginal discs, mutation of E-cadherin being the best
example [40]. Furthermore, alleles of lgl, scrib and dlg were identified in a screening
for dominant suppressors of a hypomorphic mutation of cyclin E, a key regulator of
G1-S phase transition [41], implying a direct role in negative regulation of cell cycle.
Indeed lgl -/- clones in the eye disc (see below) show ectopic Cyclin E expression and
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thus ectopic S-phases without losing apical-basal polarity [42] demonstrating that
loss of proliferation control is not a direct consequence of polarity loss, at least in
this context.
Recently it was demonstrated that the proliferative defects in the eye disc de-
scribed above are due to the deregulation of the Hpo pathway, a very conserved
signalling network that plays a central role in the control of epithelial tissues prolif-
eration, establishing for the first time a direct link between lgl and cell proliferation
control [43].
The Hpo pathway (Fig. 1.7) is composed of two core kinases, Hpo and Wts
(Warts), the adaptors Sav (Salvador) and Mats (Mob As a Tumour Suppressor)
and the transcriptional co-activator Yki (Yorkie) and it is modulated by numerous
upstream factors among which the cytoskeletal proteins Ex (Expanded) and Mer
(Merlin) and the atypical cadherins Ft (Fat) and Ds (Dachsous). When the path-
way is active Hpo can phosphorylate and activate Wts which in turn phosphorylates
Yki sequestering it in the cytoplasm; on the other hand, upon its inactivation un-
phosphorylated Yki can translocate to the nucleus and activate the transcription of
its target genes involved in cell growth, proliferation and resistance to apoptosis such
as cyc E, dMyc, dIAP1 (Drosophila Inhibitor of APoptosis 1 ) and the microRNA
bantam. Yki is thus a growth promoter, whereas the upstream components act as
tumour suppressors by antagonising the growth-promoting activity of Yki [44].
Lgl was indeed shown to take part in the regulation of this pathway: lgl mutant
cells in the eye imaginal disc show upregulation of Hpo pathway target genes as
cyc E and dIAP1 as well as genes belonging to the negative feedback loops such
as ex ; consistently in lgl -/- cells Yki was found to localise also in the nucleus and
the phosphorylated form levels were reduced. Removal of one copy of yki partially
reduced Hpo target genes upregulation as well as the ectopic S-phases phenotype
previously described [42], indicating that Yki activity is required for lgl -/- prolifera-
tive defects. Yki activation in lgl -/- cells seems to be due to Hpo mislocalisation and
to the hypothetical formation of an inactive complex with RASSF (Ras associated
factor), another regulator of the pathway, also mislocalised in mutant cells [43].
lgl -dependent regulation of Yki has also been observed in the wing imaginal disc
but it was proposed to occur through a different mechanism [45]. lgl depletion-
dependent tumours were generated by specifically knocking down lgl transcript in
the posterior compartment of the wing disc leading to overgrowth and loss of cell
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polarity. In these posterior cells Yki was mainly localised to the nucleus and Hpo
pathway reporter genes were upregulated. Indeed knockdown of Yki or overexpres-
sion of Wts in this context blocked the overgrowth and resulted in discs with reduced
posterior compartment and high levels of cell death suggesting that Yki activity is
required for growth and survival of lgl -depleted cells. Interestingly Yki activation
was found to be due to JNK (c-Jun N-terminal kinase) signalling, a conserved stress-
induced pathway the activation of which is a common feature of neoplastic TSG loss
[46] (see Section 1.2.2 for a detailed discussion of JNK functions in tumour develop-
ment). Two explanations have been proposed to account for this differences in Yki
regulation upon lgl depletion in the eye vs wing imaginal discs: first, in the experi-
mental conditions employed in the wing disc cell polarity was lost whereas this was
not the case in the eye disc (in addition Hpo seems to have a different localisation
pattern in the two tissues); second, wing and eye discs seem to have a different
sensitivity to JNK signalling since its direct activation is able to regulate Yki in
the wing disc only [45]. lgl may thus regulate cell proliferation by influencing the
Hpo pathway in a tissue specific manner through JNK-dependent and independent
pathways. scrib loss of function however induces JNK-independent impairment of
the Hpo pathway both in eye and wing imaginal discs [47]. It thus seems that the
cross-talk between cell polarity proteins, JNK signalling and the Hpo pathway are
complex and possibly context dependent and further work is needed to clarify this.
lgl and Invasion/Migration Involvement of the Scrib/Dlg/Lgl complex in
migratory behaviour has been proven in different epithelial contexts. Maybe the
most striking example is given by the migratory behaviour displayed by mutant
epithelia upon transplantation into naive hosts [48]. Indeed both lgl -/- brain and
imaginal tissues show this capability.
An attempt to quantify this metastatic potential was made by E. Woodhouse
and colleagues: marked brain fragments were found to be highly metastatic, giving
rise to 1-6 secondary tumours in 87% of transplanted hosts, mainly in the thorax and
abdomen (gut and ovaries) but also in head, wing and leg. Transplanted imaginal
discs formed secondary lesions in 43% of hosts, mostly in the abdomen where they
invaded gut and ovaries. Lineage analysis of these lgl -/- suggests that only a small
fraction of the cancer cells (less than 2%) displayed this metastatic behaviour [48].
Since the open circulatory system of the insect calls into question the possibility of
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Figure 1.7: Schematic representation of the Hpo pathway. The core of the pathway composed
of the kinases Hippo and Warts and the adaptors Salvador (Sav) and Mats converges on the
phosphorylation of the transcriptional co-activator Yki preventing it from translocating to the
nucleus where it binds its alternative partners Scalopped (Sd), Homothorax (Hth) and Teashirt
(Tsh) and activates target genes. Some of the upstream modulators of the pathway are also
represented: the atypical cadherins Fat and Dachsous (Ds); the unconventional myosin Dachs, the
adaptor proteins Rassf, Kibra, Merlin and Expanded, and the apical (Crumbs) and basolateral
(Lgl, Scrib and Dlg) polarity complexes. AJ: Adherens Junctions, BLJ: Basolateral Junctions.
Adapted from [44].
a passive transport of cancer cells to distant sites, a second and more reliable in
vivo assay to test metastatic abilities of cancer cells was developed [49]. Only those
metastases occurring in the host’s ovaries were taken into account. The Drosophila
ovary consists of 16-20 ovarioles surrounded by a peritoneal sheath of cells. Each
ovariole is in turn surrounded by a muscle layer allocated between two layers of
extracellular matrix flanking the basement membrane of the follicular epithelium.
Since cancer cells have to pass through all these continuous layers to colonise the
ovaries, the recovery of metastases within these organs is stricter evidence of ac-
tive invasion. Transplanted lgl mutant cells formed metastases in 15.8% of ovarioles
analysed and all of the hosts examined had at least one ovariole invaded. By extend-
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ing the proliferation time of primary tumours through serial transplantations into
multiple hosts, the frequency of metastases increases significantly. This, together
with lineage analysis (see above), highlights the possible requirement of additional
genetic lesions to promote invasion, very similarly to what happens in mammalian
tumourigenesis. Karyotypic instability, including increased polyploidy and aneu-
ploidy, was also observed in lgl mutant tumour cells after serial transplantations
into adult hosts [14].
Secretion of Collagenase IV [50] and Matrix Metallo-Proteinase 1 (MMP1) [51]
has also been observed in lgl -/- mutant tissues: these two proteins are involved in
basement membrane type IV collagen degradation and have been implicated in sev-
eral stages of tumour progression in mammals such as angiogenesis, proliferation and
metastasis (see Section 1.1). MMP1 appears to be essential for lgl -/- cells spreading
because lgl ; MMP1 double mutant cells show a strong reduction in the ability to
leave primary lesions [51].
lgl -/- invasive phenotype was taken as a starting point from which to isolate
novel genes involved in tumour formation and metastasis. A mutagenesis screening
was carried out to search for second locus mutations that regulated lgl malignant
behaviour upon transplantation of larval tissues into adult wild-type hosts. In-
terestingly, one of the genes identified to be required for metastasis formation is
semaphorin 5c (sema5c). Sema5c protein contains extracellular thrombospondin
type I repeats, known to regulate TGF-β signalling in mammals. Indeed, whereas
lgl null mutant primary tumours show an increased Drosophila TGF-β homologue
Dpp signalling, in lgl ; sema5c double mutants Dpp signalling levels are comparable
to wild-type tissue. This implicates the Dpp/TGF-β signalling pathway in cancer
emergence as it is known to happen for many types of human malignancies, where
TGF-β appears to switch from an antiproliferative, pro-apoptotic function to an
oncogenic role during cancer progression [52].
The employment of temperature sensitive lgl alleles has allowed to investigate
this gene’s phenotypes also during early embryonic development when the heterozy-
gous mother can supply enough protein to sustain early stages of development thus
masking the LOF effects. Development of embryos from eggs laid at 29°C by lgl ts3
homozygous females was blocked at germ band shortening resulting in a so called
“shrimp-shaped” embryo, where head involution and dorsal closure were also af-
fected [22, 53].
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In the follicular epithelium, mutation of lgl and dlg, besides resulting in loss of
apical-basal cell polarity and overproliferation, causes cells to actively migrate across
the germ line [22, 53, 54]. These movements resemble that of normal border cells
(BCs) migration; BCs are a follicular epithelium subpopulation which udergoes a
very stereotyped migration from the anterior pole of the egg chamber towards the
oocyte. During normal BC migration, however, adherens junctions are retained
(partial EMT) and cells migrate as a cluster, while lgl and dlg mutant follicular
cells adherens junctions become diffusely redistributed and cells invade mainly as
a stream and less frequently as highly disorganised clusters [54]. Also in this case,
control of cell polarity, proliferation and invasion seem to be independent functions
exerted by the proteins since partial LOF dlg mutants cause follicle cells to accu-
mulate in multilayers without invading; these cells indeed lose polarity implying
that this phenomenon is not sufficient to induce migration [55]. Furthermore, pro-
liferation does not appear to be essential for invasion, as clusters of dlg -/- cells are
observed to delaminate and migrate without overproliferating, also indicating that
these movements are active and not a mere mechanical consequence of cell stacking
[54, 55]. Loss of cell polarity in follicular cells due to LOF of members of any other
polarity complex (i.e Bazooka, Crumbs and E-cadherin complexes) does not induce
invasion [54], confirming a direct role for the Scrib/Dlg/Lgl complex in repression of
migration during oogenesis. Indeed, lgl -/- and dlg -/- BCs are also shown to migrate
faster than wild-type cells [56]
Zhao and colleagues [57] performed a wide genetic screen to identify pathways
downstream of the basolateral complex. They screened for loci enhancing invasion
in a dgl hypomorphic background and identified lgl, scrib and two genes not pre-
viously associated: roughened eye (roe) and warts. Interestingly, scrib displayed a
less strong enhancement than lgl implying that the two might not be physiologically
equivalent in this context. roe encodes a zinc-finger protein of the Kru¨ppel-family,
possibly a transcription factor and may thus represent the first identified nuclear
target of the complex. warts encodes a serine-threonine kinase known to act as a
tumour suppressor in imaginal epithelia belonging to the Hpo pathway (see above).
It is particularly interesting as it shows a strong genetic interaction with dlg (compa-
rable to that of scrib) but, in the follicular epithelium, it seems to act downstream of
the Scrib/Dlg/Lgl complex, independently of the Hpo pathway. Phenotypic analysis
revealed that scrib, wts and roe, differently from lgl and dlg, act only in repressing
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EMT and proliferation but not in repressing motility [57].
lgl and the Tumour Microenvironment As reported in Section 1.1, the
interactions occurring between mutant cells and their microenvironment are prov-
ing to play a key role in tumour development. In Drosophila an extremely powerful
genetic tool, namely clonal analysis [58], is available to generate marked patches of
homozygous mutant tissue in an otherwise heterozygous background, allowing to
investigate the complex crosstalk between mutant and wild-type tissue. Indeed lgl
LOF clonal behaviour appears to be quite different compared to that of the whole
mutant animal, at least in some contexts.
In the eye imaginal disc, lgl -/- clones show ectopic proliferation but maintain
apical-basal cell polarity. Overall clonal size is however not affected since increased
cell death is also observed. If clones are induced in a background heterozygous
for a Minute mutation, prominent loss of cell polarity occurs and several individuals
undergo extended larval period and die as giant larvae very similarly to the homozy-
gous mutant [42]. The Minute mutations are dominant, homozygous lethal, LOF
mutations of different ribosomal proteins. Heterozygous Minute cells are viable but
display a slow growing phenotype [59] (see Section 1.4.3). The authors hypothesise
that this background, delaying development, induces several extrarounds of cell pro-
liferation in lgl -/- clones, completely depleting maternal protein. This would suggest
the existence of a threshold level of Lgl protein, sufficient to sustain the function in
cell polarity maintenance but not that in proliferation control [42].
A different clonal behaviour in the eye disc was also observed for scrib LOF:
clones lose polarity and overproliferate but very little mutant tissue is recovered in
the adult eye as it is removed during development by JNK-mediated apoptosis (see
Section 1.2.2). Blocking JNK pathway in these clones greatly increases the amount
of mutant tissue and results in lethality. Interestingly, cell death is induced in a
non-autonomous manner by the surrounding wild-type tissue since upon its removal
scrib clones viability is rescued [60].
A mechanism to explain JNK non-autonomous activation in scrib or dlg clones
was provided by Igaki and colleagues [61] who linked the elimination of mutant cells
to a phenomenon they named Intrinsic Tumour Suppression (ITS) which consists in
the endocytic activation of Eiger (Egr), Drosophila TNF (Tumour Necrosis Factor),
a known activator of JNK pathway. scrib-/- or dlg -/- clones generated in an egr null
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background no longer die but overgrow and develop into tumours; the same effect
was observed in the wing imaginal disc. Mutant cells were found to have increased
endocytic activity and Egr was mislocalised and enriched at the endocytic vesicles.
Egr localisation correlated with intense phosphorylated and thus activated JNK
staining. Indeed inhibition of endocytosis by means of a dominant negative form
of Rab5 (an early endosomal marker) abolished JNK activation and mutant clones
elimination, allowing tumorous growth. Ablation of surrounding wild-type tissue
prevented endocytosis upregulation and Egr/JNK-dependent cell death in scrib-/-
implying the existence of tumour suppressive mechanisms able to sense polarity de-
ficient cells and trigger their elimination [61].
The differences between lgl -/- clones and whole mutant tissues are even more
striking in the imaginal wing disc. X-rays induced clones generated in a wild-type
background do not show aberrant growth or morphological abnormalities at all in
adult wing, possibly due to extensive cell death of mutant cells [62]. Again, gen-
eration of clones in a Minute background results in aberrant cell-cell interactions,
straddling of the anterior-posterior border, failure to differentiate and abnormal
growths in adult wings [39]. These differences clearly underline the great impact
that interactions between mutant and wild-type tissue have in tumour progression.
Figure 1.8: A Wild-type egg chamber (left) and an egg chamber of the same stage bearing lgl
loss of function clones; lgl mutant follicular cells grow as a multilayer and invade the germ line
territory [15].
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Interestingly, differently to what happens in eye and wing imaginal tissues, lgl clonal
behaviour in the follicular epithelium appears to be rather similar to that of the
whole mutant tissue. Indeed, lgl -/- clones overproliferate to form large multilayers
with loss of cell polarity and invade between nurse cells [15, 22] (Fig. 1.8). A two-
fold increase in the number of S-phase follicle cells is observed in mutant clones with
respect to wild-type tissue; phosphorylation of H3 histone (a marker for mitotic
cells) persists after stage 6, when wild-type cells have already exited cell cycle, and
increased cyclin E is also detected. Moreover, in agreement with their viability, lgl -/-
clones upregulate dIAP1 [57].
These data suggest that also the context in which the interaction between mutant
and wild-type tissue takes place has great relevance in clonal output.
Mammalian Lgl-1 and Lgl-2 Several lines of evidence showing mislocalisa-
tion, decreased expression or loss of Lgl-1/2 in primary human tumours seem to
indicate that they play a role in mammalian tumourigenesis. Indeed Lgl-1 tran-
script results decreased or completely absent in a wide variety of human epithelial
malignancies such as breast, lung, prostate, ovarian cancers and melanomas [23, 63].
It has also been implicated in colorectal cancer progression where it was found to be
associated with advanced stages and lymph node metastases [64]. Its loss has been
correlated with reduced survival in glioblastoma [65] and the occurrence of aberrant
splicing variants with hepatocellular carcinoma progression [66]. Moreover Lgl-1
subcellular localisation seems to play a crucial role as its cytoplasmic localisation
correlates to aPKC lateral spreading and to cancer progression in ovarian carcinomas
[31]. This clearly drives a strong parallel with the phenotypes observed in Drosophila
lgl epithelial cancers. Interestingly, pronounced similarities with Drosophila lgl mu-
tant were also found in Lgl-1 knock-out (KO) mice. Lgl-1 -/- individuals presented
at birth severe brain dysplasia due to an abnormal expansion in the number of
progenitor cells, unable to exit cell cycle and to differentiate. These cells formed
neuroepithelial rosette-like structures, similar to the neuroblastic rosettes found in
human primitive neuroectodermal tumors (PNETs) occurring at pediatric age [67].
Noticeably, human Lgl-1 gene maps to 17p11.2, a region often shown to undergo
chromosomal breakage in human PNETs [34]. Lgl-2 has been found to be a negative
target of ZEB1, a master regulator of EMT [68] suggesting that its loss in epithelial
cells may favour the acquisition of mesenchymal, migration-prone behaviour.
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All these data strongly support the notion that also mammalian lgl homologues
act as TSG so giving a major relevance to Drosophila lgl mutant in the study of
human tumourigenesis.
1.2.2 Cooperative Oncogenesis
The definitive confirmation of Drosophila as a model for cancer research came
with the development of the MARCM (Mosaic Analysis with a Repressible Cell
Marker) technique [69] which allows to induce somatic clones in which LOF mu-
tations of tumour suppressor genes and overexpression/activation of oncogenes are
simultaneously present. This, together with classic clonal analysis experiments,
allowed to demonstrate that also in Drosophila transformation requires the accumu-
lation of multiple genetic lesions and debunked the previously accepted view of the
“single-hit” tumourigenesis model derived from observation of whole mutant tissues’
phenotypes of the neoplastic TSGs (see above).
The first models Two seminal studies published in 2003 unveiled a strong
cooperation between scrib, lgl and dgl mutations and the constitutively activated
form of ras proto-oncogene, RasV12, in tumour growth and metastatic behaviour
[60, 70]. In the first one Brumby and colleagues [60] showed that GFP-marked
clones mutant for scrib generated in the eye disc grew poorly and were eliminated by
JNK-dependent cell death (see above), however when RasV12 was expressed within
mutant clones, these where able to overgrow in three dimesions and formed large
masses that never differentiated and fused with nearby tissues leading to the death of
the individuals as giant larvae. Clones expressing RasV12 alone overgrew but formed
non invasive tumours. The authors observed the same effect on scrib null cells upon
activated Notch expression (found to be dependent on Ras activity) but not upon
the expression of other growth-promoting pathways such us Dpp and Wg (Wingless,
Drosophila WNT homologue), indicating a specific cooperation between scrib-/- and
activated Ras. Interestingly, expression of a constitutively activated form of Raf
(Raf ACT), one of Ras signalling effectors which acts upstream of the MAPK cascade
(see Section 1.3.1) in scrib mutant clones fully recapitulated the scrib-/-; RasV12 phe-
notype, whereas overexpression of PI3K (Phosphatidyl Inositol 3 Kinase), the other
main downstream effector, did not, indicating the key role of the MAPK branch
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in cooperating with scrib loss. Cell cycle promoters such as CycE and E2F were
found to be necessary to the tumorous phenotype but not sufficient to drive it if
overexpressed in scrib-/- clones, even in the presence of apoptosis inhibitors. The
activity of specific targets downstream of Ras signalling and not its generic ability
to promote proliferation while inhibiting cell death may thus be required to promote
this oncogenic cooperation [60].
Pagliarini and colleagues [70] obtained very similar results in an attempt to
identify mutations able to promote metastatic behaviour of non-invasive RasV12 ex-
pressing clones in the eye disc. Indeed when the expression of activated Ras was
combined with scrib, dlg or lgl null mutations, clones grew aggressively and became
highly metastatic. They displayed a consistent invasion of the ventral nerve cord, an
area of the larval brain not immediately adjacent to the eye disc, active basement
membrane degradation was observed and cancer cells (Fig. 1.9) were also found
to spread and colonise other tissues, including the tracheal system. Similar pheno-
types were obtained upon the inactivation of other polarity regulators underlining
the key role of cell polarity loss in inducing metastatic behaviour. In fact, malignant
cells also showed a lowered expression of E-cadherin, a hallmark of EMT, and its
overexpression was sufficient to block invasion in scrib-/-;RasV12 clones; E-cadherin
deprivation however was not sufficient to drive invasion of activated Ras-expressing
cells. Again, expression of proliferation promoters, such as Myc, Akt or E2F as well
as apoptosis inhibitors in scrib mutant clones, despite increasing clone size failed to
induce the metastatic behaviour observed for scrib-/-;RasV12 cells [70].
The oncogenic cooperation between scrib loss and constitutively active Ras was
shown to be conserved in organotypic cultures of human epithelial cells. Non-
transformed MCF10A breast epithelial cells, when cultured in reconstituted base-
ment membrane, differentiate into polarised, hollow acini. Coexpression of RasV12
(or Raf ACT) and a Scribble knock-down construct (ScribbleKD) in these cells induced
invasive behaviour through the extracellular matrix with formation of protrusions
that projected out from the acinar structure [71].
The role of JNK signalling As reported above and in Section 1.2.1 scrib mu-
tant cells grown in a clonal context are eliminated by non-autonomous JNK-induced
cell death [60, 61]. JNK signal transduction pathway is an evolutionarily conserved
stress-induced MAPK cascade that has roles in multiple cellular processes includ-
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Figure 1.9: The oncogenic cooperation between scrib loss of function and activated Ras reported
by Pagliarini and colleagues. As shown by Laminin A and Collagen IV stainings (red), scrib-/-;
RasV12 cells (GFP+ in D-F) are able to degrade the basement membrane indicating that these
cells have acquired an invasive behaviour. The two genetic alterations alone (GFP+ in A-C) are
not sufficient to provide mutant cells with these properties [70].
ing proliferation, differentiation, morphogenesis, and most of all, apoptosis, and has
been implicated in several aspects of tumour development. The Drosophila only
JNK protein Basket (Bsk) is phosphorylated and activated by the upstream JNK
kinase (JNKK) Hemipterous (Hep) which is in turn a substrate for several upstream
JNKKKs that respond to a variety of internal and environmental stimuli. Activation
of this cascade results in phosphorylation of several JNK targets among which the
AP-1 family transcription factors Jun and Fos and is negatively regulated through
a negative feedback loop by the phosphatase Puckered that is itself a Jun/Fos tran-
scription target [46].
With the aim of understanding the possible role of JNK signalling in tumour
development Uhlirova and colleagues [72] analysed the effect of constitutive activa-
tion of the pathway in the RafACT; scrib-/- context. While increased JNK signalling
further enhanced the elimination of scrib mutant clones in the eye disc giving rise to
a wild-type adult eye, its effect on Raf ACT; scrib-/- was rather peculiar. Increasing
apoptotic cell death reduced clone size and abolished aggressive expansion of mutant
cells and thus pupal lethality but adult heads and eyes of these flies displayed massive
hyperplasia of wild-type tissue. This might be due to the non-autonomous compen-
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satory proliferation induced by JNK activation in adjacent cells to replace the dying
ones, as demonstrated in other contexts [73], in addition to a cell-autonomous effect
in promoting apoptosis; activated Raf would in this case attenuate JNK-dependent
apoptosis delaying cell death and thus boosting compensatory proliferation of the
surrounding wt tissue [72].
Nevertheless, the experimental paroxistic activation of JNK signalling in RafACT;
scrib-/- clones, by inducing massive amounts of cell death, might have masked the
cell-autonomous role of this signalling cascade in tumour development. Indeed a
few papers were subsequently published which demonstrated that JNK signalling
activation due to scrib loss is the key factor in this oncogenic cooperation and it
switches from pro-apoptotic, and thus tumour suppressive, to tumour promoting in
presence of oncogenic Ras signalling [74–77]. Similarly to scrib LOF clones, also in
scrib-/-;RasV12 malignant clones JNK pathway is strongly activated but while block-
ing it in scrib-/- cells abolished cell death and allowed overgrowth [60], blocking it in
the scrib, lgl or dlg -/-;RasV12 background completely abolished invasion of the VNC,
dramatically reduced growth and restored differentiation. Thus cell polarity loss
results in JNK activation which, if constitutive Ras signalling is present to abolish
its pro-apoptotic effect, induces invasive behaviour and stimulates growth.
Several lines of evidence seem to indicate that JNK signalling promotes invasion
by upregulating MMP1 expression in a Fos-dependent manner and thus basement
membrane degradation: inhibition of MMP activity either by genetic inactivation
or by expression of MMP inhibitors also abolished invasiveness of mutant clones
[75, 76]. Moreover growth and invasion seem to be separable effects since inhibition
of MMP1 activity blocked invasion without affecting growth [74, 75] and vice versa
insulin signalling disruption inhibited growth but did not inpinge on the metastatic
capabilites of cancerous cells [74]. Whether JNK activation is per se sufficient to
cooperate with Ras in inducing invasion may depend on the strength of the activa-
tion itself (too high levels would induce massive cell death and mask the effect) and
thus remains a matter of debate [74, 75, 77, 78].
Concerning the growth promoting capability of JNK activation, a mechanism
through which it is achieved was identified in its ability to activate JAK-STAT
signalling, a conserved proliferation-promoting pathway. scrib-/-;RasV12 (but also
lgl -/-;RasV12) clones showed upregulation of the unpaired (upd) genes which encode
JAK/STAT-activating cytokines and JNK-dependent activation of a JAK-STAT re-
32 1. Introduction
porter. Not only reduction of JAK-STAT activity completely abolished growth and
invasion of mutant clones, but upd genes overexpression was sufficient to cooperate
with Ras to give large invasive tumours which were insensitive to Bsk depletion, plac-
ing cytokines production and JAK-STAT activation downstream of JNK signalling
in this cooperation model. The authors also demonstrated that STAT function is
required in the compensatory proliferation induced by scrib mutant cells elimina-
tion in the eye disc as adult eyes are smaller in size if mutant clones are induced
in a STAT - background and thus propose that JAK-STAT activation downstream
of JNK represents a mechanism to ensure recovery after damage through compen-
satory proliferation that explains the development of scrib-/-; RasV12 tumours [79].
Interestingly, similar results were obtained even when scrib loss of function and Ras
activation occurred in adjacent clones rather than in the same cells. JNK signalling
induced in scrib mutant cells was proven to be able to propagate (also explaining
the non-autonomous JNK activation often observed upon scrib clonal loss [60]) and
promote Upd production in adjacent RasV12-expressing cells thus sustaining growth
even after scrib deficient cells were eliminated by JNK-dependent cell death (see
above) [79]. This indicates that oncogenic cooperation can also occur when genetic
lesions do not coexist in the same cell and since it is well known that human can-
cers are often composed of genetically heterogeneous cell populations, this findings
might be relevant to gain a better understanding of the interactions between these
populations.
Overgrowth has also been proposed to be a consequence of the extended larval
period that scrib-/-;RasV12 clones-bearing animals undergo and thus would be due
to the JNK-dependent block in differentiation rather than to a direct effect in cell
growth [78].
Notably, a role in disrupting epithelial cell polarity has also been suggested for
JNK signalling activity downstream of lgl loss of function, despite not in a clonal
context. Upon inhibition of the Hep/JNK/Fos cascade, besides reversion of the
tumour-like phenotype (overgrowth and invasion), localisation of polarity markers
as well as epithelial folding were also partially restored in whole lgl -/- imaginal discs
[80]. Similar results were also obtained by Sun and Irvine [45]. Nevertheless, rescue
of polarity defects was not observed upon JNK inhibition in a scrib LOF clonal
context [47] and JNK activation alone is not sufficient to induce loss of cell polarity
[45]; further analysis will therefore be required to fully address this aspect of JNK
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function.
Since JNK signalling is implicated in human cancer development [81] it is likely
that this oncogenic cooperation model represents a relevant tool for a better under-
standing of the mechanisms behind JNK function in tumourigenesis.
The role of the Hpo pathway Similarly to what has been demonstrated for
lgl and scrib loss of function phenotypes (see Section 1.2.1.2), deregulation of the
Hpo pathway also seems to contribute, at least in part, to the overgrowth that char-
acterises the oncogenic cooperation between activated Ras/Raf and polarity genes
loss [47, 82, 83]. Dogget and colleagues found that Yki target genes were upregu-
lated in scrib-/-; Raf ACT (or RasV12) tumours in the eye imaginal disc and inhibition
of Yki activity significantly reduced tumour growth. However, despite this reduc-
tion of tumorous mass, mutant clones were still able to invade and differentiation
remained blocked indicating that Hpo pathway impairment does not contribute to
these phenotypes. Moreover the fact that the growth of these clones was not to-
tally abrogated by blocking Yki function suggests that other pathways may also
be involved in driving scrib-/-; Raf ACT cells clonal expansion in this context [47].
In another study analysis of large overgrown and fast-proliferating lgl -/-; RasV12
clones in the wing disc revealed an evident Yki nuclear staining and, accordingly, a
strong upregulation of its target genes dIAP1 and dMyc. The authors did not test
whether Yki was required for the overgrowth of lgl -/-; RasV12 clones but showed that
its expression within lgl -/- clones is sufficient to promote it [82]. Similarly scrib-/-;
RasV12 clones in the wing disc also showed upregulation of Yki target genes and Yki
overexpression was able to promote overgrowth of scrib mutant cells [83].
The role of PI3K signalling Several lines of evidence seem to indicate that
the Raf/MAPK pathway is the downstream branch of Ras signalling involved in
the cooperation with polarity genes loss [47, 60, 72]. While activated Raf fully re-
capitulates Ras-mediated phenotypes, induction of PI3K signalling pathway (the
other main branch, see Section 1.3.1) can only moderately increase scrib-/- clone
size but is not sufficient to promote their malignant growth [60, 70, 74]. Its ability
to promote growth but not invasion is confirmed by the reduction in tumour size
upon its disruption in scrib-/-;RasV12 clones which however still display metastatic
capabilities [74].
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Interestingly, in a screening attempting to identify genes required for neoplas-
tic tumour growth which employed a modified version of the scrib-/-; RasV12 tu-
mour model, PI3K signalling was found to be absolutely indispensable for tumorous
growth [84]. The authors induced overgrowth by coexpressing RasV12 and a dlg
RNA interference construct (dlgRNAi) throughout the eye disc (using the Flp-out
technique [85]); silencing PI3K or other downstream members of the pathway, such
as Akt, severely reduced growth in this context resulting in eye discs much smaller
than the wild-type ones and, accordingly, knockdown of the negative regulator,
PTEN, enhanced overgrowth. On the other hand manipulation of the pathway in
wild-type discs only had mild effects. These results were also confirmed inducing
dlgRNAi; RasV12; pi3k -/- MARCM clones. This dependency on PI3K signalling
was neither observed in RasV12 or dlgRNAi eye discs nor in large overgrown discs
obtained coexpressing dlgRNAi, Yki and Upd where reduction of PI3K levels had
a less pronounced effect, indicating that it is a specific feature of dlgRNAi; RasV12
cells. Surprisingly dlgRNAi; RasV12 discs showed low levels of activated Akt sug-
gesting that RasV12 expression is not able to activate PI3K pathway if cell polarity
is compromised; according to the authors this paradoxical result could indicate that
PI3K signalling is rate-limiting in dlgRNAi; RasV12 tissue overgrowth and hence
explain the sensitivity to its alterations they observed [84].
Interactions with the immune system In 2008 the interesting observation
that scrib-/-;RasV12 clones in the eye disc displayed many cells on their surface that
did not belong to the tumour led to the discovery that Drosophila innate immune
system cells, the hemocytes, specifically associate with the tumorous mass [86].
They were mainly found to adhere to areas where basement membrane was com-
promised and consistently they were also found on scrib mutant tissues, where BM
degradation is observed, but not on RasV12 clones. Mechanical disruption of BM as
well as expression of MMP1 also caused hemocytes recruitment confirming the role
of BM alteration in this process. Interestingly, the number of circulating hemocytes
in scrib(or lgl)-/- ;RasV12 and scrib mutant larvae was dramatically increased; the
authors demonstrated that JNK activation in the tumour induced local as well as
systemic activation of JAK-STAT signalling, through the production of cytokines,
that was in turn responsible for hemocytes hyperproliferation. This mechanism was
also proved to be true for tissue damage-dependent JNK activation pointing towards
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the existence of an innate mechanism of response to tissue damage that can be trig-
gered both by tumours and wounds [86].
Some indications were also given that hemocytes recruitment functioned in re-
stricting tumorous growth of scrib mutant imaginal disc but definitive evidence
for a role of hemocytes in tumour development came in a subsequent paper where
Cordero and colleagues [87] demonstrated that tumour associated hemocytes are
stimulated to produce Eiger that is sufficient to induce MMP expression in tumour
cells and may have two different outcomes according to the context. lgl mutant
clones in the wing disc display increased viability and aberrant morphology upon
hemocytes-specific egr knockdown indicating that in this case it functions in elim-
inating mutant cells probably by activating JNK as it was demonstrated for scrib
mutant clones [61] (although in that case Eiger activation was attributed to au-
tocrine production of Egr itself). On the contrary Egr depletion, blocking JNK
activation, completely abolished invasion and MMP1 expression and restored pu-
pation of scrib-/-;RasV12 clones-bearing larvae, confirming that Egr/JNK signalling
acquires a tumour-promoting role in presence of oncogenic Ras. In this latter case,
however, for technical reasons, egr function was abrogated in the whole individual
and thus a specific role for hemocytes-produced Eiger can only be speculated by the
observation that transfusion of egr+/+ hemocytes was sufficient to induce MMP1
expression in scrib-/-;RasV12 clones generated in egr -/- individuals [87]. These data
add evidence to support the notion that tumour cells hijack organismal self-defence
mechanisms to promote growth and invasion.
Other RasV12 cooperators Besides polarity regulators, other genes have
been recently added to the list of Ras-cooperating tumour suppressors. Loss of
function of genes belonging to the Class C VPS (Vacuolar Protein Sorting) pathway,
involved in lyosomes delivery and degradation, cooperate with RasV12 to promote
growth and invasion. This cooperation was found to be specific as it did not occur
with dMyc or Insulin pathway activation. The authors were also able to confirm
the role of lysosomes degradation impairment in oncogenic cooperation by showing
that administration of drugs that block this process promoted tumour progression
and metastasis of cells expressing oncogenic Ras [88].
A genome-wide screen for enhancers of RasV12 hyperplastic phenotype in the
eye imaginal disc allowed to identify several genes among which Rac1, Rho1 and
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RhoGEF2, all involved in cell morphology regulation, that when overexpressed clon-
ally cooperated with activated Ras to induce overgrowth and invasion [78].
Interestingly the cooperation between RasV12 and both loss of function of lysoso-
mal delivery genes and gain of function of morphology regulators depends on JNK
activation since growth, invasion and differentiation blockade are abolished upon
coexpression of a dominant negative form of Bsk, further underlining the key role
of this pathway in tumour development [78, 88]. It will be interesting to investigate
how JNK signalling is activated in these contexts.
1.3 Ras Signalling Pathway
Ras family proteins are membrane-associated guanine nucleotide-binding pro-
teins involved in extracellular signals transduction. They belong to the small GT-
Pase proteins (or G proteins) class and function by switching from GDP-bound to
GTP-bound state. Extracellular signals are received by membrane-bound receptors
which activate guanine-nucleotide-exchange factors (GEFs). GEFs are in turn able
to transiently activate Ras by promoting its association with GTP. Activated GTP-
bound Ras undergoes a conformational change and is able to recruit and activate its
downstream effectors. Under physiological conditions Ras signalling is terminated
when bound GTP is hydrolysed to GDP and the bound effectors are released. GTP
hydrolysis is stimulated by GTPase-activating proteins (GAPs) [89, 90].
Ras signalling has been shown to promote a wide variety of cellular functions
among which cell growth and proliferation, survival, migration and differentiation,
hence it is not surprising that Ras-activating mutations are found in approximately
30% of human malignancies. Tumour-associated Ras mutations cause persistent
GTP binding and thus constitutive signalling to downstream effector proteins; one
of the best examples is the glycine-to-valine mutation at residue 12 which results in
the highly oncogenic RasV12 variant [89, 90].
Mammalian genomes contain three Ras proto-oncogenes which encode H-Ras,
K-Ras and N-Ras proteins, highly related to each other [89, 90]; Drosophila has
three Ras homologues, but only Ras1 (also known as Ras oncogene at 85D and
hereafter referred as Ras) has substantial homology to mammalian Ras proteins
(75% identity) [91] and the same effectors [92].
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1.3.1 Ras Effectors
Given its undisputed involvement in tumourigenesis, Ras proteins are perhaps
the best studied molecules in molecular oncology and among the first transforming
oncogenes to be identified [93]. The continuously increasing body of work produced
to understand the mechanisms behind its pleiotropic effects demonstrated that GTP-
bound Ras can interact with and activate a wide range of molecules depending on
cell context but the two main downstream effectors, both in Drosophila and mam-
mals, are the Raf/MAPK signalling cascade and the PI3K pathway [94] (Fig. 1.10).
Figure 1.10: The two main pathways activated downstream of GTP-bound Ras: the Raf/MAPK
and PI3K cascades. P indicates phosphorylation. Details are in the text.
The Raf/MAPK signalling pathway is perhaps the best characterised Ras down-
stream effector. Raf proteins are serine/threonine kinases that activate the MEK-
MAPK kinase cascade. Activated MAPKs (or Extracellular signal Regulated Ki-
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nases, ERKs) can phosphorylate both cytosolic and nuclear substrates, which include
transcription factors such as JUN and FOS. Activation of these transcriptional reg-
ulators can lead to the expression of proteins that control cell-cycle progression, cell
survival and many other processes. The importance of this pathway downstream of
Ras-mediated tumourigenesis is highlighted by the fact that activated Raf and MEK
are able to transform different cell types and Raf-activating mutations are frequent
in human cancers and may be equivalent to those of Ras genes as their occurrence
never overlap [95].
GTP-bound Ras is able to directly bind the catalytic subunit of type I PI3Ks, a
family of kinases involved in intracellular Insulin signal transduction. This binding
results in the translocation of PI3K to the plasma membrane and subsequent activa-
tion. Active PI3K phosphorylates membrane phosphatidylinositol-4,5-bisphosphate
(PIP2) thus generating a second messenger, phosphatidylinositol-3,4,5-triphosphate
(PIP3), which in turn recruits and activates downstream effectors such as Akt by
binding to their pleckstrin homology (PH) domains. Akt is a protein kinase B (PKB)
that promotes growth and survival in many cell types regulating glucose and lipid
import and nutrient storage as well as inhibiting pro-apoptotic molecules. Similarly
to MAPK/ERK, PI3K pathway is also found deregulated in many human cancers
and has shown in different contexts to be required for Ras-induced transformation
[95, 96].
Drosophila activated-Ras also signals through Raf/MAPK and PI3K signalling
although it does not seem to be required, with some exceptions, to maintain physi-
ological levels of this latter [92, 97].
Among the other pathways activated by mammalian Ras there is also the JNK
signalling cascade, however, this does not seem to be the case for Drosophila coun-
terparts [74].
Both in flies and mammals Ras signalling affects very different aspects of cell
physiology and behaviour. In Drosophila, Ras has been shown to promote processes
as diverse as proliferation, migration and differentiation even in the same cell type.
Just to give a few examples, it regulates cell fate and patterning of follicular cells
[98], it is required for photoreceptors differentiation [99] and in the imaginal wing
disc it promotes both proliferation [100, 101] and cell fate determination [102]; in
adult life it is involved in maintenance and proliferation of intestinal stem cells [103,
104]. The specificity of these effects depends on the cellular context: different cell-
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specific regulators and downstream targets as well as specific subcellular localisation
of pathway components can influence the outcome, moreover also the amplitude and
duration of the signalling impact on its effects [105–107].
1.3.2 Mechanisms of Oncogenesis
Extensive analysis of the effects of oncogenic Ras signalling on cell behaviour of
the past decades has unveiled its capacity to contribute to most of the hallmarks of
cancer discussed in Section 1.1 [90].
Sustained Proliferation The ability to promote cell cycle entry in absence of
growth factors in mammalian cells was attributed to constitutive Ras activity since
the very early studies. It was subsequently shown that it is able to promote prolif-
eration in several ways including transcriptional upregulation of growth factors and
their receptors, activation of transcription factors that regulate genes involved in cell
cycle progression such us c-Myc and CycD1, activation of pathways that regulate
the stability of these genes’ products and inhibition of cell cycle inhibitors [90].
Similarly, also activated Drosophila Ras promotes cell proliferation. In the wing
and eye imaginal disc cells RasV12 ectopic expression is sufficient to drive cell prolif-
eration and cause hyperplastic growth of the tissue [100]. Its clonal expression in the
wing disc has been shown to increase cell size and growth rates and to promote G1/S
transition. These effects are mediated by its ability to increase post-transcriptional
levels of dMyc (see Section 1.4.2) and Cyc E [101]. Moreover Ras is required for pro-
liferation and maintenance of Drosophila adult intestinal stem cells and it is involved
in regeneration upon tissue damage downstream of EGFR (Epidermal Growth Fac-
tor Receptor) in the adult midgut [103, 104].
Evasion of Cell Death Ras ability to promote cell survival is well documented
in mammalian cells. Both Raf/MAPK and PI3K signalling pathways contribute by
inhibiting a wide range of pro-apoptotic factors as well as activating anti-apoptotic
ones [90].
In Drosophila one major target for the anti-apoptotic activity of Ras is the pro-
apoptotic Head Involution Defective (Hid) protein. Active Hid induces apoptosis by
binding to and inhibiting dIAP1, an essential inhibitor of Caspases in Drosophila,
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through stimulation of its auto-ubiquitination. Hid is transcriptionally downregu-
lated as well as post-transcriptionally inactivated via phosphorylation by MAPK
signalling [108, 109]. It has also been proposed that inhibition of JNK signalling
contributes to Ras anti-apoptotic effects [110].
Angiogenesis As mentioned in Section 1.1, hypoxic cancer cells can induce
proliferation of endothelial cells and sprouting of new blood vessels by releasing
VEGF. Under physiological conditions, low oxygen tension leads to stabilisation
of the pro-angiogenic transcription factor HIF1α (Hypoxia-Inducible Factor 1α) by
inhibiting the prolyl hydroxylases which would otherwise prime it for degradation.
HIF1α is a potent activator of VEGF promoter. Secreted VEGF triggers angiogen-
esis by binding and activating VEGFR downstream signalling in endothelial cells
[111]. Indeed, oncogenic Ras signalling is able to upregulate VEGF, via HIF1α and
other VEGF regulators, as well as other endothelial growth factors such as FGF2.
Moreover Ras activity promotes angiogenesis by producing inflammatory cytokines
that contribute to the recruitment of angiogenic growth factors-releasing immune
cells [90].
In Drosophila oxygen is transported to the tissues through a tracheal system
that consists of an interconnected tubular network made of epithelial monolayered
tubes, the regulation of which shares significant similarities with that of mammalian
angiogenesis, with Drosophila FGF/FGFR (FGF Receptor) cascade performing a
function analogous to that of VEGF/VEGFR [112, 113]. Drosophila Ras signalling
has shown to be cell-autonomously required for tracheal cells migration [114] but no
evidence exists for a role in tracheogenesis.
Tracheal network development begins during embryogenesis and depends on
three main processes: directional cell migration, cell rearrangements and cell shape
changes. Clusters of tracheal cells in the embryo are specified by the expression of
the transcription cofactor, Trachealess (Trh) [115] a direct target of STAT [116]; Trh
is phosphorylated by Akt and this event is required for its nuclear localisation and
transactivating abilities [117]; Trh in turn activates the transcription of breathless
(btl) gene which encodes the Drosophila FGFR. Surrounding epithelial cells pro-
duce the FGF ligand (encoded by branchless, bnl) which activates Btl and stimulate
directional migration and branching of tracheal cells by activating Ras signalling
through a tracheal-specific adaptor protein called Dof (Downstream-Of-EGFR, also
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known as Stump) [112–114]. The FGF/FGFR signalling pathway is also involved
in later phases of tracheal development, during larval life, and is required for pro-
liferation and migration of tracheoblasts of the air sac, a sac-like structure which
develops attached to the wing imaginal discs and will originate large reservoirs con-
nected with the flight muscles of the adult fly. Air sac cells are induced to proliferate
by, migrate and extend filopodia towards a group of FGF/Bnl-expressing epithelial
cells of the wing imaginal disc; also in this case FGFR/Btl signalling in tracheal
cells requires downstream Ras activity and the transcription factor Pointed [118];
despite being essential, Ras activation is however not sufficient to promote FGF/Bnl
dependent cell migration, indicating that additional downstream effectors might be
required to induce chemotactic movements of tracheal cells [114]. Recently it has
also been demonstrated that heparan sulphate proteoglycans (HSPGs) are necessary
to respond to FGF/Bnl [119].
Drosophila tracheal network has also been shown to respond to oxygen require-
ments: while shape and size of the tubes are genetically determined, fine terminal
branches form in response to local hypoxic conditions. Oxygen deprivation induces
FGF/Bnl expression which acts as a chemoattractant for terminal branches. The
mechanism is strikingly similar to that of mammalian angiogenesis: hypoxia is sensed
by prolyl hidroxilases that stabilise Sima, Drosophila HIF1α, which then activates
FGF/Bnl expression to attract new terminal branches towards the expressing cells
[113]. Terminal branching of tracheal cells depends on the formation of long cyto-
plasmic processes with intracellular lumen which connect to the lumen of the main
branches and are regulated by blistered, the fly homologue of serum response factor
(SRF), known to regulate sprouting in mammalian angiogenesis [120]. It is however
still not known how FGF signalling coordinates these cell rearrangements.
Migration and Metastasis Many metastatic tumours contain Ras mutations
and oncogenic Ras signalling has been implicated in promoting migration and metas-
tasis in several contexts mainly by downregulating E-Cadherin, a hallmark of EMT,
and altering cytoskeletal dynamics. Moreover BM remodelling enzymes are also up-
regulated downstream of Ras activation [90].
In Drosophila Ras has been linked to physiological migration of tracheal cells
(see above paragraph, [114]), border cells in the ovary [121] and primordial germ
cells in the embryo [122], downregulation of E-Cadherin has also been observed in
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scrib-/-; RasV12 clones [70]. Nevertheless, in imaginal epithelia production of BM-
modifying enzymes has been observed in RasV12-expressing cells only in the context
of cell polarity loss (see Section 1.2.2).
Metabolism Reprogramming and Immune Surveillance Evasion Sev-
eral lines of evidence also implicate Ras in the regulation of the two emerging hall-
marks: deregulation of metabolism and evasion of immune destruction. Oncogenic
Ras-dependent regulation of HIF1α is indeed responsible for the stimulation of the
glycolytic shift often observed in tumour develoment, known as the Warburg effect.
HIF1α enhances both glucose uptake, metabolism and intermediates processing [90].
Moreover Ras activity was shown to reduce immunogenicity of cancer cells in differ-
ent ways, for example by decreasing surface antigen-presenting MHC (Major Histo-
compatibily Complexes) [90]. Neither of these two effects have been observed so far
downstream of activated Ras in Drosophila.
1.4 Myc and Cell Competition
1.4.1 Myc Oncogene
Myc family proteins are evolutionarily conserved basic helix-loop-helix leucin
zipper (bHLH-Zip) transcription factors that coordinate several key cell functions
such as cell cycle progression, growth, metabolism, differentiation, apoptosis. Gen-
erally they heterodimerise with their binding partners of the Max proteins family
and control target genes expression by binding to regulatory regions, called E-Box
sequences; E-Box- and Max-independent functions of Myc have however also been
reported.
Mammals possess three members of this family: c-Myc, N-Myc and L-Myc. c-
myc gene is ubiquitously expressed in dividing cells and normally downregulated
in quiescent and/or differentiated cells; on the other hand N-Myc and L-Myc are
expressed only during particular stages of embryonic development and in some im-
mature hematopoietic and neuronal cells [123–125]. For this reason c-Myc will be
further considered in this review and referred to as Myc.
Recently it has been estimated that Myc regulates 10-15% of all genes and is re-
sponsible of genome-wide chromatin remodelling and is thus able to promote global
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changes in gene expression, confirming its master role in controlling cell physiology
and behaviour [123, 125, 126]. Consistently, Myc is found deregulated in a strikingly
high percentage of human malignancies and is often associated with aggressive and
poorly differentiated tumours. For this reason, together with Ras, it is one of the
most intensely studied molecules in cancer biology [123, 124, 127].
Oncogenesis Three decades of research have proved that Myc is a master
regulator of cell growth and proliferation. From the early observations that Myc
expression was sufficient to drive quiescent cells into S-phase in the absence of mi-
togenic signals, much progress has been made to understand the complex biology
behind Myc activity and its substantial implication in tumour development [127].
Myc targets genes involved in cell cycle progression like cyclins, Cdks (cyclin-
dependent kinases) and their regulators, it participates in DNA replication and is
a key promoter of cell growth; it indeed regulates protein synthesis acting on ribo-
somal RNA (rRNA) and rRNA-processing factors, ribosomal proteins, tRNAs and
translation initiation and elongation factors. Myc is also a positive regulator of the
glycolytic pathway as well as of the oxygen-dependent mitochondrial energy produc-
tion chain. Moreover it has been clearly implicated in maintenance and self-renewal
of stem cells and in suppressing differentiative programmes [123, 124].
Evidence exists that Myc can regulate cell migration and invasion in different
ways, in some contexts it was shown to promote EMT and to regulate cell adhe-
sion and cytoskeletal dynamics [128]. Myc has been implicated in several events
involved in cross-talk with the tumour-microenvironment and a clear and direct link
has also been established between Myc activity and both physiological and tumour-
associated angiogenesis [129]. Moreover a context dependent interplay between Myc
and HIF1α has been described in tumour development: whereas under physiologi-
cal conditions HIF1α inhibits Myc, it has been reported that in oncogenic contexts
they can either cooperate in promoting both the Warburg effect and angiogenesis
through the release of factors such as VEGF [130] or antagonise each other [131].
Since very early in the history of its research, Myc has also been shown to coun-
teract senescence and promote immortalisation. Finally, not only Myc contributes to
nearly all the hallmarks of cancer, it also activates a complex inflammatory response
[129] and intensifies mutation rates by inducing high degree of genomic instability
[132], the two characteristics that favour and accelerate tumour development (see
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Section 1.1).
Myc is therefore an extremely potent oncogene and its upregulation is often
accompanied by increased levels of cell death, most probably as a safe-guard mecha-
nism evolved to protect cells from the detrimental effects of its uncontrolled activity.
The detailed mechanisms by which Myc triggers the apoptotic programme are still
unclear although its ability to repress transcription of anti-apoptotic genes is well
documented [123, 124]. The existence of these tumour-suppressive mechanisms is at
the basis of the requirement of multiple genetic lesions for full tumourigenic transfor-
mation and accounts for the well-known oncogenic cooperation between activated
Ras signalling and Myc in human cell lines: oncogene-induced senescence caused
by Ras is suppressed by Myc activity and, in turn, Ras provides cells with strong
survival hints which counteract Myc-induced cell death [123, 124].
Regulation Due to its biochemical properties, Myc deregulation in human
cancers does not usually derive from activating mutations in its coding sequence as
is true for Ras (see Section 1.3) but rather to an increase in its protein levels that can
be caused by gross genetic abnormalities such as enhancer insertions, chromosomal
translocation and gene amplification, or by deregulation of signalling pathways that
control its expression and mRNA and/or protein stability [127]. Since most, if not
all, oncogenic signalling pathways regulate Myc at some level, it is not surprising
that abnormal Myc levels and activity are found in a strikingly high percentage
of human cancers [125]. Indeed, under physiological conditions Myc abundance is
tightly regulated through the integration of several signals acting at transcriptional,
post-transcriptional, translational, and post-translational levels [123, 125].
myc is generally expressed at extremely low levels in quiescent cells and it is
rapidly induced by mitogenic signals. Myc promoter is regulated by a multitude
of pathways, depending on cell type and physiological context. A few examples of
myc transcription activators are Wnt, Notch, interleukins, cytokines, growth factors,
hormones, Ras/MAPK and PI3K/Akt, JAK-STAT and NF-kB signalling pathways,
all major cell proliferation-promoting pathways; on the other hand it is inhibited by
antiproliferative factors such as TGF-β and p53 [125].
Both Ras/MAPK and PI3K/Akt pathways, among many others, also regulate
Myc post-transcriptionally. They are able to enhance its translation, increasing
ribosomal recruitment of myc mRNA, and its protein stability [125, 133]. Myc pro-
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tein, in fact, undergoes a very rapid turn-over with a half-life of 20-30 minutes.
This turn-over is regulated by phosphorylation events at two conserved sites: thre-
onine 58 (Thr-58) and serine 62 (Ser-62). Phosphorylation at Ser-62 increases its
stability whereas concomitant phosphorylation at Thr-58 and dephosphorylation at
Ser-62 targets Myc for proteasomal degradation. Indeed, Erk downstream of Ras
signalling can increase Myc protein stability by phosphorylating it at Ser-62 whereas
PI3K pathway can do so by inhibiting GSK-3β, which is responsible for the phos-
phorylation event at Thr-58. [123, 125, 133]. Enhanced protein stability is often
observed in cancers associated with abnormal Myc levels and its importance is high-
lighted by the fact that the factors that regulate its proteolytic turn-over are often
lost in many malignancies [134].
1.4.2 Drosophila Myc
dmyc (also known as diminutive, dm) encodes the single Drosophila homologue
of the Myc family of proto-oncogenes [135]. dMyc has proven to be functionally ho-
mologous to c-Myc, it can indeed rescue growth defects in c-Myc knock out mouse
embryo fibroblasts [136], can functionally substitute for c-Myc in transactivation
assays in human cell culture [137] and can cooperate with activated Ras to trans-
form rat embryo fibroblasts [138]. Moreover, human c-Myc can rescue dmyc loss of
function lethality [139]. Similarly to human Myc proteins, dMyc regulates its target
genes forming heterodimers with its partner, Max, and binding to the E-boxes [135].
Functions Consistent with a well conserved role in regulating growth and pro-
liferation, dmyc loss of function causes strong growth defects; null embryos hatch
into larvae but are not able to grow further and die at early second larval instar.
Individuals bearing weakest alleles show delayed development and reduced body
size. Conversely, overexpression of dMyc increases animal dimensions by 30% [140].
Clonal analysis has revealed that dmyc-/- cells are of smaller size and have an im-
paired cell cycle progression. Indeed dMyc is required to stimulate G1-S transition;
its overexpression increases Cyclin E levels and accelerates S phase entry [140]. Cy-
clin E regulation appears to be post-transcriptional as mRNA levels do not markedly
increase, but other cell cycle regulators, such as CycD and its partner Cdk4, are
transcriptionally activated by dMyc. Overall division rate is however not altered
probably because G2 inducer Cdc25 phosphatase (String) is not affected by dMyc
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levels and a compensatory lengthening of G2 phase occurs [101].
Also in Drosophila dMyc plays a fundamental role in regulating basic cellular
growth machinery. Its overexpression, as opposite of its loss of function, considerably
increases cell size accelerating growth through regulation of several factors involved
in RNA binding, rRNA processing, nucleolar function, translation and, above all,
ribosomal biogenesis [141, 142].
In the ovary, dmyc is required for efficient DNA endoreplication in follicle cells,
but it seems not to be essential for their mitotic proliferation. dmyc-/- follicle cells
are unable to perform more than one cycle of endoreplication, moreover they show
a dose-dependent reduction in nuclear and cell size [143].
Another parallel between mammalian and Drosophila Myc can be found in the
regulation of stemness: high dMyc levels are observed both in germline stem cells
[144, 145] and in larval neuroblast [146]. These cells undergo asymmetric cell divi-
sion that originates another stem cell and a daughter cell, the cystoblast and the
ganglion mother cell respectively, which will then commit to a specific cell fate; in-
deed dMyc levels are dramatically reduced in daughter cells of both types, moreover
dMyc constitutive expression in germ line daughter cells confers them stem cell-like
features indicating that also in Drosophila Myc is able to suppress differentiation
[145].
The capability of Myc to sensitise cells to various apoptotic stimuli is another
conserved feature of its activity and, consistently, imaginal wing disc cells with in-
creased dMyc expression are subject to high levels of autonomous cell death [147]. It
is not clear how dMyc promotes cell death but its overexpression has been linked to
the upregulation of dIAP1 inhibitors such as Hid, and Hid function has been shown
to be required for dMyc-dependent cell death of imaginal wing disc cells [147, 148].
Regulation dmyc transcriptional regulation is not as well understood as it is
that of c-myc but in recent years a few key signalling pathways have been implicated
in the regulation of dmyc transcription.
During imaginal wing disc development dmyc is initially expressed in all cells
starting from the second larval instar (L2), then its expression undergoes dynamic
changes and by the third larval instar (L3) it decreases in the ventral and dorsal
hinge regions while remaining high in the notum, the dorsal body wall primordium.
Concurrently dmyc expression increases in the wing pouch, the region that will orig-
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inate the wing blade. Towards the end of larval development, at the dorso-ventral
border - the future wing margin - dmyc is repressed in a stripe of cells, called ZNC
(Zone of Non-proliferating Cells) where growth and cell cycle are arrested [149].
This dynamic expression pattern seem to depend, at least in part, on the activity of
Wg and Notch pathways. In the ZNC dmyc is repressed by Notch signalling [150]
whereas in other regions Wg acts through a double repression mechanism, that is to
say by repressing Notch pathway which would in turn repress dMyc transcription.
Wg-dependent positive regulation of dMyc is also involved in wing disc regenerative
growth after damage [151] and in the control of the larval hematopoietic niche in
the limph gland [152]. Nevertheless the detailed mechanisms of these regulatory
events are still largely unknown, moreover in imaginal wing disc cells Wg has also
been implicated in dMyc repression and thus might have context-dependent effects
on dMyc transcription [153].
The RNA-recognition motif protein Half pint (Hfp) is a direct regulator of dmyc
as it binds to dmyc promoter and represses its transcription. Indeed, hfp knockdown
leads to increased dMyc levels and dMyc ablation can rescue hfp loss of function
phenotypes [154]. Since Hfp is upregulated by Wg signalling, this might account for
the repressive effect of this latter on dMyc transcription observed in some contexts
[155].
Recently, we and others identified dMyc as a direct transcriptional target of the
growth-promoting Hpo pathway (see Section 1.2.1.2) [156, 157]. We found that
dMyc protein was upregulated in Yki-overexpressing and in Hpo pathway mutant
clones and this correlated with an increase in dMyc mRNA; moreover hyperactiva-
tion of Hpo pathway members and thus repression of Yki function led to a reduction
in dMyc abundance [156]; dmyc promoter has consensus binding motifs for Scalloped
(Sd), a Yki DNA-binding partner and indeed these motifs were shown to be directly
bound by Yki/Sd complex [157] and consistently, we found that knockdown of Sd
in the wing disc prevented dMyc upregulation upon Yki overexpression in the wing
pouch; conversely in the notum we found that dMyc regulation depended on the
ability of Yki to bind another partner, Homothorax (Hth), highly expressed in this
region [156]. dMyc transcriptional upregulation plays a key role in mediating the
growth-promoting capabilities of Yki as its ablation was sufficient to abolish the
overgrown phenotype due to Yki overexpression; nevertheless dMyc alone is not suf-
ficient to rescue yki -/- growth defects indicating that other Yki targets are required
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for an efficient promotion of cell growth [156, 157]. This regulation is likely to be
functionally conserved as c-myc appears to be upregulated in a murine model of Yki
mammalian homologue YAP-induced hepatocarcinoma [158].
Other factors have been shown to regulate dmyc expression in various tissues.
For example Twist transcription factor binds and activates dmyc promoter during
early mesoderm development [159] and dmyc transcription is systemically regulated
by nutrients signalling [160] and, in the fat body, by the moulting hormone Ecdysone
[161].
Finally, similarly to c-Myc, dMyc autorepresses it-self by negatively regulating
its own transcription [162].
Control over dMyc levels has also been demonstrated to occur via translational
repression mechanisms. In the cystoblast originated from the germline stem cell in
the Drosophila ovary, a translational repression complex containing Brat (encoded
by the brain tumour gene) has been shown to cause dMyc downregulaton by tar-
geting its mRNA [163]. Interestingly, dMyc repression in the ganglion mother cell
(derived from larval neuroblasts) also seems to be mediated by Brat [146] possibly
through a similar mechanism.
Like its mammalian counterpart, dMyc protein is subject to a very rapid turn-
over and has a half-life of 35 minutes in S2 cells [164]. Similarly to mammalian
c-Myc, dMyc stability its regulated, in vitro and in vivo, through phosphorylation
by GSK-3β (Shaggy, Sgg, in Drosophila) which results in dMyc ubiquitination and
proteasomal degradation. Notably, the same effect on dMyc stability is observed
upon phosphorylation by a member of the casein kinase 1 family (CK1), encoded by
discs overgrown (dco). Clonal inhibition of both Sgg and Dco causes an increase in
dMyc levels in imaginal wing discs, but only in those regions where Wg signalling
is not active. In fact, both kinases are negative regulators of Wg pathway and
probably since their inactivation leads to increased Wg levels this might lead to a
dmyc transcriptional repression [164]. dMyc ubiquitination depends on the activity
of Archipelago (Ago), the F-box component of the E3 ubiquitin ligase complex SCF
(Skp, Cullin, F-box); Ago’s human orthologue, Fbw7, is a tumour suppressor and
regulates c-Myc protein stability [165].
As mentioned in Section 1.3.2, activated Ras, via Raf/MAPK, increases dMyc
protein levels in the wing imaginal disc [92]. Since mammalian c-Myc is phospho-
rylated and stabilised by Erk (see 1.4.1), a similar mechanism can be hypothesised
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for dMyc, however dMyc sequence does not contain Erk phosphorylation consensus
sites and therefore other molecules downstream of Ras/Raf probably participate in
regulating dMyc stability in Drosophila [164]. Ras signalling seems to be required
to maintain physiological levels of dMyc in the wing disc cells since this latter is
downregulated in ras -/- clones [92]. In that context the authors also investigated
a possible cross-talk between dMyc and PI3K signalling but did not find any evi-
dence of reciprocal regulation [92]. Nevertheless, consistently with what is known in
mammalian systems, Drosophila PI3K pathway was shown to increase dMyc protein
stability by inhibiting the GSK-3β Sgg in cultured S2 cells and consistently ectopic
activation of PI3K pathway caused dMyc upregulation in imaginal wing disc cells
[166]. The discrepancy between these two reports might lie in the fact that the
analysis of dMyc levels was carried out with different time scales. In both cases
PI3K ectopic activity was clonally induced by overexpressing PI3K catalitic sub-
unit dp110, however, in the first report dMyc levels were analysed 48 hours after
clone induction [92] whereas in the second one an inducible system was employed
and dMyc abundance was tested after having induced dp110 expression for 5 hours
only [166]. This suggests that PI3K pathway transiently affects dMyc stability and
that dMyc levels in PI3K-overexpressing clones rapidly adjust to eventually nor-
malise by the end of development. Additionally, Parisi and colleagues showed that
the nutrient-sensing TOR pathway also converges on GSK-3β to positively regulate
dMyc protein stability [166].
Post-transcriptional regulation of dMyc in the wing imaginal disc may also oc-
cur via the micro-RNA bantam. bantam targets Mei-P26 mRNA for degradation.
Mei-P26 is the orthologue of mouse TRIM32, a c-Myc-ubiquitinating protein, and
its upregulation has been shown to lead to reduction of dMyc [167].
1.4.3 dMyc-Induced Cell Competition
Cell competition is a phenomenon of short-range cell-cell interaction described in
Drosophila imaginal wing discs over 30 years ago [59]. It consists in the elimination
during development of normally viable but slow-dividing cells by the surrounding
faster growing populations (Fig. 1.11), ensuring that the adult organ reaches proper
size.
It was initially observed analysing a group of dominant mutations called Minute
(M ) that concern various ribosomal protein genes. These mutations, affecting more
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than 60 loci in the Drosophila genome [168], are recessive lethal and display a
dominant growth defect: M+/- cells are viable but have a slow growing rate and
consequently M+/- flies are of normal size but their development is delayed with
respect to wild-type counterparts. However, if mitotic clones of M+/- cells are gen-
erated in a wild-type wing imaginal disc tissue, they are eliminated by apoptosis.
Compensatory proliferation in the wild-type tissue occurs to replace apoptotic cells
during competition, the total number of cells in the developing tissue remains un-
changed and no morphological alterations are observed in the resulting organ [169].
Moreno and colleagues [170] found in out-competed cells reduction in Dpp sig-
nalling. This pro-survival pathway, when activated, inhibits the transcription re-
pressor Brinker, that would otherwise lead to the activation of the JNK pathway,
ultimately causing death of the cells under competitive stress, that are eventually
lost from the epithelium [171].
Apoptosis is required for cell competition to occur; inhibition of cell death by
means of the baculovirus p35 IAP protein not only rescues M+/- cells from death
but also decreases neighbouring wild-type cells’ proliferation rate [170, 172]. Minute-
mediated cell competition seems also to require the elimination of apoptotic cells
by means of engulfment (phagocytosis) by surrounding tissue, as loss of function of
genes involved in this process prevents competition [172]; nevertheless basal extru-
sion of dead cells, the process by which apoptotic wing disc cells are physiologically
eliminated, has also been frequently observed [170].
The non-autonomous elimination of scrib mutant clones in the eye imaginal disc
is reminiscent of cell competition ([60] and Section 1.2.2). Indeed scrib-/- mutant tis-
sues overgrow in a homotypic context whereas mutant cells undergo JNK-dependent
apoptotic cell death if surrounded by wild-type tissue and the resulting adult eye is
unaffected. This clearly parallels the effects of M+/--induced cell competition in the
wing imaginal disc; competitive interactions have however never been characterised
in the eye imaginal disc and their involvement in scrib cells elimination can only be
hypothesised.
In recent years dMyc has been strongly implicated in the phenomenon of cell
competition [148, 171]. Clones bearing hypomorphic dmyc mutations, viable in a
homotypic environment, were found to be eliminated by non-autonomous cell death
when generated in a wild-type imaginal disc [140]. In 2004 two papers were pub-
lished in which it was clearly demonstrated that this phenomenon is not simply
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Figure 1.11: Mechanism of cell competition: slow-growing cells survive in a homotypic back-
ground (a) but are eliminated when surrounded by wild-type cells (b). However wild-type cells
can be outcompeted if surrounded by faster-growing cells (c) [183].
caused by cellular defects associated with dmyc loss because, as it was shown, also
wild-type cells are out-competed if surrounded by dMyc-overexpressing cells and cell
competition is rather triggered by a sharp difference in dMyc protein levels between
adjacent populations [148, 171].
de la Cova and colleagues [148] showed that clones overexpressing dMyc were sig-
nificantly larger than control clones, due to promotion of cellular growth; however,
sibling clones generated in recombination events were smaller than control siblings.
They also showed that wild-type cells appeared to be subject to competition only if
they lied within about eight cell diameters of dMyc-expressing cells (it was indeed
later demonstrated that cell competition is mediated by soluble factors [173]), and
in the same developmental compartment [148].
Using a dmyc tandem duplication, similar results were obtained by Moreno and
Basler [171] (Fig. 1.12). Sibling clones were generated that were composed of cells
with four (4xdmyc) or two copies (2xdmyc) of the endogenous dmyc gene. Interest-
ingly, not only 4xdmyc clones were significantly larger than their 2xdmyc wild-type
siblings but they were also larger than control clones that were induced simultane-
ously in different animals in which all cells carried four copies of dmyc. Likewise,
clones carrying two copies of dmyc were not only smaller than their 4xdmyc siblings,
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but also smaller than control clones growing in a background where all cells had two
copies of dmyc, demonstrating that clonal growth strongly depends on cellular envi-
ronment. As for Minute-mediated cell competition, Moreno and Basler found reduc-
tion of Dpp signalling in out-competed cells. They proposed the so-called “ligand
capture” model, according to which cells compete with different success for limiting
amounts of extracellular survival and growth factors, such as Dpp, by actively in-
ternalising them. “Winner cells”, due to their optimal growth status, would be able
to capture more survival factors than “loser cells” that, as a consequence, would
undergo JNK-mediated apoptosis. Accordingly to this hypothesis, overexpression
of the endocytic pathway component Rab5, as well as stimulation of the Dpp signal
transduction pathway, rescued wild-type cells from being eliminated by surrounding
cells with elevated dMyc levels [171]. Dpp involvement is however still controversial
as de la Cova and colleagues neither obtained evidence of Dpp signalling reduction
nor found JNK-mediated apoptosis to take place in out-competed cells [148].
Interestingly, Tyler and colleagues [174] demonstrated that mutations in genes
belonging to the Hippo pathway were able to protect M+/- cells from being out-
competed in a wild-type background and even to provide them with competitive
capabilities as indicated by active Caspase 3 staining visible outside the mutant
clones [174]. These competitive properties of Hpo mutant cell have been explained
by the identification of dmyc as a target of this pathway ([156, 157] and Section
1.4.2). Indeed we were able to demonstrate that dMyc upregulation is responsible
for Hpo mutant or Yki-overexpressing clones competitive behaviour as their over-
growth was drastically reduced if they were generated in a dMyc-overexpressing
background [156].
Similarly, other dMyc regulators have been found to trigger competitive interac-
tions. ras loss of function clones were found to be out-competed [92] probably due
to their lower levels of dMyc compared to neighbouring wild-type cells and miRNA
machinery mutant clones were subject to cell competition because of their inability
to repress dMyc negative regulator Mei-P26 [167] (see Section 1.4.2).
The differential expression of splicing variants of Flower (Fwe) surface protein has
been shown to be an early event of dMyc-mediated cell competition. Out-competed
cells are labelled with a truncated form of Fwe and this is necessary and sufficient
to trigger their apoptotic elimination [175]. Moreover in out-competed cells the
gene sparc is transcriptionally upregulated; it encodes a secreted multifunctional
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glycoprotein, Sparc, that seems to transiently protect these cells from apoptosis.
This mechanism would hypothetically allow cells that are subject to transient or
less intense stress to recover and thus avoid cell death [176]. Interestingly, truncated
Fwe and upregulation of Sparc are characteristic of loser cells both in Minute- and
dMyc-induced cell competition, suggesting that they might be part of a common
mechanism that senses differences in cell fitness within a tissue [175, 176].
Similarly to that of Minute, also for dMyc-induced cell competition to occur,
apoptosis is essential. When cell death is inhibited by reducing the gene dosage of
hid [148] or by ectopically expressing the antiapoptotic proteins dIAP1 or p35 [171],
out-competed clones grew larger while their competitive twins were smaller.
Why differences in dMyc protein levels among cells are able to trigger cell compe-
tition is still unclear. A simple difference in growth rate between neighbouring cells
is not sufficient to induce the phenomenon: overexpression of Cyclin D and Cdk4
indeed promotes cell autonomous growth but does not trigger competition. The
same is true for PI3K: clonal overgrowth is observed upon dp110 overexpression but
neighbouring cells do not result to be affected [148]. Thus, cell competition probably
depends on Myc ability to influence ribosomal activity. Indeed dMyc overexpressing
clones bearing only one copy of the Minute gene M(2)60E (a known dMyc transcrip-
tional target) were no longer able to out-compete surrounding cells [171]. Since it
was demonstrated that raising the copy number or expression level of a Minute gene
above wild-type had no effect on survival or proliferation properties of imaginal cells
[177], it can be hypothesised that a global rise of protein synthesis coordinated by
dMyc might be necessary for cell competition to occur. Nevertheless, the ability of
Hpo mutant cells to confer competitive capabilities to M+/- cells, which are partially
impaired in ribosomal biogenesis, argues against this hypothesis [174].
1.4.3.1 Cell Competition in Mammalian Cells
Evidence exists that cell competition is conserved also in mammals. It has
been shown in mice that a deletion within the Rpl24 riboprotein gene significantly
impairs ribosome biogenesis and results in decreased rates of protein synthesis and
proliferation, clearly mirroring Drosophila Minute phenotype. Heterozygous mutant
cells, while viable in a homotypic environment, giving rise to almost normal mice,
are indeed out-competed by wild-type cells in chimeric blastocysts [178].
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Figure 1.12: The experiment by which Moreno and colleagues showed that cell competition is
triggered by relative dMyc levels: clones carrying 4 copies of dmyc gene (4xdmyc) are larger than
their wild-type twin clones, 2xdmyc (B) but also larger than 4xdmyc clones induced in discs in
which all cells were 4xdmyc (C). Similarly wild-type (2xdmyc) clones were not only smaller than
their 4xdmyc twins clones (B) but also smaller than wild-type clones induced in a background
where all cells carried two copies of dmyc (A) [171]
Another example is given by rat liver progenitors transplants: under certain
conditions transplanted cells can overproliferate and induce cell death of the host
cells to an extent that the entire liver is repopulated by donor-derived cells [179].
Compelling evidence of cell competition occurring in mammalian cell cultures
has however been produced in two recent papers [180, 181]. These reports and their
implications will be discussed in Chapter 4 in the light of the results presented in
this thesis.
On the other hand, clear evidence of Myc-induced cell competition in mammals
akin of that described in Drosophila epithelia is still missing. Nevertheless, it was
demonstrated that in mice intestinal crypt, loss of APC (Adenomatous Polyposis
Coli) leads to unrestricted proliferation and even when only 10% of crypts are APC
deficient, several lesions and adenomas are recovered in the intestine. However,
if these crypts are simultaneously mutant for APC and c-Myc, they are rapidly
replaced by surrounding wild-type stem cells that repopulate the crypts, leading
to complete absence of pathological changes [182]. This, far from being a strict
demonstration of Myc-mediated cell competition in mammals, might still represent
a first hint of the existence of mechanisms, dependent on the coexistence of cell
populations with different Myc levels, able to restrain growth of cancerous cells.
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1.4.3.2 Cell Competition and its Relevance to Cancer
Myc expression is deregulated in a wide range of human cancers and is often
associated with aggressive, poorly differentiated tumours [123]. In the light of the
information above reported it is becoming increasingly evident that Myc induced
cell competition could play a role in cancer development [183, 184]. Clones of high
Myc expressing cells could expand at the expenses of the surrounding normal cells,
without generating morphological changes. Further, expansion may increase the
probability of accumulation of other mutations in subsets of cells that would confer
new oncogenic properties to their descendants, as predicted by the “cancerisation
field” theory. On the other hand, cell competition may represent a mechanism of
defence that tumour cells need to overcome in the very early steps of cancer onset
in order to survive within the tissue [183].
1.5 Aims of the Thesis
Cancer is a complex and heterogeneous disease and its development is linked to
dramatic alterations in cell physiology and behaviour. Such alterations arise from
the progressive accumulation of genetic lesions within the transforming cells but, as
it is becoming increasingly clear, they also strongly depend on the complex interplay
that occurs between cancer cells and their environment. Fine in vivo modelling of
these processes in mammalian systems is still far from being trivial and thus, given
the high degree of conservation of most, if not all, signalling pathways and regulatory
circuits compromised in cancer, the employment of easily manipulatable invertebrate
models represents a golden opportunity towards the understanding of basic cancer
cell biology.
During my PhD, I made use of the powerful genetic tools available in Drosophila
to model different stages of epithelial cancer development.
Loss of function of the conserved tumour suppressor gene lgl induces compro-
mission of cell polarity and tissue architecture, hyperproliferation and inhibition of
differentiation when mutant cells grow in a homotypic context. When embedded in
a wild-type context, however, these cells seem to display a rather different behaviour
and fail to develop into tumours. In the first part of this work I aimed to characterise
the tumour suppressive mechanisms responsible for counteracting lgl -/--dependent
tumour initiation.
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As well established in literature, activation of oncogenic Ras signalling within
lgl -/- cells unleashes their neoplastic potential and promotes the development of tu-
morous masses which display many of the hallmarks of human cancers. In the second
part of this work I thus employed this oncogenic cooperation model to investigate
the role of key signalling pathways in later traits of tumour development such us
tissue overgrowth and invasion.
Chapter 2
Materials and Methods
2.1 Model Tissues
2.1.1 The imaginal wing disc
Imaginal discs are larval epithelial organs that, following metamorphosis, give
rise to adult structures and appendages. The imaginal wing disc, precursor of the
adult wing, appears composed of a pseudostratified columnar epithelium made of
undifferentiated, proliferating cells that represent the actual imaginal disc, and by a
squamous epithelium that forms the peripodial membrane (Fig. 2.1). The first will
originate the integument and the wing, the second will originate the epithelial veil
that welds the structures [185].
When it is formed during embryonic development, the wing imaginal disc com-
prises around 20 cells [185]. These cells intensely proliferate during second and third
larval instars to generate a disc of around 50,000 cells in the late third instar (96h
after hatching). By this stage, the wing primordium is established and its major ele-
ments can be identified. The centrifugal regions will originate the dorsal and ventral
body wall thorax structures: notum and pleura. The middle region will give rise
to the hinge, while the central region, the wing pouch, is the presumptive territory
from which the wing lamina differentiates (Fig. 2.1, [185]); for this reason the wing
pouch is defined as the distal region of the wing disc while hinge and pleura are
considered as proximal.
The imaginal wing disc represents a widely used excellent model for studying
growth and proliferation control in epithelial tissues. It is morphologically and
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biochemically very similar to mammalian epithelia and it encounters a dramatic
increase in cell number in a relatively short length of time with an average cycle time
of 8.5 h [186]. Proliferation is random but uniform across the tissue and uniformly
ceases when correct disc size is attained [187].
Figure 2.1: A: A third instar imaginal wing disc. The presumptive regions that correspond to
the adult wing structures (shown in B) are labelled. Dorsal and ventral wing surfaces compose
the wing pouch. A cross section of the epithelium and the peripodial membrane is also shown
on the right. B: Adult wing. the different structures are coloured according to the presumptive
territories they originate from (shown in A). Longitudinal veins (L 1-5), anterior (A) and posterior
(P) compartments are also indicated. Adapted from [185]
2.1.2 The Follicular Epithelium
Drosophila female reproductive system is composed of two ovaries connected
through an oviduct to the uterus. The ovary is made of 15-20 ovarioles, each con-
taining a string of developing oocytes of progressive ages and consists of two regions:
the germarium, where the pro-oocyte originates, and the vitellarium, where the ma-
jor phases of oocyte growth and development take place [188] (Fig. 2.2).
In the egg chamber, the functional unit of oogenesis, the oocyte and fifteen
germ-line-derived nurse cells (whose function is to synthesise materials to supply
the growing oocyte) are surrounded by an epithelium of somatic origin, the follic-
ular epithelium (Fig. 2.3). The follicular epithelium is a monolayered columnar
2.1 Model Tissues 59
Figure 2.2: Confocal image of an ovariole consisting of egg chambers at progressive stages of
development. F-Actin cytoskeleton and nuclei are labelled in green and red respectively. The
germarium (Germ.) is shown at higher magnification. Stages (St.) from 9 to 14 are indicated
[189].
epithelium that carries out some essential functions in oogenesis: follicular cells se-
crete the eggshell, produce its specialised structures and, above all, provide oocyte
with patterning signals [188]. The majority of follicle cells proliferate until stage 6
to form a uniform epithelium of about 1000 cells. By stage 7, they cease prolifera-
tion and enter 4 rounds of endocycle, after which they begin to acquire different cell
fates.
Figure 2.3: Schematics of a stage 10 egg chamber. The oocyte, nurse cells and follicular epithe-
lium are labelled. Apical-basal polarity of follicular cells is also indicated.
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2.2 Stocks and Genotypes
Stocks and crosses were raised at 25°C on a growing medium composed of H2O,
agar, corn meal, yeast, glucose and the antifungine Nipagine to avoid mould infec-
tion.
2.2.1 Stocks
All stocks are derived from Bloomington Stock Centre strains unless otherwise
stated. Stock numbers of key constructs are indicated (Bl = Bloomington Stock
Center, VDRC = Vienna Drosophila RNAi Center)
w, hs-Flp; arm-LacZ, FRT40A
w; lgl27S3 [42], FRT40A / In(2LR)1
w, hs-Flp; Ubi-GFPnls, FRT40A
yw, hs-Flp, tub-GAL4, UAS-GFP; tub-GAL80, FRT40A
w; lgl4, FRT40A / In(2LR)2
w, hs-Flp; FRT40A
w; lgl4, Ubi-GFPnls, FRT40A / In(2LR)
w; FRT40A
w, P [LacW ]l(1)G0354 (dm-LacZG0354) [193]/ yw, FM7a; lgl4, FRT40A / In(2LR)
yw, hs-Flp, tub-GAL4; tub-GAL80, FRT40A
w; lgl4, Ubi-GFPnls, FRT40A / In(2LR); UAS-dIAP1 (Bruce Hay)
yw, UAS-bskDN [77]; w; lgl4, Ubi-GFPnls, FRT40A / In(2LR)
w; lgl4, FRT40A / In(2LR); tub-YFP::Rab5 (L.A. Baena-Lo´pez)
w; Ubi-GFPnls, FRT40A / In(2LR); UAS-egrRNAi (VDRC 45252)
For a validation of UAS-egrRNAi construct see Fig. 2.4
w; lgl4, Ubi-GFPnls, FRT40A / In(2LR); UAS-egrRNAi
w; lgl4, Ubi-GFPnls, FRT40A / In(2LR), UAS-YFP::Rab5DN [192]
yw, hs-Flp; M(2)24F, Ubi-GFPnls, FRT40A / SM5
yw, hs-Flp, tub-GAL4, UAS-GFP; M(2)24F, tub-GAL80, FRT40A / SM5
w; lgl4, FRT40A / In(2LR); UAS-dmycRNAi (VDRC 2947, jumped on III chr.)
For a validation of UAS-dmycRNAi construct see Fig. 2.5
1lgl27S3 is a null allele.
2lgl4 allele is a deletion of the entire locus.
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yw, hs-Flp; act5c>CD2>GAL4, UAS-GFP / TM6b (B.A. Edgar)
w; UAS-dmyc [190]
w; His2A-GFP
w; FRT40A; UAS-Ras85DV12 (UAS-RasV12, Bl 4847)
w; lgl4, FRT40A / In(2LR); UAS-RasV12
yw, UAS-dp110CAAX [191]
For a validation of UAS-dp110CAAX construct see Fig. 2.6
yw, UAS-dp110CAAX; lgl4, FRT40A / In(2LR)
w; en-GAL4, UAS-GFP / In(2LR)
w; UAS-RasRNAi (VDRC 28129)
For a validation of UAS-RasRNAi construct see Fig. 2.7
yw, hs-Flp, tub-GAL4, UAS-GFP; tub-GAL80, FRT40A; UAS-Ras85DRNAi
yw, UAS-hRaf GOF (Bl 2074); lgl4, FRT40A / In(2LR)
For a validation of UAS-hRaf GOF construct see Fig. 2.8
yw, hs-Flp, tub-GAL4, UAS-GFP; tub-GAL80, FRT40A; UAS-dmycRNAi
w; lgl4, FRT40A / In(2LR); UAS-dmyc
w; lgl4, FRT40A / In(2LR); UAS-dmyc, UAS-dIAP1
yw, UAS-hRaf GOF; lgl4, FRT40A / In(2LR); UAS-YkiRNAi(Bl 31965)
For a validation of UAS-YkiRNAi construct see Fig. 2.9
w; lgl4, FRT40A / In(2LR); UAS-Yki (Bl 28819)
ry506, PZ [bnl06916] (bnl-LacZ) / TM3 (Bl 11704)
yw, hs-Flp, tub-GAL4, UAS-GFP; tub-GAL80, FRT40A; ry506, PZ [bnl06916] / TM6b
w; M(2)24F, en-GAL4, UAS-GFP / In(2LR)
w; lglRNAi (VDRC 51249)
For a validation of UAS-lglRNAi construct see Fig. 2.10
w; M(2)24F, en-GAL4, UAS-GFP / In(2LR); UAS-dmycRNAi
2.2.2 Genotypes
Detailed genotypes of the tissues analised in Chapter 3 are as follows:
- Figure 3.1:
A-C: hsFLP/+; lgl27S3, FRT40A/arm-LacZ,FRT40A
D,E: w,hsFLP/+; lgl27S3, FRT40A/Ubi-GFP,FRT40A
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F,G: w, hsFLP, tub-Gal4, UAS-GFP/+; lgl4, FRT40A/tub-Gal80, FRT40A
- Figure 3.2:
A,B and D (left panel): w, hs-Flp/+; lgl4, FRT40A/Ubi-GFPnls, FRT40A
C: w, hs-Flp/+; lgl4, Ubi-GFPnls, FRT40A/FRT40A
D (right panel): w, hs-Flp/+;Ubi-GFPnls, FRT40A/FRT40A.
- Figure 3.3:
A,B: w, hs-Flp/+; lgl4, FRT40A/Ubi-GFPnls, FRT40A
C: w, hs-Flp/+; lgl4, Ubi-GFPnls, FRT40A/FRT40A
D: yw, dm-LacZG0354/w, hs-Flp; lgl4, FRT40A/Ubi-GFP, FRT40A
- Figure 3.4:
A-C: w, hsFLP, tub-Gal4, UAS-GFP/+; lgl4, Ubi-GFPnls, FRT40A/tub-Gal80,
FRT40A; UAS-dIAP1/+
- Figure 3.5:
A-C: w, hsFLP, tub-Gal4, UAS-GFP/UAS-bskDN; lgl4, Ubi-GFPnls, FRT40A/tub-
Gal80, FRT40A
- Figure 3.6:
A: w, hsFLP, tub-Gal4/+; lgl4, FRT40A/tub-Gal80, FRT40A; tub-YFP::Rab5/+
B,C: w, hsFLP, tub-Gal4/+; lgl4, Ubi-GFPnls, FRT40A/tub-Gal80, FRT40A;
UAS-egrRNAi/+
D: w, hsFLP, tub-Gal4, UAS-GFP/+; lgl4, FRT40A/tub-Gal80, FRT40A; UAS-
YFP::Rab5DN/+
E,F: w, hsFLP, tub-Gal4/+; lgl4, Ubi-GFPnls, FRT40A/tub-Gal80, FRT40A; UAS-
YFP::Rab5DN/+
- Figure 3.7:
A-B’,D,E: w, hs-Flp/+; lgl4, FRT40A/M(2)24F, Ubi-GFPnls, FRT40A
C:w, hs-Flp/+; FRT40A/M(2)24F, Ubi-GFPnls, FRT40A
F: w, hs-Flp/yw, dm-LacZG0354; lgl4, FRT40A/M(2)24F, Ubi-GFPnls, FRT40A
G,H: w, hs-Flp/+; lgl4, FRT40A/M(2)24F, Ubi-GFPnls, FRT40A;
UAS-dmycRNAi/+
- Figure 3.8:
A,B,D,F,G: w, hs-Flp/+; lgl4, FRT40A/Ubi-GFPnls, FRT40A
C: w; His2A-GFP
E: yw, dm-LacZG0354/w, hs-Flp; lgl4, FRT40A/Ubi-GFP, FRT40A
- Figure 3.9:
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A: yw, hs-Flp, tub-GAL4, UAS-GFP/+; FRT40A/tub-GAL80, FRT40A
B: w, hsFLP, tub-Gal4, UAS-GFP/+; lgl4, FRT40A/tub-Gal80, FRT40A
C: w, hsFLP, tub-Gal4, UAS-GFP/+; FRT40A/tub-Gal80, FRT40A; UAS-RasV12/+
D-G: w, hsFLP, tub-Gal4, UAS-GFP/+; lgl4, FRT40A/tub-Gal80, FRT40A;
UAS-RasV12/+
- Figure 3.12:
A: w, hsFLP, tub-Gal4, UAS-GFP/UAS-dp110CAAX; lgl4, FRT40A/tub-Gal80, FRT40A
B: w, hsFLP, tub-Gal4, UAS-GFP/UAS-dp110CAAX; lgl4, FRT40A/tub-Gal80, FRT40A;
UAS-RasRNAi/+
C,D: w, hsFLP, tub-Gal4, UAS-GFP/UAS-hRaf GOF; lgl4, FRT40A/tub-Gal80, FRT40A
E,F: w, hsFLP, tub-Gal4, UAS-GFP/UAS-hRaf GOF; lgl4, FRT40A/tub-Gal80, FRT40A;
UAS-RasRNAi/+
- Figure 3.13:
A: w, hsFLP, tub-Gal4, UAS-GFP/+; lgl4, FRT40A/tub-Gal80, FRT40A; UAS-
RasV12/UAS-dmycRNAi
B-E: w, hsFLP, tub-Gal4, UAS-GFP/+; lgl4, FRT40A/tub-Gal80, FRT40A; UAS-
dmyc/+
F: w, hsFLP, tub-Gal4, UAS-GFP/+; lgl4, FRT40A/tub-Gal80, FRT40A; UAS-
dmyc, UAS-dIAP1/UAS-RasRNAi
- Figure 3.14:
A,B: w, hsFLP, tub-Gal4, UAS-GFP/UAS-hRaf GOF; lgl4, FRT40A/tub-Gal80, FRT40A;
UAS-YkiRNAi/+
C,D: w, hsFLP, tub-Gal4, UAS-GFP/+; lgl4, FRT40A/tub-Gal80, FRT40A; UAS-
Yki/+
E,F: w, hsFLP, tub-Gal4, UAS-GFP/+; lgl4, FRT40A/tub-Gal80, FRT40A; UAS-
RasRNAi/UAS-Yki
- Figure 3.15:
A-D: w, hsFLP, tub-Gal4, UAS-GFP/+; lgl4, FRT40A/tub-Gal80, FRT40A; UAS-
RasV12/+
E: w, hsFLP, tub-Gal4, UAS-GFP/+; lgl4, FRT40A/tub-Gal80, FRT40A; UAS-
RasV12/ry506, bnl-LacZ
F: ry506, bnl-LacZ / TM3
- Figure 3.16:
A,B: w, hsFLP, tub-Gal4, UAS-GFP/+; lgl4, FRT40A/tub-Gal80, FRT40A; UAS-
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RasV12/UAS-dmycRNAi
C,D: w, hsFLP, tub-Gal4, UAS-GFP/UAS-hRaf GOF; lgl4, FRT40A/tub-Gal80, FRT40A;
UAS-YkiRNAi/+
- Figure 3.17:
A-C: w; M(2)24F, en-GAL4, UAS-GFP /+; UAS-lglRNAi/+
D,D’: w; M(2)24F, en-GAL4, UAS-GFP /+; UAS-lglRNAi/UAS-dmycRNAi
E: w; M(2)24F, en-GAL4, UAS-GFP /+; UAS-dmycRNAi/+.
2.2.3 Validations
Figure 2.4: A,B: Egr staining (red) of a wild-type disc (A) and a disc bearing egrRNAi clones
(GFP2+). As can be seen in A, Egr is expressed mainly in the notum. In B, the arrows indicate
UAS-egrRNAi mutant tissue in the notum where downregulation of Egr protein within the mutant
clone is clearly visible confirming the efficacy of the RNAi construct. Full genotype of tissues shown
in B is yw, hs-Flp, tub-Gal4/+; Ubi-GFPnls, FRT40A /tub-Gal80, FRT40A; UAS-egrRNAi/+.
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Figure 2.5: A: dMyc staining (red) of a wild-type wing disc, the main regions are indicated
on the left. dMyc is more abundant in the wing pouch and in the notum while it is expresses
at low levels in the hinge and pleura. B : dMyc staining (red) of a M+/- wing disc in which lgl4;
dmRNAi (GFP+) were induced (B). dMyc protein levels are reduced in clones throughout the disc,
two clones are outlined as an example. Full genotype of the tissue shown in B is yw, hs-Flp/+,
tub-Gal4, UAS-GFP; lgl4, FRT40A/M(2)24F, tub-Gal80, FRT40A; UAS-dmycRNAi/+.
Figure 2.6: A dp110CAAX Flp-out clone (GFP+). This form of dp110 carries a prenylation motif
(CAAX) which targets the protein to the plasma membrane causing constitutive activity. Consis-
tently, high levels of phosphorylated AKt (pAkt, red) are evident within dp110CAAX-expressing
clone. The wing disc is outlined. Full genotype of the tissue is yw, hs-Flp / UAS-dp110CAAX;
act5c>CD2>GAL4, UAS-GFP / TM6b.
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Figure 2.7: An adult wing derived from an individual expressing a RasRNAi construct in the
posterior compartment of the wing disc is shown in the right panel. Longitudinal vein 4 (L4),
part of longitudinal vein 5 (L5) and both anterior and posterior cross veins (ACV and PCV,
respectively) are absent in the corresponding wing compartment (cyan); a wild-type wing is shown
in the left panel for comparison. Loss of wing veins is a reported phenotype of Ras loss of function
[101], thus confirming the efficacy of the RNAi construct. Longitudinal veins 1-3 (L1-3) are also
indicated. A, anterior compartment; P, posterior compartment. Full genotype of tissue shown in
the right panel is w; en-GAL4, UAS-GFP /+; UAS-RasRNAi/+.
Figure 2.8: dpErk staining of a wing disc in which lgl4;Raf GOF clones (GFP+) were induced.
High levels of activated Erk are visible within the mutant clone indicating that hRaf can activate
MAPK pathway in Drosophila. Wing disc is outlined. Full genotype of tissues shown is yw, hs-Flp,
tub-Gal4, UAS-GFP / UAS-Raf GOF; lgl4, FRT40A /tub-Gal80, FRT40A.
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Figure 2.9: Yki staining (white) of a wing disc in which lgl4;Raf GOF; ykiRNAi clones (GFP+)
were induced. Evident downregulation of Yki protein is visible within mutant clones. Full genotype
of tissues shown is yw, hs-Flp, tub-Gal4, UAS-GFP / UAS-Raf GOF; lgl4, FRT40A /tub-Gal80,
FRT40A; UAS-ykiRNAi/+.
Figure 2.10: An imaginal wing disc in which the lglRNAi construct has been expressed under
the control of the en promoter. Coexpression of a UAS-GFP construct allows to visualise the
expression domain (green). Lgl staining is absent in the posterior compartment (P) confirming
the efficacy of the construct. Full genotype of tissue shown is w; en-GAL4, UAS-GFP /+; UAS-
lglRNAi/+.
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2.3 Protocols
2.3.1 Genetic Manipulations
For the twin analysis [58], larvae were heat shocked 48 hours After Egg Laying
(AEL) for one hour at 37°C and adult females were heat shocked one to two days
after eclosion for one hour at 37°C. For larval staging, freshly hatched larvae were
collected in a one-to-four hour time window. For the MARCM clones generation
[69], larvae were heat shocked 48 hours AEL for 30 minutes at 37°C and adult
females one to two days after eclosion for 30 minutes at 37°C. Minute individuals
were always heat shocked at 72 hours AEL to compensate for developmental delay.
Flp-out clones [85] were generated heat shocking 48h AEL-larvae and one-two days
old females for eight minutes at 37°C. For all the clonal systems used, tissues were
collected 72 hours after the heat shock both for larvae and adults, unless otherwise
specified.
M+/- larvae expressing either lglRNAi or lglRNAi; dmycRNAi under the control
of en-GAL4 driver were dissected 7 or 11 days AEL (as indicated in the figure
legends).
2.3.2 Immunohistochemistry
Larvae and adult females were dissected in PBS (Phosphate Buffer Saline, pH
7.5) and fixed in 3,7% formaldehyde (Sigma) in PBS. Tissues were permeabilised in
PBS-Triton 0,3% for 1 hour at room temperature, blocked for 1 hour in PBS-Triton
0,3%, 2% BSA (Bovine Serum Albumine, Sigma ) and incubated overnight at 4°C
in PBS-Triton 0,3%, 2% BSA with primary antibody. Tissues were then incubated
with secondary antibody for 2 hours at room temperature. Accurate washes in PBS-
Triton 0,3% were performed following each step. Samples were then mounted on
microscopy slides using anti-quenching slide mounting medium Fluoromount (Beck-
man Coulter).
The following antibodies and dilutions were used: rabbit α-active-Caspase 3
(1:200, 9664S - Cell Signaling Technology); mouse α-dIAP1 (1:100, B.A. Hay);
rabbit α-Laminin A (1:200, Y. Kitagawa); rabbit α-Scribble (1:100, C.Q. Doe);
mouse α-dMyc (1:5 [92]); mouse α-βGal (1:25, 40-1a - DSHB); rabbit α-βGal (1:50,
F. Graziani); rabbit α-aPKCζ (1:200, sc-216 - Santa Cruz Biotechnology); mouse
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α-phospho-JNK (1:100, G9 - Cell Signaling Technology); rabbit α-Egr (1:500, M.
Miura); mouse α-MMP1 (1:50, 3A6B4 - DSHB); mouse α-dpERK (1:50, MAPK-YT
- Sigma); rabbit α-pAkt (1:100, Cell Signaling); rabbit α-Trh (1:10, J. Casanova);
rat α-Trh (1:50, L. Jiang); rat α-Ci (1:20, 2A1 - DSHB); mouse α-En (1:50, 4D9 -
DSHB); mouse α-Dlg (1:50, 4F3 - DSHB); rabbit α-Yki (1:100, G. Morata); rab-
bit α-Lgl (1:400, D. Strand). Alexa Fluor 555 or 568 goat α-mouse and α-rabbit
(1:200, Invitrogen); Cy3-conjugated goat α-rabbit (1:200, Jackson ImmunoResearch
Laboratories); Cy3-conjugated donkey α-rat (1:400, Jackson ImmunoResearch Lab-
oratories); Cy5-conjugated goat α-mouse and α-rabbit (1:200, Jackson ImmunoRe-
search Laboratories) and DyLight 649-conjugated goat α-mouse and α-rabbit (1:200,
Jackson ImmunoResearch Laboratories) were used as secondary antibodies. Nu-
clei were stained with DAPI (4’,6-diamidine-2’-phenylindole dihidrochloride, Sigma)
or TOPRO (Invitrogen) and Phalloidin staining (phalloidin-tetramethylrhodamine
isothiocyanate, Sigma) was used to to detect F-actin.
Samples were analysed with Leica TSC SP2 laser confocal microscope and entire
images were processed with Adobe Photoshop software. All the images shown rep-
resent a single confocal stack unless otherwise specified. ImageJ free software from
NIH was used for rebuilding the projections along the Z axis starting from 25-45 Z
stacks.
2.3.3 Statistics
Clone areas (in pixel2) were measured using ImageJ free software (NIH) on im-
ages captured with 90i widefield fluorescence microscope (Nikon) at a a magnification
of 200x. Areas of clones grown as multilayers are likely to be underestimated. Mean,
Standard Deviation and the t-Student test P value were calculated with GraphPad
Prism software. Clone shapes were measured with ImageJ using the formula 4piA/L2,
in which A = clone area and L = clone circumference [194]. By use of this formula,
a perfect circle has a value of 1 and more irregular shapes have values <1.

Chapter 3
Results and Discussion
3.1 Tumour Initiation
Understanding the molecular bases of tumour initiation is of pivotal importance
in the field of cancer biology. Human neoplasias are often diagnosed at late stages
when the tumour is morphologically and genetically extremely heterogeneous and it
is hard, if not impossible, to identify the first hits that led to the development of the
tumorous mass. Animal models are thus a precious tool to investigate the first steps
of cancer formation. As described in Section 1.2.2 Drosophila oncogenic cooperation
models faithfully reproduce most of the aspects of human carcinogenesis and offer
an ideal genetic approach to address the issue of cancer onset.
Loss of function of lethal giant larvae(lgl) and the other polarity tumour sup-
pressor genes provides cells with undisputed neoplastic features: mutant epithelia
overgrow, lose cell polarity, tissue architecture and the ability to differentiate and are
able to invade adjacent tissues, migrate and form metastases. Nevertheless, these
neoplastic traits fail to show when mutant cells arise in a clonal context, a condition
that most closely resembles the onset of human cancers, indicating the existence
of some mechanisms of suppression of tumour initiation (see Sections 1.2.1.2 and
1.2.2).
3.1.1 lgl Mutant Clones Die by Apoptosis
To investigate the fate of polarity mutant cells in a clonal condition, the be-
haviour of lgl mutant clones generated in a wild-type imaginal wing disc (Section
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2.1.1) was analysed. As can be observed in Figures 3.1 and 3.2, lgl -/- clones do
not overgrow, on the contrary mutant cells exhibit a rather poor viability: at two
days after induction lgl -/- clones and their wild-type twins were similar in size (Fig.
3.1A), while at three days lgl -/- clones were about half the size of their twins (Fig.
3.1B; n=40 each) and 37% disappeared by the end of larval development leaving
only the twin clone (Fig. 3.1B, arrow; n=187). Those which persisted to the end of
development resulted in minor scarring of the adult wing (Fig. 3.1C).
lgl mutant clones showed slight defects in disc folding as revealed by F-actin
staining (Fig. 3.1D, arrow); however mutant cells did not seem to be strongly com-
promised in apical-basal polarity as detected by Scribble (Fig. 3.1F and G) and
aPKC (Fig. 3.3A and C) polarity markers and no discontinuities of basement mem-
brane were visible (not shown), in agreement with previous observations [70].
In Figure 3.1E many pycnotic nuclei are visible within lgl -/- clones in basal sec-
tions. As basal extrusion is the process by which apoptotic cells are eliminated in
the imaginal wing disc [171] I employed a specific antibody against active effector
Caspase 3 to confirm that mutant cells were undergoing apoptosis: indeed many
lgl -/- cells resulted positive to this staining (Fig. 3.2A), especially at the border of
the clone, where mutant and wild-type tissue are in contact (see magnification in
Fig. 3.2A*). Coherently, the anti-apoptotic protein Drosophila Inhibitor of Apop-
tosis 1 (dIAP1) was downregulated in lgl -/- cells (Fig. 3.2B, arrow). Apoptotic cell
death is also known to be induced in the imaginal tissue by the JNK signalling, a
conserved stress-induced pathway (see Section 1.2.1.2). To ask whether this pathway
was involved in lgl-/- cells death, imaginal wing discs were stained with an antibody
against the phosphorylated and thus activated form of JNK; as can be observed
in Figure 3.2C mutant clones show a strong activation of JNK signaling pathway
(arrow).
3.1.2 lgl -/- Cells Are Eliminated by Myc-Induced Cell Com-
petition
As reported in Section 1.4.3, clonal analysis in Drosophila imaginal tissues has
allowed to discover and characterise a non-cell autonomous developmental phe-
nomenon, named cell competition, which occurs when two cell populations with
different growth rates coexist in the same tissue and results in the elimination by
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apoptosis of the slow-dividing cells by the surrounding faster-growing population;
compensatory proliferation of the so-called “winner cells” ensures that the organ
reaches its proper final size.
Since lgl mutant tissues have been shown to overgrow but with a much slower
proliferation rate with respect to wild-type ones [15], I tested whether competitive
interactions were involved in the elimination of lgl -/- cells from the normal tissue
by performing a double clonal assay in which lgl -/- clones and wild-type clones were
induced in parallel in a wild-type background (Fig. 3.2D). As expected, while no
differences were observed between wild-type control clones and their twins (right
panel, black and white bars respectively, P = 0.86), lgl mutant clones were smaller
than their wild-type twins (left panel, black and white bars respectively, P < 0.001),
as well as smaller than wild-type clones induced in control discs (right panel, black
bars, P < 0.001). The wild-type twins of lgl -/- clones (left panel, white bars) were
instead much larger than the wild-type twins from control discs (right panel, white
bars, P < 0.001). Since no dominant effects on cellular growth rate have been re-
ported for lgl null mutations, and developmental stages of lgl+/- animals are of the
same duration as those of lgl+/+ individuals, even in clonal assays, this result sug-
gests that some non-autonomous mechanisms are at work in lgl -/- clone elimination
and that mutant cells are being replaced by the normal surrounding tissue.
Since it is known that differences in dMyc abundance among adjacent cells can
trigger competitive behaviour (see Section 1.4.3, [148, 171]), I next analysed dMyc
protein levels and found that dMyc was weakly expressed within lgl mutant clones
with respect to the surrounding tissue (Fig. 3.3A-C). This downregulation does not
seem to occur at a transcriptional level: as assayed by a dm-LacZ construct (dm,
diminutive is the gene that encodes for dMyc), dm promoter results active in mutant
cells (Fig. 3.3D) indicating the involvement of a post-transcriptional mechanism.
It is therefore possible to speculate that cells bearing precancerous lesions that
do not confer a survival or proliferative advantage relative to neighbouring cells,
as with lgl -/- cells that lack dMyc protein, can be eliminated by apoptosis. In the
wing disc, dMyc protein accumulates mainly in the distal region, the wing pouch,
and is expressed only weakly in the proximal regions, hinge and pleura (Fig. 2.5A).
In these proximal regions, no differences in dMyc levels were visible between lgl -/-
clones and the adjacent cells (not shown); such clones were larger than those in the
wing pouch (Fig. 3.1, compare G with F and 3.3E) and showed low levels of cell
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death (not shown), although they never formed tumours (Fig. 3.1G). Thus, low
dMyc levels in lgl -/- cells seem to affect growth and viability of these cells mainly in
the distal region (wing pouch), where the surrounding tissue expresses high levels
of dMyc.
3.1.3 Inhibition of Cell Death Is Not Sufficient for Driving
Tumourous Growth of lgl -/- Clones in the Wing Pouch
Since several molecules associated with cell death were found to be deregulated in
lgl mutant clones generated in a wild-type background (see Fig. 3.2), I tried to res-
cue lgl mutant clones viability by co-expressing dIAP1 or a dominant negative form
of the Drosophila JNK, Bsk. As can be seen in Figure 3.4A, lgl -/-; dIAP1 clones in
the wing pouch still showed active-Caspase 3 signals (arrow) and grew smaller than
their wild-type twins (Fig. 3.4D). Since the JNK pathway is activated in lgl mutant
clones in the wing pouch (Fig. 3.2C, arrow), it could significantly contribute to their
death; indeed, as shown in Figure 3.4B, despite dIAP1 expression, active JNK is
still present, as detected by pJNK staining (arrow), indicating that it contributes to
the elimination of lgl mutant clones independently of dIAP1. Both active-Caspase
3 and pJNK were also visible in the mutant clones in the proximal regions of the
wing disc (Fig. 3.4A and B, hinge and pleura respectively, white arrowheads), but
their phenotype was quite different from that of clones in the wing pouch; they were
large, round-shaped and, as can be seen in Figure 3.4A, active-Caspase 3 signal was
also present in several cells surrounding the mutant clone (grey arrowheads). A
statistical analysis showed that such clones were larger than their wild-type twins
(Fig. 3.4D). Interestingly, these phenotypes were associated with higher dMyc levels
with respect to the background (Figure 3.4C, arrow); thus JNK signalling may here
be subverted from a pro-apoptotic to a pro-growth function, as it has been demon-
strated to occur in genetic contexts in which alterations in the polarity genes lgl,
scrib and dlg are accompanied by an ectopic expression of oncogenes such as Ras
or Notch (see Section 1.2.2, [74, 75, 77]).
I then blocked the JNK pathway inside the lgl -/- clones by using a bskDN trans-
gene and found that the active-Caspase 3 signal was no longer observable in lgl -/-
clones, regardless of the region in which they were located (not shown), indicating
that JNK signalling-induced cell death is the main pathway by which lgl mutant
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cells die. As can be seen in Figure 3.5A, lgl -/-; bskDN clones in the wing pouch (out-
lined) expressed low levels of dMyc and did not form tumours; statistical analysis
performed in this region showed that, despite the fact that lgl -/-; bskDN clones no
longer died, their size was smaller than that of their wild-type twins (Fig. 3.5B),
demonstrating that even when cell death is blocked lgl -/-; bskDN cells have a prolif-
erative disadvantage with respect to the wild-type tissue.
In contrast to the wing pouch, lgl -/-; bskDN clones in the proximal regions (hinge
and pleura) showed high dMyc protein levels (Fig. 3.5C), lost polarity and over-
grew (not shown), indicating that the pro-growth role of the JNK pathway observed
in polarity-compromised clones overexpressing activated Ras or Notch (see Section
1.2.2, [74, 75, 77]) appears not to be necessary in the wing disc for the tumourous
growth induced by the cooperation between lgl mutation and dMyc oncoprotein.
Altogether, these data show that the difference in clonal growth reported in
Section 3.1.2 for lgl -/- cells in the wing pouch versus the hinge/pleura regions also
occurs for lgl -/- clones in which cell death has been inhibited and is also associated
with the different levels of dMyc protein in the mutant versus the adjacent normal
tissue.
3.1.4 Intrinsic Tumour Suppression Is Not Involved in lgl -/-
Cells Elimination in the Wing Pouch
A recent study demonstrated that clones of scrib and dlg tumour suppressor mu-
tants generated in wild-type imaginal discs are eliminated by the Intrinsic Tumour
Suppressor (ITS) pathway, involving JNK-dependent apoptosis induced by an en-
docytic accumulation of the TNF homologue, Eiger (Egr) (See Section 1.2.1.2, [61]).
Since scrib and dlg are well-known lgl partners in regulating apical-basal cell polarity
and proliferation and show similar neoplastic phenotypes in a homotypic background
(see Section 1.2.1.1), it could be expected that lgl -/- clones could be eliminated by a
similar mechanism. To investigate this, I first looked for alterations in endocytosis
in lgl mutant clones by using an early-endosome reporter, Rab5, since Igaki and
colleagues [61] observed that Rab5-positive endosomes accumulated in scrib mutant
clones in the eye disc and correlated with pJNK staining. Nevertheless, in the wing
pouch region I did not observe changes in Rab5 levels within lgl -/- clones with re-
spect to the neighbours (see Fig. 3.6A, arrowhead, and respective magnification),
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whereas outside the wing pouch a moderate increase in Rab5 levels in lgl -/- clones
was observed (see Fig. 3.6A, arrow, and respective magnification). Since it was also
demonstrated that ITS depends on an autocrine TNF signalling [61], I silenced the
TNF homologue, egr, in lgl mutant cells by expressing a UAS-egrRNAi construct (for
validation see Fig. 2.4 in Section 2.2.3) and scored for changes in clone morphology,
but no alterations were observed relative to the lgl -/- clonal phenotype (Fig. 3.6B).
lgl -/-; egrRNAi clones in the wing pouch were comparable in size to lgl -/- clones
induced by the same system (P = 0.58, n=19 each). Similar effects were seen in lgl
mutant clones in discs in which the UAS-egrRNAi construct was expressed under
the control of the hedgehog promoter in the whole posterior compartment, thereby
also removing Egr protein in the background (not shown). In Figure 3.6B, the apical
and basal sections of a wing pouch are shown in which an lgl mutant clone is being
basally extruded (arrow, the position of the mutant clone with respect to its twin is
outlined in the apical section). In Figure 3.6C, an increased pJNK staining is visible
in the mutan clone (arrow). The fact that JNK signalling is increased here suggests
that, in this case, JNK pathway activation is not triggered by Egr-mediated ITS.
I next expressed in lgl mutant clones a dominant negative form of Rab5 to block
endocytosis, since it was shown that endocytosis blocking decreased JNK signalling
and cell death of scrib mutant clones [61]. Indeed, I found that some lgl -/- mutant
clones expressing Rab5DN in the proximal regions overgrew (48%, n=27 Fig. 3.6D),
while clones in the wing pouch never did. Again, lgl -/-; Rab5DN clones in the wing
pouch expressed both active-Caspase 3 (Fig. 3.6E, arrow) and pJNK (Fig. 3.6F,
arrow), distinct from what has been observed for scrib mutant clones in the eye disc,
where Rab5DN expression increased their growth [61]. Notably, all the overgrowing
clones observed in the proximal regions of the wing disc were characterised by high
dMyc protein levels (Fig. 3.6D).
Taken together, these data exclude egr -mediated ITS as the main mechanism
responsible for lgl mutant clones elimination in the wing pouch.
3.1.5 lgl -/- Cells Grown in a Minute Background Overex-
press dMyc and Form Malignant Tumours
As shown in Section 3.1.3, lgl -/- cells grow slower than wild-type cells in a clonal
context, which is possibly the main reason why they are eliminated from the ep-
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ithelium. To confirm the hypothesis for an active role of cell competition in re-
straining lgl -/- clonal growth, I induced lgl mutant clones in the slow-dividing and
non-competitive Minute background (see Section 1.4.3), to give them a prolifera-
tive advantage. As can be seen in Figure 3.7A and B, lgl mutant clones in this
context were able to overgrow, on average a 5-fold increase in size with respect to
lgl -/- clones was detected, (n=40 each genotype, P < 0.001), displayed rounded cells
and lost apical-basal polarity, as can be seen in the Z projection where aPKC apical
determinant spreads cortically (Fig. 3.7A). lgl -/- clones showed high levels of dMyc
protein (Fig. 3.7A, arrow), which accumulated mainly in those outside of the wing
pouch. dMyc upregulation is attributable to lgl loss of function because wild-type
cells did not show any changes in dMyc levels when growing in a M+/- background
(Fig. 3.7C). On the other hand, lgl -/- clones in the wing pouch did not overgrow,
showed a level of dMyc similar to that found in the adjacent cells (Fig. 3.7D, clone
outlined) and did not undergo apoptosis (not shown). In large lgl -/- clones in the
hinge or pleura, dIAP1 was also expressed (Fig. 3.7B’) and active-Caspase 3 signal
was evident in few cells in the mutant clones, but marked mainly groups of sur-
rounding cells (Fig. 3.7B,B’, arrows), which were deficient in dIAP1 (Fig. 3.7B,B’,
arrowheads). Moreover, basement membrane showed signs of discontinuity (arrows
in Fig. 3.7E) as demonstrated by Laminin A staining, a major component of the
basement membrane, indicating invasive behaviour.
The upregulation of dMyc protein inside lgl -/- proximal clones induced in the
M+/- background may be a consequence of an increase in dmyc transcript levels,
since an upregulation of dmyc transcription, assayed by a dm-LacZ construct was
observed (Fig. 3.7F).
Altogether, these data show that lgl -/- cells grown in a M+/- background can
acquire a competitive advantage, which correlates with high dMyc expression and
polarity loss.
To determine the functional importance of dMyc upregulation in lgl -/- clones in-
duced in the M+/- background, I silenced dmyc expression inside lgl -/- clones using
a UAS-dmycRNAi construct (for validation see Fig. 2.5B in Section 2.2.3). Knock-
down of dmyc in lgl -/- clones prevented the cell polarity defects observed with lgl -/-
clones alone even when the lgl mutant tissue occupied a larger proportion of the
disc (Fig. 3.7G); no degradation of basement membrane occurred (not shown) and
clones did not form tumourous masses, regardless of the region in which they were
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located. Concerning the cell death pattern in these clones, it ranged from a complete
absence of active-Caspase 3 signal in the majority of discs analysed (not shown) to
scattered signals, either in lgl -/- cells, surrounding cells, or in regions distant from
mutant clones (Fig. 3.7H, arrows). These results indicate that lgl -/-; dmycRNAi and
M+/- cells coexist in the same tissue without undertaking competitive interactions,
possibly because both populations show a similar impairment in cell proliferation.
Similar results were obtained by Wu and Johnston upon the induction of dm loss-
of-function clones in a M+/- background [149]. M+/- tissue could also intrinsically
possess a low level of dMyc protein, but I was not able to detect differences in dMyc
protein levels between wild-type and M+/- cells throughout the wing disc by clonal
analysis (see Fig. ??X). Thus, the silencing of dmyc in lgl -/- clones and the re-
duced ribosomal pool in the M+/- background may make their levels of biosynthesis
comparable. The ability of lgl mutant patches to grow despite dMyc deprivation
might also be due to the upregulation of other growth-promoting factors in the M+/-
context, which are however per se unable to provide lgl -/- cells with tumourigenic
features.
3.1.6 The Oncogenic Cooperation Between lgl -/- and dMyc
Protein Is Conserved in the Follicular Epithelium
With the aim of assessing whether the oncogenic cooperation between lgl muta-
tion and dMyc protein could be conserved in other Drosophila tissues, I investigated
lgl -/- clonal behaviour in the ovarian follicular epithelium, a monolayered adult tis-
sue of somatic origin that surrounds the germ line of the egg chamber (see Section
2.1.2). Interestingly, the phenotype of lgl -/- clones in the follicular epithelium re-
ported in literature (see Section 1.2.1.2) appeared to be rather different from that
observed in the wing imaginal epithelia, but similar to that of the whole mutant
animal; in females bearing a homozygous temperature-sensitive lgl mutation, egg
chambers invariantly show hyperproliferation of follicular cells that display loss of
apical-basal polarity and migrate between the nurse cells [53].
I found that lgl mutant clones overproliferated, lost apical-basal polarity and
formed multilayers near the chamber poles (Fig. 3.8A), consistent with previous
studies [22, 57]. Active-Caspase 3 staining revealed that apoptosis was occasion-
ally observable in egg chambers from stage 8 onward in wild-type cells at the clone
3.1 Tumour Initiation 79
border (Fig. 3.8B). This cell death pattern is reminiscent of a mechanism of dMyc-
induced cell competition. Cell competition, however, has never been described in
the follicular epithelium, so I induced dmyc-overexpressing (dmycover) Flp-out clones
[85] in adult females and observed that the wild-type tissue underwent massive cell
death (not shown), suggesting that dmyc is also able to induce apoptosis in the
surrounding cells in this tissue. Indeed, lgl -/- clones expressed dMyc protein in early
egg chambers as well as at later stages (Fig. 3.8D), where endogenous protein is
normally absent (Fig. 3.8C). dmyc was also transcriptionally activated, as can be
seen from dm-LacZ expression in Figure 3.8E. Thus, lgl -/- clonal behaviour in the
follicular epithelium positively correlates with dmyc expression. dIAP1 levels in
lgl -/- follicular clones were similar to those seen in the wild-type adjacent tissue
(Fig. 3.8F), and no autonomous apoptosis was visible in lgl -/- follicular cells (not
shown). Further, I allowed clones to grow for four additional days in order to obtain
stronger phenotypes. As can be seen in Figure 3.8G, dMyc protein was detectable
in all lgl -/- cells; clonal phenotype varied from larger areas of multilayered tissue
(arrowed), which sometimes extended away from the poles (asterisk), to clones that
invaded into the nurse cells territory (arrow).
To determine the contribution of dmyc to the lgl mutant phenotype in this tis-
sue, dMyc levels inside lgl -/- cells were lowered using the UAS-dmycRNAi construct.
A pronounced decrease both in clone size and number was observed (visible clone
area: 44% decrease in 60 clones at chamber poles analysed for each genotype; clone
number: 74% decrease on a total of 20 pairs of ovaries for each genotype) and no
multilayered tissue was seen (not shown).
Taken together these data demonstrate that also in the follicular epithelium
dMyc protein is required for lgl mutant clones to grow as malignant tumours.
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Figure 3.1: A,B: 2 (A) and 3 days-old (B) lgl -/- clones (black). In B, the arrow indicates a twin
clone (bright white) with no lgl -/- counterpart; C: adult wing from a female of the same genotype
as in A and B showing apoptotic scars. D,E: apical (D) and basal (E) sections of wing discs
bearing lgl -/- clones (GFP-); in D, F-actin staining shows there is folding at the clonal boundaries
(arrow); in E, pycnotic nuclei inside lgl -/- clones (GFP-) are visible. F,G: Scrib staining of wing
discs bearing lgl -/- MARCM clones (GFP+). In the lower panel, the respective projections along
the Z axis are shown; no changes in localisation of the subapical marker Scrib are appreciable in
the lgl -/- cells (GFP+) with respect to the surrounding wild-type tissue (GFP-), even when mutant
cell nuclei are being basally extruded (arrow). Scale bars are 35 micron. Experiments shown in
A-E have been performed by Nicola A. Grzeschik in Helena Richardson Lab, Peter MacCallum
Cancer Center, Melbourne, VIC.
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Figure 3.2: A,B: lgl -/- clones (GFP-) induced in a wild-type background (GFP+). Wild-type
twin clones are GFP2+. A: active-Caspase 3 staining shows that many apoptotic cells are present
in lgl -/- clone; in A*, a magnification of the region outlined is shown. B: dIAP1 staining; its
expression within the mutant clone (arrow) is visibly lower. C: lgl -/- clones (GFP2+) induced in
a wild-type background (GFP+). Wild-type twin clones are GFP-. pJNK staining shows that the
JNK pathway is activated inside the lgl mutant clone (arrow). Wing discs are outlined in A and
C. Scale bars are 35 micron. D: lgl -/- (left panel) and wild-type (right panel) clone profile from a
twin analysis of lgl4 or wild-type clones sampled in the wing pouch region induced in a wild-type
background. Black bars indicate lgl4 (n=40) and wild-type (n=40) clones and white bars indicate
the respective twins. For this experiment, freshly hatched larvae were collected in a 1-hour time
window and staged on cornmeal medium to 90 hours after hatching before collecting tissues.
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Figure 3.3: A,B: lgl -/- clones (GFP-) induced in a wild-type background (GFP+). Wild-type
twin clones are GFP2+. A: dMyc and aPKC staining; clone is outlined and the projection along
the Z axis shows that dMyc expression within the mutant clone is low all along the disc thickness
(enclosed between two white bars) and does not show defects in apical-basal cell polarity (asterisk).
The apical-basal axis of the disc proper is also shown. Another lgl -/- clone showing low dMyc levels
(arrow) can be observed in B at higher magnification. C: lgl -/- clones double positive for GFP
(GFP2+, arrow) were also induced to show mutant nuclei. Wild-type twin clones are GFP-. In
the projection along the Z axis it can be seen that lgl -/- cells are being basally extruded from the
epithelium. Wing disc is outlined in A. Scale bars are 35 micron. D: β-Gal staining of lgl -/- clones
induced in dm-LacZ individuals showing a mutant clone (outlined) in which dmyc transcriptional
activity does not seem to be impaired. In the projection along the Z axis, in which the apical (A)
and basal (B) sides of the disc proper are shown, note that lgl mutant nuclei are more basal with
respect to neighbours (asterisk). E: A graph showing the average size of lgl -/- clones originated in
distal and proximal regions of the wing disc: distal clones are significantly smaller than proximal
ones; ***= P < 0.001, n=15 each.
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Figure 3.4: A-C: lgl -/-; dIAP1 clones (GFP2+) induced in a wild-type background (GFP+).
Wild-type twin clones are GFP-. Active-Caspase 3 (A) and pJNK (B) signals are both visible
inside lgl mutant clones (arrows). Arrowheads indicate clones in the proximal regions and grey
arrowheads point to active-Caspase 3 signals in wild-type cells surrounding the mutant clone. In
C, an lgl -/-; dIAP clone expressing high levels of dMyc protein is shown (arrow). Wing discs are
outlined in A and B. Scale bars are 35 micron. D: A graph showing the average area of lgl -/-; dIAP1
clones and their wild-type twins; while in distal regions (dark bars) mutant clones are smaller than
their twins, the opposite is true in proximal regions (light bars), ***= P < 0.001, **= P < 0.01,
n=28 and n=22, respectively.
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Figure 3.5: A: lgl -/-; bskDN clones (GFP2+) induced in a wild-type background (GFP+). Wild-
type twin clones are GFP-. dMyc staining shows that the protein is low in the mutant clone in the
wing pouch (outlined). B: A graph showing the average area of lgl -/-; bskDN clones and their wild-
type twins sampled in the distal region of the wing disc, mutant clones are significantly smaller;
**= P < 0.01, n=15. C: a disc of the same genotype as in A is shown in which a lgl -/-; bskDN
clone (GFP2+) in the pleura display increased dMyc staining. Clone boundaries are indicated by
the white dotted line. Scale bars are 35 micron.
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Figure 3.6: A: Lgl antibody staining (red) of tub-YFP::Rab5 discs bearing lgl -/- clones (black).
The wild-type twin clones are red2+. The arrow indicates an lgl mutant clone in the notum where
the YFP::Rab5 signal is slightly increased and the arrowhead indicates an lgl mutant clone in the
pouch where the YFP::Rab5 signal is comparable to that found in the surrounding wild-type tissue.
Magnifications of the mutant clones are shown on the right. B,C: lgl -/-; egrRNAi clones (GFP2+)
induced in wild-type background (GFP+). Wild-type twin clones are GFP-. In B the apical (left)
and basal (right) sections of the same disc are shown; in the basal section a mutant clone contains
cells that are basally excluded from the epithelium (arrow) and shows pJNK staining (C). The
clone contour is outlined in C. D: lgl -/-; YFP::Rab5DN clones (GFP+) induced in a wild-type
background (GFP-), stained with aPKC and dMyc. E,F: lgl -/-; YFP::Rab5DN clones (GFP2+)
induced in a wild-type background (GFP+). Wild-type twin clones are GFP-. In E active-Caspase
3 and in F pJNK signals are visible within the mutant clone (arrows). Wing discs are outlined in
C, E and F. Scale bars are 35 micron.
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Figure 3.7: A-B’: lgl -/- clones (GFP-) in a M+/- background (GFP+). A: dMyc and aPKC
staining. A strong dMyc accumulation is visible in the mutant clone located in the hinge region
(arrows). A Z projection shows that loss of cell polarity accompanies the dramatic overgrowth. A
Z projection of a region of the disc without mutant clones is shown on the right as a control. B-B’:
Activated Caspase 3 and dIAP1 staining. Arrows indicate M+/- cells dying around the mutant
clones; the Z projection confirms that dying cells are outside the lgl -/- tissue. Arrowheads indicate
that dying cells are deprived of dIAP1. C: wild-type clones (GFP-) induced in a M+/- background
(GFP+). No differences in protein level are appreciable in wild-type clones originated in diverse
disc regions with respect to the background. D,E: lgl -/- clones (GFP-) in a M+/- background
(GFP+). In D, dMyc staining shows that while the protein is upregulated in a clone in the
notum (arrow) no increase is observed in mutant cells in the wing pouch (clone outlined), aPKC
staining is also shown. In E Laminin A staining of lgl -/- clones (GFP+) indicates that basement
membrane integrity is lost in several points (arrows). F: β-Gal (white) and dMyc (red) staining
of of lgl -/- clones induced in dm-LacZ -bearing M+/- individuals. The clone in the pleura shows a
dmyc transcriptional upregulation. G,H: lgl -/-; dmycRNAi clones (GFP+) in a M+/- background
(GFP-).G: aPKC staining reveals that lgl -/-; dmycRNAi mutant cells in a M+/- background do not
lose apical-basal polarity (Z projection, compare with A). H: Caspase staining shows that apoptosis
is scattered throughout the disc (arrows). Scale bars are 35 micron.
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Figure 3.8: A,B: Follicular cells’ lgl -/- clones (GFP-) induced in a wild-type background (GFP+).
Wild-type twin clones are GFP2+. A: lgl -/- clones (bordered by white bars) stained for Scrib are
shown in early and late egg chambers. Scrib distribution spreads from lateral to cortical. B: active-
Caspase 3 staining of stage 8-9 egg chambers; arrows indicate wild-type cells (GFP+) undergoing
apoptosis. C: dMyc protein pattern during oogenesis, chamber stages are indicated; from stage
8 onwards dMyc is no longer detectable in follicular cells. D: lgl -/- clones (GFP-) stained for
dMyc, an early (top) and a late (bottom) egg chamber is shown. Bars mark clone boundaries and
arrows indicate dMyc expression inside the mutant clones. E: D: β-Gal (white) and dMyc (red)
staining of lgl -/- clones (marked by bars) induced in dm-LacZ females: dmyc is transcriptionally
upregulated in mutant cells. F: lgl -/- clones (GFP-) in early (top) and late (bottom) egg chamber
stained with dIAP1. The arrows indicate high dIAP1 expression in the lgl -/- clones. G: dMyc
staining in older lgl -/- clones; the arrowhead indicates multilayers of mutant follicular cells, the
arrow indicates mutant cells migrating into the nurse cell territory and the asterisk refers to a large
clone away from the egg chamber pole, where lgl mutant clones usually originate. Scale bars are
35 micron.
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3.2 Tumour Progression
As described in Section 1.2.2 the oncogenic cooperation between constitutive
Ras signalling (RasV12) and the polarity mutants has been very useful to investigate
different aspects of tumour progression such as the genetic requirements for invasion
and migration as well as interactions with the innate immune system. I thus took
advantage of this model to further analyse the features of lgl -induced tumours once
the tumour suppressive mechanisms described in the above section have been eluded.
3.2.1 Constitutive Ras Activity Promotes lgl -/- Neoplastic
Growth in the Wing Imaginal Disc
RasV12 oncogenic cooperation with either scrib, lgl or dlg loss of function has been
extensively described in the eye imaginal disc (Section 1.2.2), however Mene´ndez and
colleagues [82] showed that, at least in the case of lgl, this oncogenic cooperation
also occurs in the imaginal wing disc: the authors showed that lgl -/-; RasV12 clones
dramatically overgrow and proliferate with a much higher rate with respect to the
surrounding cells.
To further analyse the phenotypes associated to this oncogenic cooperation I
generated lgl -/-; RasV12 clones (Fig.3.9). As can be seen in Figures 3.9 and 3.10 they
are indeed larger than wild-type, lgl -/- or RasV12 clones induced with the same system
(also compare in Fig. 3.9 D with A, B and C respectively) and in some cases formed
huge tumorous masses that occupied a large percentage of the disc (Fig. 3.9E)
possibly because of the phenomenon of clone merging previously described [82]. In
lgl -/-; RasV12 clones apical-basal cell polarity was compromised as indicated by aPKC
cortical spreading (Fig. 3.9D, Z projection) while this was never the case for wild-
type, lgl -/- or RasV12 clones (Fig. 3.9A, B and C respectively, Z projections). RasV12
clones, consistent with their documented extrusion from the epithelium [195], formed
cyst-like structures (Fig. 3.9C, arrow) in which, however, apical-basal polarity was
maintained. Moreover, lgl -/-; RasV12 clones in the wing imaginal disc, similarly to
what was reported for the eye disc [70, 74, 75] showed signs of invasive behaviour as
indicated by the production of the basement membrane-degrading enzyme MMP1
(Fig. 3.9F) that never occurred in wild-type, lgl -/- or RasV12 clones (Fig. 3.9A-C).
Activated Caspase-3 positive cells can be seen in wild-type tissue surrounding lgl -/-;
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RasV12 cells (Fig. 3.9F, arrow), suggesting that these latter can acquire competitive
capabilities; nevertheless apoptotic cell death is also present within mutant clones in
the wing pouch, where cell competition is fiercer (Fig. 3.9F, arrowhead), confirming
the hypothesis that merging of multiple clones could be required for mutant cells to
avoid apoptotic elimination [82].
The data presented in Section 3.1 showed that lgl -/- overgrowth in all the contexts
analysed was always accompanied by high levels of dMyc protein. Indeed, also in
lgl -/-; RasV12 mutant clones throughout the disc dMyc was highly expressed (Fig.
3.9D also reported in [82]). Interestingly, while inhibiting cell death (Figures 3.4 and
3.5) or limiting the proliferative drive of the surrounding tissue (Fig. 3.7) was not
sufficient to promote lgl -/- overgrowth and dMyc upregulation in the wing pouch,
RasV12 expression in lgl -/- cells allowed them to form large, round-shaped clones
characterised by high levels of dMyc, loss of apical-basal polarity and invasiveness
also in this region (Fig. 3.9D and F)1. Since Ras signalling pathway is known to
stabilise dMyc at a post-transcriptional level [92, 101] it may allow to counteract
lgl LOF-dependent downregulation of dMyc protein abundance (see Section 3.1.2)
and promote overgrowth in distal regions where surrounding wild-type cells show
the highest dMyc expression (Fig. 2.5A in Section 2.2.3).
Altogether these data indicate that lgl loss of function and RasV12 oncogenic
cooperation in the wing disc epithelium is characterised by neoplastic features such
as overgrowth, loss of cell polarity and invasiveness and is accompanied by high
levels of dMyc even in those regions where lgl -/- growth is usually restricted.
3.2.2 Raf/MAPK and not PI3K Signalling Cooperate with
lgl -/- Downstream of Ras
Activated Ras signals through two main downstream growth-promoting path-
ways: the Raf/MAPK and the PI3K pathway (Section 1.3.1). Both Ras effectors
are activated in lgl -/-; RasV12 clones as can be seen by intense staining of the diphos-
phorylated form of the MAPK, Erk, (dpErk) and of phosphorylated Akt (pAkt) in
Figure 3.9G. I thus investigated how these pathways contribute to the oncogenic
cooperation with lgl loss of function. As can be seen in Figure 3.12A, expression of
1The neoplastic traits described in the text for all the genotypes analysed in this work are
summarised in Figure 3.18
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an activated form of the catalytic subunit of PI3K, dp110CAAX (see Fig. 2.6 in Sec-
tion 2.2.3 for a validation) failed to rescue the defective growth of lgl mutant cells.
Indeed, lgl -/-; dp110CAAX clones are smaller than lgl -/- clones (Fig. 3.10), show a
wild-type morphology (Fig. 3.12A) and no significant impairments in cell polarity
(Fig. 3.12A, Z projection) or MMP1 expression (not shown) were observed. Consis-
tently, a similar inability of activated PI3K in promoting lgl -/- cells growth was also
observed upon inhibition of upstream Ras activity by means of an RNAi construct
(see Fig. 2.7 in Section 2.2.3 for a validation). lgl -/-; dp110CAAX; RasRNAi clones
(Fig. 3.12B) were comparable to lgl -/-; dp110CAAX (Fig. 3.10) and smaller than
lgl -/- clones (Fig. 3.10), did not lose apical-basal-polarity (not shown) or showed
MMP1 expression (Fig. 3.12B).
On the other hand, expression of a constitutively activated form of human Raf
(hRafGOF) in lgl -/- clones fully recapitulated the phenotypes observed for lgl -/-;
RasV12 (Fig. 3.12C and D). hRaf has been demonstrated to be functionally con-
served in Drosophila [196] and it indeed activated MAPK pathway as shown by
dpErk staining (Fig. 2.8 in Section 2.2.3). lgl -/-; hRaf GOF clones are overgrown and
round in shape (Fig. 3.12C and 3.10), lose apical-basal cell polarity (Fig. 3.12C,
Z projection) and produce the basement membrane-degrading enzime MMP1 (Fig.
3.12D). Moreover, similarly to lgl -/-; RasV12 ones, also lgl -/-; hRaf GOF clones were
able to grow in the wing pouch (Fig. 3.11) and extensive tumorous growth with
mutant cells taking over half of the entire disc was also observed (Fig. 3.12D).
Knockdown of Ras activity in lgl -/-; hRaf GOF cells did not affect their growth or
neoplastic behaviour. As can be observed in Figure 3.10, lgl -/-; hRaf GOF; RasRNAi
clones were comparable in size to lgl -/-; hRaf GOF clones and similarly showed com-
promised apical-basal cell polarity (Fig. 3.12E, Z projection) and expressed high
levels of MMP1 in proximal regions as well as in the wing pouch (Fig. 3.12F, arrow
and arrowhead respectively).
Since both Raf/MAPK and PI3K pathways are able to stabilise dMyc protein
(see Section 1.4.2, [92, 164, 166]) I analysed dMyc abundance in lgl -/- cells in which
these pathways were activated. Interestingly, no increase in dMyc levels was de-
tected in lgl -/-; dp110CAAX clones (Fig. 3.12A) nor in lgl -/-; dp110CAAX; RasRNAi
clones (not shown). On the contrary high levels of dMyc were detected both in
lgl -/-; hRaf GOF clones (Fig. 3.12C) and lgl -/-; hRaf GOF; RasRNAi clones (Fig.
3.12E) throughout the wing disc, suggesting that post-transcriptional regulation
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of dMyc downstream of Ras signalling is due to the Raf/MAPK activity and that
PI3K-dependent stabilisation of dMyc, given its transient nature (see Section 1.4.2,
[92, 166]) may not be sufficient to allow a significant accumulation of the protein.
Taken together these data indicate that, similarly to what has been observed
for scrib-/- clones in the eye disc [60], the Raf/MAPK branch downstream of Ras
signalling is responsible for the oncogenic cooperation with lgl loss of function. Its
activation indeed phenocopied the effect of RasV12 on lgl mutant cells while activated
PI3K had no effect on mutant clones behaviour. Moreover, once again, neoplastic
behaviour of lgl mutant clones was found to positively correlate with dMyc protein
levels.
3.2.3 dMyc Is Necessary and Sufficient to Promote lgl -/-
Cells Growth
The fact that high levels of dMyc are found to be associated with neoplastic lgl -/-;
RasV12 and lgl -/-; hRaf GOF clones but not with the poorly-grown lgl -/-; dp110CAAX
clones (see above) suggests that dMyc might play a key role in the oncogenic coop-
eration between lgl loss and activated Ras signalling as it does in driving tumorous
growth of lgl -/- clones generated in the Minute+/- background in the wing imaginal
disc (Section 3.1.5) or in the follicular epithelium (Section 3.1.6). Indeed expression
of a dmycRNAi construct in lgl -/-; RasV12 clones drastically reduced their size (Fig.
3.13A) and rescued the defects in apical basal cell polarity (Fig. 3.13A, Z projec-
tion); moreover no MMP1 expression was detected in the wing disc proper (Fig.
3.13A) and mutant clones were recovered at an extremely low frequency suggesting
that dMyc is required for lgl -/-; RasV12 cells neoplastic behaviour. To test whether
dMyc is per se sufficient to drive lgl -/- cells growth in a wild-type background, I ex-
pressed a UAS-dmyc construct in lgl -/- clones. As can be observed in Figure 3.13B,
lgl -/-; dmyc clones were round in shape and massively overgrown, with larger clones
located in the proximal regions of the disc (Fig. 3.10 and 3.11). A staining for
the apical marker aPKC indicated that lgl -/-; dmyc cells displayed impaired apical-
basal polarity (Fig. 3.13D, Z projection) and signs of discontinuity of the basement
membrane across the mutant clones were detected by staining for Laminin A (Fig.
3.13E, arrows), indicating that lgl -/-; dmyc cells acquire invasive properties.
As discussed above, lgl -/-; dmyc clones in the wing pouch are on average smaller
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than those in wing hinge/pleura (3.11) and also displayed a different behaviour: in
Figure 3.13D, the arrow indicates a clone in the wing pouch that does not exhibit
evident tumourous properties. Notably, despite expression of UAS-dmyc transgene,
these clones do not show the high levels of dMyc protein observable in the clone
located in the hinge. Since dmyc expression was induced using a heterologous pro-
moter, the fact that dMyc protein is low in the lgl mutant clones in the wing pouch
suggests that in this region the lgl -dependent post-transcriptional downregulation
of dMyc (see Section 3.1.2) counteracts the accumulation of the protein even when
the gene is highly expressed. This probably explains why dmyc overexpression in
lgl -/- cells had a different outcome depending on the region of the disc where clones
were located. In lgl -/-; dmyc clones in the proximal regions, where the endogenous
levels are very low, dMyc is upregulated (Fig. 3.13D) and thus mutant cells are able
to overgrow and outcompete surrounding cells as indicated by Caspase 3 staining in
wild-type cells at clonal border (Fig. 3.13C, arrowheads). lgl -/-; dmyc clones located
in the distal region instead fail to upregulate dMyc (Fig. 3.13D) and the high levels
of the endogenous protein in this region are likely to prevent these lgl -/-; dmyc clones
from acquiring a competitive advantage as suggested by Caspase 3-positive mutant
cells (3.13C, arrows).
I then asked if dMyc overexpression was able to cooperate with lgl loss of func-
tion even in the absence of endogenous Ras signalling. lgl -/-; dmyc; RasRNAi clones
in the proximal regions lost cell polarity and expressed MMP1 (not shown) indi-
cating that they acquired neoplastic features. These clones moderately overgrew
(Fig. 3.11), while those located in the wing pouch do not overgrow (Fig. 3.11), do
not express MMP1 or lose apical-basal polarity (not shown). Since many pycnotic
nuclei were observed in these clones (not shown), the inhibition of Ras signalling
and its pro-survival effects (Section 1.3.2) may enhance apoptotic elimination of
dMyc-overexpressing cells, possibly causing a reduction in size of proximal clones
and completely abolishing growth in the wing pouch, where cell competition is also
at work. Indeed coexpression of dIAP1 in lgl -/-; dmyc; RasRNAi clones significantly
increased their size both in the proximal and distal regions (Fig. 3.11 and 3.13F);
nevertheless tumorous features such as high MMP1 expression and cell polarity loss
were invariantly observed only in clones outside the wing pouch indicating that a
favourable dMyc gradient is however necessary for neoplastic growth to occur.
Taken together, these data demonstrate that dMyc is necessary to lgl -/-; RasV12
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oncogenic cooperation and its stable upregulation is sufficient to promote tumorous
growth of lgl mutant cells even in the absence of Ras signalling.
3.2.4 Oncogenic Cooperation between lgl -/- and Activated
Raf/MAPK Signalling Requires Yki Function
Mene´ndez and colleagues [82] reported that in lgl -/-; RasV12 clones the transcrip-
tional coactivator Yorkie (Yki) is mainly localised to the nucleus and its target gene
dIAP1 is upregulated, indicating that the Hippo pathway is inactive in these cells
(see 1.2.1.2). Since RasV12 clones did not show Yki nuclear enrichment [82], it is
plausible that this effect is due to lgl mutation. Indeed it has been demonstrated
that lgl loss of function is able to deregulate this pathway both in the eye [43] and
wing imaginal disc (in a condition in which mutant cells growth is not restricted
by cell competition) [45] (1.2.1.2). Since I observed an increase in Yki nuclear lo-
calisation in lgl -/-; hRaf GOF clones (not shown), it is possible that deregulation of
Hpo pathway is a feature of overgrown lgl mutant tissues. As we and others demon-
strated, dmyc is a Yki transcriptional target [156, 157]; this clearly suggests that
activation of Yki in lgl -/-; RasV12 or lgl -/-; hRaf GOF clones could significantly con-
tribute to the upregulation of dMyc and to the tumorous features of these cells. To
test this hypothesis I lowered Yki levels in lgl -/-; hRaf GOF cells by co-expressing a
YkiRNAi construct (see Fig. 2.9 in Section 2.2.3 for a validation). In lgl -/-; hRaf GOF;
YkiRNAi clones growth was drastically reduced (Fig. 3.14A e 3.10), mutant clones
were still round in shape but apical-basal polarity of mutant cells was not altered
(Fig. 3.14A, Z projection) and no MMP1 expression was detected throughout the
wing disc proper, indicating that these clones had lost their tumorous behaviour.
Consistently, dMyc levels within lgl -/-; hRaf GOF; YkiRNAi clones were comparable
to those of the surrounding wild-type tissue (Fig. 3.14B); some accumulation of the
protein was detected in wild-type cells at clonal border (Fig. 3.14B, arrow) suggest-
ing that a phenomenon of compensatory proliferation may take place in these cells.
These data indicate that Yki-dependent dmyc transcriptional upregulation is re-
quired for this oncogenic cooperation to occur, although other Yki targets may also
play a role in the tumourigenesis downstream of lgl -/-; hRaf GOF.
I then asked whether Yki could cooperate with lgl loss of function in promoting
neoplastic growth and overexpressed a wild-type form of Yki in lgl mutant cells. As
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can be appreciated in Fig. 3.14C and 3.11, lgl -/-; Yki clones originated in the prox-
imal regions are overgrown, display strong impairments in apical basal cell polarity
and are invasive as indicated by MMP1 staining (Fig. 3.14D). On the other hand,
clones generated in the wing pouch are smaller than those in the hinge and pleura
(Fig. 3.11) and show, in most cases, dMyc levels comparable to those of the sur-
rounding tissue (not shown). Since Yki overexpression is per se able to upregulate
dMyc in the wing pouch [156], failure to do so in the context of lgl loss of function
might be due to the lgl LOF-dependent impairment in dMyc post-transcriptional
stabilisation reported in other genetic contexts (Sections 3.1.2 and 3.2.3); alter-
natively lgl mutation might deregulate the Hpo pathway, and thus promote Yki
activity, to a lesser extent in the wing pouch. It was recently demonstrated that,
similarly to lgl, scrib mutant clones in the wing imaginal disc are subject to cell
competition [83]; while in non-competitive conditions scrib-/- clones show enhanced
Yki activity, when competitive interactions take place upregulation of Yki activity
is prevented. A similar mechanism can thus be hypothesised for lgl mutant cells in
the wing pouch where competitive stress is high. Analysis of dMyc transcription
levels by means of the dmyc-LacZ reporter and of other Yki transcriptional targets
in lgl -/-; Yki clones in the wing pouch or the use of a constitutively active form of
Yki will help clarify this issue.
Inhibition of Ras signalling in lgl -/-; Yki clones further enhanced the difference
in clonal behaviour in proximal vs distal regions: despite expression of RasRNAi led
to a reduction in clone size throughout the tissue (Fig. 3.14E and 3.10), clones orig-
inated in the wing pouch, besides having a correct apical-basal polarity (Fig. 3.14E,
Z projection, arrow) and not showing MMP1 production (Fig. 3.14F, arrow), ap-
peared wild-type in shape and consistently, no upregulation of dMyc was detected in
this region (Fig. 3.14E, outlined clone), suggesting that dMyc post-transcriptional
stabilisation may indeed play a key role in unleashing the neoplastic features of lgl -/-
clones in distal regions.
Altogether this data show that lgl loss of function-dependent deregulation of
the Hpo pathway is required to promote oncogenic cooperation between lgl -/- and
activated Raf/MAPK signalling, but the expression of a wild-type form of Yorkie is
not sufficient to drive neoplastic growth of lgl -/- cells in the wing pouch.
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3.2.5 lgl -/-; RasV12 Cells Interact With the Tracheal System
and Express Tracheal Fate Determinants
In the process of analysing lgl -/-; RasV12 cells clonal behaviour an interesting phe-
nomenon emerged. Basally to the wing disc proper, abnormal tracheal networks were
often observed that contained both GFP positive (lgl -/-; RasV12) and GFP negative
cells (Fig. 3.15A). Tracheal tubes are the organs responsible for supplying larval
tissues with oxygen and are specified by the expression of the transcription factor
Trachealess (Trh, see Section 1.3.2). Staining with a specific antibody revealed that
some lgl -/-; RasV12 clones expressed Trh similarly to tracheal cells (Fig. 3.15B and
C, arrows). Most of these Trh-expressing mutant clones were clearly interconnected
with tracheal segments (Fig. 3.15A, C and D), but in some cases Trh-positive lgl -/-;
RasV12 cells that did not undertake obvious interaction with tracheal tubes were
also recovered (Fig. 3.15B, arrow). To rule out the possibility that these clones
could have originated from tracheal tissue, I stained for Engrailed (En) and Cu-
bitus interuptus (Ci) which mark the posterior and anterior compartments of the
imaginal wing disc epithelium respectively; as can be appreciated in Figure 3.15B
and C no differences in Ci expression are visible in Trh-positive (arrow) and Trh-
negative lgl -/-; RasV12 adjacent clones, suggesting that these cells are of epithelial
origin and are probably undergoing a phenomenon of trans-differentiation. Pastor-
Pareja and colleagues demonstrated that JAK-STAT pathway is hyperactivated in
lgl -/-; RasV12 clones [79] (see Section 1.2.2) and since Trh is a STAT transcriptional
target [116], it is possible that activation of this pathway might promote trans-
differentiation of mutant cells. Further experiments will be required to confirm and
characterise this interesting phenomenon. The acquisition of tracheal fate by lgl -/-;
RasV12 would be reminiscent of the recently documented ability of human carcinoma
cells to trans-differentiate into endothelial cells and form vascular-like structures to
increase oxygen supply in the early stages of tumour development, a process known
as vasculogenic mimicry (see Section 1.1).
In the light of these observations it is tempting to speculate that the interactions
between lgl -/-; RasV12 clones and the tracheal network described above might serve
the tumour to gain access to an oxygen source to sustain extensive growth in a pro-
cess resembling mammalian neoangiogenesis or vasculogenic mimicry (see Section
1.1). As reported in Section 1.3.2, imaginal wing disc cells that suffer from hypoxia
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express branchless (bnl) gene, which encodes Drosophila FGF homologue; FGF/Bnl
production attracts tracheal cells and promotes their migration. To investigate if
lgl -/-; RasV12 tumours expressed FGF/Bnl I employed a bnl-LacZ reporter construct.
As can be seen in Figure 3.15F, wild-type imaginal wing discs possess a region of
FGF/Bnl production which is located in the notum and stimulates migration and
proliferation of the air sac tracheal cells (arrow). Ectopic expression of FGF/Bnl is
clearly visible in lgl -/-; RasV12 cells (Fig. 3.15E); this allows to speculate that in-
deed lgl -/-; RasV12 tumours might undergo a “tracheogenic switch” to gain access to
oxygen sources as it happens for mammalian tumours which secrete pro-angiogenic
factors such as VEGF and FGF to attract blood vessels and stimulate their growth
or produce vascular structures through a trans-differentiative process. It will thus be
interesting to explore a possible correlation between FGF/Bnl production in lgl -/-;
RasV12 clones and the interaction with tracheal system or the activation of Trh ex-
pression in mutant cells them-selves.
3.2.6 dMyc Is Not Required for Mutant Cells Interactions
with the Tracheal System
As I showed in Section 3.2.3, knockdown of dmyc expression in lgl -/-; RasV12
clones dramatically abolishes their growth (Fig. 3.13A). Unexpectedly, however, ab-
normal interactions between mutant cells and the tracheal network were still present
and even enhanced as can be appreciated in Figure 3.16A and B where basal sec-
tions of discs of the same genotype as in Fig. 3.13A are shown. A continuum of
mutant cells (GFP+) from the apical to the basal surface of the epithelium can be
observed in the Z projection of these discs (Fig 3.16B) with the basally located cells
physically enveloping tracheal tubes. While mutant cells in apical sections do not
show MMP1 expression (Fig. 3.13A), those located basally express extremely high
levels of basement membrane-remodelling enzyme. This suggests that, since these
cells no longer belong to the epithelial sheath but are still in continuity with it, they
might be in the process of active migration over the tracheal segment.
Interestingly, similar interactions between mutant cells and the tracheal network
were observed for lgl -/-; hRaf GOF; YkiRNAi clones (Fig. 3.16C and D): wing discs
bearing clones of this genotype invariantly showed mutant cells contacting tracheal
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tubes (outlined) and forming a network that links several distant clones. Notably
also in these clones dMyc levels are reduced (Fig. 3.14B) further suggesting that
dMyc is probably dispensable for this phenomenon to occur and might even coun-
teract it.
Since lgl -/-; RasV12; dmycRNAi clones were recovered at an extremely low fre-
quency, to confirm this hypothesis, a more efficient genetic system was used. A
lglRNAi construct was expressed in the posterior compartment of the imaginal wing
disc, under the control of the engrailed, en, promoter (see Fig. 2.10 in Section 2.2.3
for a validation of the RNAi construct and for en expression pattern). Since cell com-
petition does not affect cells belonging to different compartments [148], lgl -deficient
cells are viable and able to grow in this context; moreover these experiments were
carried out using M+/- individuals that show a delay in development (Section 1.4.3)
and thus allow tumorous growth to proceed for up to 11 days. In these conditions,
as can be seen in Figure 3.17A, lglRNAi-expressing compartments massively over-
grow, lose cell polarity and express high levels of dMyc, thus recapitulating many
of the features of lgl -/-; RasV12 clones. Indeed, extensive interaction with the tra-
cheal network is reproducibly observed in basal section of these discs with large
clusters of mutant cells migrating and extending cytonemes towards tracheal tubes
(Fig. 3.17B and B’). Extreme phenotypes in which tumorous cells formed tubular
structures them-selves where also observed (Fig. 3.17C). Strikingly, expression of
the dmycRNAi construct in these tumorous discs totally abolished growth leading
to a severe reduction of the posterior compartment (Fig. 3.17D) but did not pre-
vent lglRNAi; dmycRNAi cells from migrating towards and interacting with tracheal
tubes as can be seen in Fig. 3.17D’ where basal sections are shown. Since expression
of dmycRNAi alone in the same genetic system does not induce any of these pheno-
types (Fig. 3.17E), the effect of dMyc reduction is specific to lgl -deprived tissue.
Altogether these data indicate that dMyc is dispensable for the extensive inter-
action that tumorous lgl -deficient cells undertake with the tracheal system.
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Figure 3.9: A-C: aPKC (white) and MMP1 (red) staining of wild-type (A), lgl -/- (B) and RasV12
(C) clones (GFP+) induced in a wild-type background (GFP-). The Z projections of each disc are
shown (apical, A, and basal, B, polarity is indicated). Neither impairments in aPKC localisation
nor MMP1 expression are visible in clones of these genotypes. In C the arrow indicates a RasV12
clone forming a cyst-like structure. D-G: lgl -/-; RasV12 clones (GFP+) generated in a wild-
type background (GFP-). In D and E, aPKC (white) and dMyc (red) staining are reported. A Z
projection in D shows that loss of cell polarity accompanies the overgrowth; the apical-basal axis of
the disc proper is shown. Increased dMyc levels are visible in lgl -/-; RasV12 clones both in proximal
and distal regions. In E an extreme phenotype in which mutant cells occupy a large proportion of
the disc is observable. F: Caspase 3 (red) and MMP1 (white) staining: the arrow indicates wild-
type cells undergoing cell death at the clonal border, while arrowheads points towards Caspase
3-positive cells within the mutant clone. MMP1 is expressed at high levels in lgl -/-; RasV12 clones.
G: dpErk (white) and pAkt (red) staining. Arrows indicate mutant clones where pAkt staining is
particularly intense. All images are 400x.
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Figure 3.10: A graph showing the average clone area of all the genotypes analysed in Section
3.2 sampled all across the imaginal wing disc. The dotted line is referred to the area of wild-
type clones. Areas of clones growing as multilayers are likely to be underestimated. Error bars
indicate the standard deviation of the mean; n=26 each genotype. Due to low sample number, the
data concerning lgl -/-; RasV12; dmycRNAi were not included in the analysis. All the comparisons
described in the text are statistically significant with a P < 0.001 except for that between lgl -/-;
dmyc and lgl -/-; dmyc; RasRNAi clones for which P < 0.01. No statistical difference was found for
the following comparisons: lgl -/-; RasV12 versus lgl -/-; hRaf GOF and lgl -/-; hRaf GOF versus lgl -/-;
hRaf GOF; RasRNAi.
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Figure 3.11: A graph showing the average clone area of all the genotypes analysed in Section
3.2 sampled in distal (dark bars) and proximal (light bars). The dotted line is referred to the
area of wild-type clones. Error bars indicate the standard deviation of the mean; n=13 each
genotype for both regions. All the comparisons described in the text are statistically significant
with a P < 0.001. No statistical difference was found between the average areas of proximal and
distal clones of the following genotypes: wild-type, lgl -/-; RasV12, lgl -/-; hRaf GOF, lgl -/-; hRaf GOF,
RasRNAi, lgl -/-; hRaf GOF, RasRNAi and lgl -/-; hRaf GOF, YkiRNAi.
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Figure 3.12: A: lgl -/-; dp110CAAX clones (GFP+) generated in a wild-type background (GFP-).
aPKC staining (white) in the Z projection shows that mutant cells do not have impaired apical-
basal polarity (indicated with A-B). dMyc staining (red) is also shown; two clones are outlined
(arrowed in A, left) as an example in which no increase in dMyc levels is observed. B: lgl -/-;
dp110CAAX; RasRNAi clones (GFP+) generated in a wild-type background (GFP-) stained with
aPKC (white) and MMP1 (red). No MMP1 expression is visible in mutant cells. MMP1 signal in
the notum corresponds to a tracheal tube [197]. C,D: lgl -/-; hRaf GOF clones (GFP+) generated in
a wild-type background (GFP-). C: aPKC (white) and dMyc (red) staining: Z projection shows
that loss of cell polarity accompanies the overgrowth of these clones (the apical-basal axis of the
disc proper is shown); increased expression of dMyc is visible in mutant clones regardless of the
region they are located. D: aPKC (white) and MMP1 (red) staining, high levels of MMP1 are
associated to lgl -/-; hRaf GOF clones. E,F: lgl -/-; hRaf GOF; RasRNAi clones (GFP+) generated in
a wild-type background (GFP-). In E loss of apical-basal cell polarity (aPKC staining, white, in
the Z projection) and dMyc upregulation (red) are observable in mutant tissue all across the disc.
F: MMP1 staining, both in distal (arrowhead) and in proximal (arrow) clones MMP1 production
is evident; wing disc is outlined. Apical-basal polarity of the wing disc proper is indicated in the
Z projections. All images are 400x.
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Figure 3.13: A: lgl -/-; RasV12; dmycRNAi clones (GFP+) generated in a wild-type background
(GFP-). aPKC staining (white) indicates that mutant cells are not impaired in apical-basal po-
larity as can be observed in the Z projection. No positivity in MMP1 staining (red) is detected
in these cells. B-E: lgl -/-; dmyc clones (GFP+) in a wild-type background (GFP-). B: clone
morphology, DAPI marks nuclei. C: active-Caspase 3 and dIAP1 staining; the arrows indicate
groups of mutant cells undergoing autonomous apoptosis and the arrowheads indicate wild-type
cells dying outside a mutant clone. D: dMyc and aPKC staining; the projection along the Z axis
shows loss of cell polarity; the multilayered nature of the epithelium inside the mutant clone is
also visible. The arrows indicate clones in the wing pouch that show low levels of dMyc protein.
E: Laminin A staining; the arrows indicate regions of discontinuity. Wing disc is outlined in D. F:
lgl -/-; dmyc; dIAP1 ; RasRNAi clones (GFP+) in a wild-type background (GFP-). aPKC staining
reveal impairments in cell polarity (Z projection) and discontinuities in the epithelial sheath (see
magnification of the region outlined). MMP1 antibody positively stains mutant cells as visible in
the red channel. The apical-basal axis of the disc proper is indicated in all Z projections. Scale
bars are 35 micron.
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Figure 3.14: A,B: lgl -/-; hRaf GOF; YkiRNAi clones (GFP+) generated in a wild-type background
(GFP-). A: aPKC staining: as can be observed in the Z projection aPKC is correctly localised
to the apical surface of mutant clones in all regions of the disc. B: Yki (white) and dMyc (red)
staining; a few clones in the wing pouch are outlined as an example which show low levels of dMyc,
the arrow indicates an enrichment of this latter in the wild-type tissue at the clonal border. C,D:
lgl -/-;Yki clones (GFP+) generated in a wild-type background (GFP-). In C loss of cell polarity, as
indicated by aPKC staining, as well as multilayered growth are clearly visible in the Z projection.
dMyc staining is also shown in red: mutant clones express high levels of the protein. D: MMP1
expression is high in clones grown in the proximal regions. E,F: lgl -/-; Yki ; RasRNAi clones
(GFP+) generated in a wild-type background (GFP-). E: aPKC (white) and dMyc (red) staining.
Correct apical-basal polarity is maintained in distal mutant clones as shown in the Z projection
(the arrow indicates the position of the GFP+ cells). A clone in the wing pouch is outlined which
shows a wild-type morphology and no upregulation of dMyc. In F, the arrow indicates a clone
in the wing pouch that does not express MMP1 and has a wild type morphology; MMP1 signal
is observable in proximal clones. The apical-basal axis of the disc proper is indicated in all Z
projections. All images are 400x.
3.2 Tumour Progression 105
Figure 3.15: A-D: lgl -/-; RasV12 clones (GFP+) generated in a wild-type background (GFP-).
A-D: Trh staining. In A, the basal section and relative magnification of a disc in which mutant cells
(outlined) express Trh and are in contact with the tracheal segment are shown. Similar interactions
are also shown in C (the arrow indicates a Trh-positive mutant clone contacting a tracheal branch)
and D (the arrow indicates the tracheal segment). In B a Trh-positive clone not interacting with
tracheal tubes is indicated by the arrow. Staining with En and Ci (both red) in B and C shows
that the Trh-positive clone (outlined and arrow) express Ci similarly to an adjacent Trh-negative
clone (outlined). Wing disc is outlined in A and C. E: lgl -/-; RasV12 clones (GFP+) generated
in bnl-LacZ individuals. Many cells in the mutant clone (outlined) are positive to β-Gal staining
indicating that the FGF/Bnl promoter is active. F: β-Gal (red) and (aPKC) staining of bnl-LacZ
wing discs: endogenous FGF/Bnl is produced in a limited area located in the notum, in proximity
of which the air sac develops (arrow). All images are 400x except for magnification in A.
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Figure 3.16: A,B: lgl -/-; RasV12; dmycRNAi clones (GFP+) generated in a wild-type background
(GFP-). aPKC (white) and MMP1 (red) staining in basal sections of the disc are shown. Mutant
cells are clearly interconnected with the tracheal segments and show high levels of MMP1 (less
intense staining is also visible in GFP-negative tracheae). In B a Z projection resulting from
superimposition of several Z stacks is shown in which continuity between the apical and the basal
GFP+ cells is appreciable. Apical-basal polarity of the wing disc proper is also shown. C,D: lgl -/-;
hRaf GOF; YkiRNAi clones (GFP+) generated in a wild-type background (GFP-). Superimposition
of a basal (clones in green) and an apical (clones in blue) section of the disc (outlined) is shown.
Stainings are: Yki (white, apical) and MMP1 (red, basal). Basal clones are coplanar with the
tracheal branches (outlined in red). In A-D wing discs are outlined. All images are 400x.
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Figure 3.17: A,C: lglRNAi expression in the posterior compartment (GFP+) of M+/- wing discs.
A: aPKC (white) and dMyc (red) staining. The compartment overgrowth is accompanied by loss
of tissue architecture and dMyc accumulation. B: MMP1 staining reveals interactions between
mutant cells and tracheal tubes, the outlined region is magnified in B’. C: lgl -deprived cells form
tracheal-like structures; stainings are MMP1 (red) and aPKC (white). D,D’: lglRNAi, dmycRNAi
expression in the posterior compartment (GFP+) of M+/- wing discs. In D an apical section is
shown in which a reduction in compartment size is evident, in D’ MMP1 staining (red) shows that
mutant cells migrate towards and contact tracheal segments; aPKC staining (white) is also shown.
E: dmycRNAi expression in the posterior compartment (GFP+) of M+/- wing discs. No major
alterations in disc morphology are visible as indicated by aPKC and MMP1 staining, white and
red respectively. All images are 400x, except for magnification in B’. The experiments shown in
this Figure have been carried out by Elisabetta Fontana, an undergraduate student in our lab.
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Figure 3.18: Summary of the neoplastic traits analysed for the genotypes discussed in Section
3.2. Note that roundness is a parameter of non-wild-type shape and characterises both hyperplastic
and neoplastic growth. Detailed description in given in the text. BM, basement membrane; A/B,
apical/basal.
Chapter 4
Conclusions and Perspectives
Deciphering the molecular crosstalk occurring between genetically different cell
populations growing within a tissue is relevant to both developmental and cancer
biology. A world of intimate and extensive interactions between transformed and
normal cells has been unveiled in the past decades and has revolutionised the field of
cancer biology. Much has been done towards the understanding of how the tumour
microenvironment promotes and sustains tumour development whilst very little is
known about possible safe-guard mechanisms that might counteract cancer devel-
opment. Due to the conservation of signalling pathways involved in cell growth,
cell proliferation and cell death between fly and humans, Drosophila represents an
ideal system for analysing the early events occurring in tumourigenesis upon the
confrontation of different cell populations.
In Drosophila, lgl mutant larvae show neoplastic overgrowth of the epithelial
tissues, whereas lgl -/- cells growing in mosaic larvae are usually eliminated by cell
death; thus this opposite phenotype results from mechanisms triggered by the con-
frontation of lgl - and lgl+ cells. In literature, two main processes have been described
to mediate the elimination of unfit/polarity-deficient cells from Drosophila imaginal
epithelia: Cell Competition (Section 1.4.3) and Intrinsic Tumour Suppression (ITS)
(Section 1.2.1.2). Both mechanisms work by the induction of cell death in the mu-
tant population; in addition, in the first one normal tissue grows at the expense of
the unfit cells. There is suggestive evidence in literature regarding the relevance of
cell competition to cancer biology 1.4.3.2, however a clear connection between cell
competition and tumour development is yet to be made.
dMyc oncoprotein has been shown to play a leading role in cell competition:
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cells bearing low levels of this protein die by apoptosis if growing in a high dMyc-
expressing context [148, 171]. In ITS, cell death is instead triggered in the presence
of cells with impaired polarity in an otherwise normal epithelium [61]. I found that
JNK-mediated apoptosis is the main process through which lgl mutant clones are
eliminated from imaginal wing epithelia. Clonal phenotype is however different in
the distal (wing pouch) and proximal (hinge/pleura) regions of the wing disc: lgl
mutant clones located in the wing pouch showed massive cell death and were rapidly
extruded from the epithelium, while clones located in the hinge/pleura grew to a
larger extent, although they never formed tumours. This regional difference in clonal
behaviour could depend on dMyc protein pattern in the wing disc; the protein is
highly expressed in the wing pouch and very low in the hinge/pleura. Indeed lgl -/-
clones in the wing pouch expressed very low levels of dMyc protein relative to the
background; such clones died and were replaced by the surrounding wild-type tis-
sue. Moreover, lgl -/- clonal behaviour in the slow-dividing Minute background or in
the follicular epithelium switched from “outcompeted”to “overgrown and invasive”,
with the tumourous mutant clone invariantly showing high dMyc levels relative to
the neighbouring tissue. Lowering dMyc abundance inside those clones prevented
the tumourous phenotype, whereas dMyc overexpression in lgl mutant clones in a
wild-type background was able to confer increased proliferation, survival and in-
vasive properties clearly demonstrating that dMyc plays a key role in lgl -/- cells
behaviour. Notably, dMyc effect on lgl clonal behaviour seems very specific as acti-
vation of a growth-promoting pathway that however failed to increase dMyc levels
within mutant cells, such as PI3K, was unable to promote their neoplastic growth.
I also showed that ITS is not responsible for lgl mutant cells elimination in the
wing pouch, in contrast to what was observed for the other two neoplastic tumour
suppressor mutants scrib and dlg [61]; lgl -/- clones located in the distal regions still
died even upon ITS inhibition. On the other hand, its blockade in lgl mutant tis-
sue located outside of the wing pouch resulted in clonal overgrowth (accompanied
by dMyc upregulation), indicating that ITS and cell competition are likely to be
involved in the elimination of lgl mutant cells in complementary regions.
This is first evidence that cell competition functions as a tumour suppressive
mechanisms in preserving epithelial integrity in Drosophila. Besides a well estab-
lished role in favouring expansion of cells with supercompetitive abilities at the
expenses of the surrounding tissue, it also serves the elimination of damaged and
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potentially harmful cells before they acquire additional oncogenic mutations.
Several reports have been published that confirmed that polarity-deficient cells
are subject to cell competition, both in Drosophila [82, 83, 180] and mammalian
epithelia [180, 181]. Indeed, inducible cell culture systems have been employed
to demonstrate that such non-cell autonomous phenomenon is conserved. Tamori
and colleagues knocked down the Lgl interactor Mahjong (that they proved to be
involved in lgl -mediated cell competition in Drosophila) in Madin-Darby canine kid-
ney epithelial cells and showed that Mahjong-deficient cells undergo apoptotic cell
death only when surrounded by wild-type cells [180]. Similar results were obtained
by Norman and colleagues upon scrib knockdown in the same cell line: the authors
demonstrated that while ScribKD cells were viable when surrounded by cells of the
same kind, they died and were apically extruded in presence of ScribWT cells. In
addition, in a murine model of familial polyposis, APC- cells deprived of c-Myc were
out-competed by surrounding, c-Myc-expressing wild-type cells, thereby reverting
the malignant phenotype, suggesting that Myc-induced cell competition could play
a role in mammalian carcinogenesis [182]. Hence, given the high degree of conserva-
tion of these processes and of the molecules involved, the results I showed are likely
to be relevant to human cancer biology.
The work I presented also demonstrates that dMyc protein not only affects the
ability of lgl -/ to overcome tissue constraints and avoid elimination, but also influ-
ence the behaviour of mutant cells in later phases of tumour development. High
levels of the oncoprotein were indeed found to be associated with neoplastic be-
haviour induced by the cooperation between lgl loss of function and activated Ras
signalling and reduction of dMyc abundance abolished clonal expansion of mutant
cells.
Ras cooperation with lgl mutation resulted in massive overgrowth of mutant tis-
sues accompanied by loss of cell polarity and invasive behaviour indicated by the
secretion of basement membrane-degrading enzymes. These phenotypes were found
to be dependent on the activation of the Ras effector Raf/MAPK pathway. Expres-
sion of a constitutively active form of Raf kinase in lgl mutant cells fully recapitu-
lated the phenotypes observed in lgl -/-; RasV12 clones, including dMyc upregulation,
even when upstream Ras signalling was completely abolished by co-expression of a
RasRNAi construct. On the other hand, despite its role in promoting cell growth,
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constitutive activation of PI3K failed to induce overgrowth and invasiveness of lgl
mutant cells. Notably no dMyc upregulation was observed in lgl -/-; dp110CAAX
clones. Since activated PI3K signalling has been shown to increase dMyc levels in a
transient manner (see Section 1.4.2, [92, 166]), this might indicate that dMyc pro-
tein must be stably upregulated in lgl mutant clones in order to trigger overgrowth;
this mirrors the condition observed in many human cancers, where Myc protein is
highly and stably overexpressed [134]. Consistently, constitutive dmyc expression
was sufficient to promote lgl mutant cells neoplastic growth in those regions of the
epithelium where accumulation of the protein occurred (hinge and pleura); con-
versely, in the distal region of the wing disc, dmyc transcriptional overexpression
did not result in a consistent increase in protein abundance and tumorous traits
failed to appear in these clones. Similar restriction of dmyc post-transcriptional
accumulation in the wing pouch was also observed for lgl -/- clones generated both in
a wild-type and Minute+/- background. lgl loss of function might therefore interfere
with dmyc mRNA stability or translation or might block the activity of molecules
that enhance dMyc protein stability or promote that of pathways involved in dMyc
degradation. Further work is required to address this issue.
Whatever the mechanism of lgl LOF-dependent post-transcriptional downreg-
ulation of dMyc is, constitutive activity of the Ras/Raf/MAPK pathway is able
to counteract it. lgl -/-; RasV12 or lgl -/-; hRaf GOF clones in the wing pouch were
indeed able to overgrow and form large masses of neoplastic tissue in which high
levels of dMyc were observed. Post-transcriptional stabilisation of dMyc by acti-
vated Erk may thus be sufficient to ensure high levels of the oncoprotein despite the
lglLOF-dependent destabilisation effect; in alternative this latter might be somehow
abolished by the activation of Ras/Raf/MAPK.
The elevated levels of dMyc observed in lgl mutant clones with constitutive
Ras/Raf/MAPK activity, besides being due to post-transcriptional regulation of the
protein, also depend on increased transcription of dmyc gene. Loss of function of lgl
and scrib has been demonstrated to lead to the deregulation of the Hpo pathway
(Sections 1.2.1.2 and 1.2.2) and activation of the transcriptional co-factor Yki (indi-
cated by its nuclear localisation) was observed in both in lgl -/-; RasV12 and scrib-/-;
RasV12. As we recently demonstrated [156], dmyc is a Yki transcriptional target and
I was able to show that knockdown of Yki levels in lgl -/-; hRaf GOF clones (which also
displayed Yki nuclear enrichment) dramatically reduced dMyc levels suggesting that
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Yki-dependent transcriptional upregulation of dmyc is required for elevated dMyc
levels to accumulate in lgl mutant cells with activated Ras/Raf/MAPK signalling.
Reduction of Yki in lgl -/-; hRaf GOF clones also abolished their neoplastic behaviour
indicating that deregulation of Hpo pathway, also by virtue of is positive effect on
dMyc levels, plays a key role in the oncogenic cooperation model here analysed. Sur-
prisingly however, overexpression of a wild-type form of Yki failed to increase dMyc
abundance above wild-type levels in the majority of lgl -/- clones grown in the wing
pouch, leading to the speculation that increased post-transcriptional stabilisation by
Ras/Raf/MAPK signalling may play a key role in allowing dMyc accumulation in
this region. Accordingly, silencing of endogenous Ras signalling in lgl -/-; Yki clones
completely reverted clonal phenotype in the wing pouch and reduced growth and
dMyc upregulation even in the distal territories. It is however also possible that lgl
mutation in the wing pouch is not able to deregulate the Hpo pathway due to com-
petitive stress as it has been demonstrated for scrib LOF clones [83] and thus even if
overexpressed, a substantial fraction of Yki pool might still be phosphorylated and
sequestered in the cytoplasm, impeding its transcriptional activity. Nevertheless,
consistent with dMyc levels of these clones being comparable to those of the sur-
rounding tissue in the wing pouch, neoplastic behaviour was not triggered in lgl -/-;
hRaf GOF; YkiRNAi nor in lgl -/-; Yki ; RasRNAi indicating that both pathways are
required in this region for lgl cells to acquire malignant features.
I can therefore conclude that when dMyc is highly expressed it cooperates with
lgl loss of function in a cell-autonomous manner, driving malignant growth in differ-
ent contexts and organs; when dMyc levels in lgl -/- tissue are comparable to those
of the wild-type surrounding cells, the two populations “peacefully” coexist and
no major alterations of epithelial integrity occur; where dMyc protein abundance
is lower in the lgl mutant cells with respect to the surrounding tissue, these cells
undergo apoptotic cell death and are eliminated by cell competition.
Given the high incidence of dMyc upregulation in human cancers, understand-
ing how this key molecule is regulated in the process of transformation and how it
influences the crosstalk with the tumour microenvironment represents an important
goal in the field of molecular oncology. As shown in this work, the employment of
a genetically tractable model like Drosophila, that closely recapitulates the features
of human carcinogenesis, may help gain insight into the complex biology of Myc
oncoproteins.
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Interestingly, from the analysis presented in this thesis a novel aspect of the
oncogenic cooperation between lgl loss of function and activated Ras signalling has
emerged: tumorous cells have been found to interact with the tracheal tubes, the
organs which supply larval tissues with oxygen, and to produce the diffusible factor,
FGF, that stimulate tracheogenesis and tracheal cells migration. Further analysis is
required to better characterise this phenomenon; nevertheless given the similarities,
it is possible to speculate that it might represent a process analogous to that of
mammalian tumour-associated angiogenesis. It is indeed well known that cancer
cells produce pro-angiogenic factors that stimulate the blood vessels in order to vas-
cularise the growing tumorous mass. In imaginal wing disc cells, hypoxia triggers
cellular responses very similar to those of mammalian epithelial cells (Section 1.3.2),
it is therefore plausible that also in the fly, cells within an expanding mass may sense
oxygen deprivation and trigger cellular responses that promote the interaction with
the respiratory system.
Extensive crosstalk with tracheal tubes was also observed in another genetic
model of lgl deprivation-induced tumourigenesis. With this system, the sole knock-
down of lgl in the posterior compartment of the imaginal wing disc in individuals
in which larval life is extended is sufficient to drive a severe neoplastic growth as
cell competition is avoided and tumour development is allowed to progress longer
in time. In this context large clusters of tumorous cells invariantly migrate towards
and contact tracheal segments, indicating that this interaction may also depend on
an active movement of cancer cells towards the oxygen source. The fact that inter-
action between mutant cells and the tracheal system is clearly evident also in this
genetic system may indicate that it does not depend on active Ras signalling but is
instead a feature of lgl -deprived cells that are allowed to grow and acquire neoplastic
traits. Surprisingly, while elevated dMyc levels are required for the growth of lgl -
deprived cells and are consistently associated with increased clone size and defects
in apical-basal cell polarity, dMyc seems to be dispensable for their interaction with
the tracheal network as in both the genetic contexts analysed knockdown of dmyc
did not affect the ability of cells to migrate towards tracheal tubes.
Further to interacting with the tracheal system, I also showed that lgl -/-; RasV12
clones can express the tracheal fate determinant, Trachealess. This interesting find-
ing opens the possibility that a trans-differentiation occurs in some mutant cells.
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In human cancers such phenomenon has been attributed to the multipotent cancer
stem cells which produce high levels of pro-angiogenic factors and trans-differentiate
into different cell types including endothelial cells to form a vascular-like structure
that supplies oxygen and nutrients to the tumour before the normal vasculature is
recruited (see Section 1.1). Further analysis of this phenomenon in the oncogenic
model here presented may help shed light on these still poorly characterised events
in human carcinogenesis.
As described in Section 1.2.2 many of the hallmarks of cancer have been faithfully
recapitulated in the cooperative oncogenesis models in Drosophila. The preliminary
data described above seem to indicate that also the strategies that cancer cells en-
force to overcome oxygen deprivation may be profitably investigated in this model
animal.

Appendix
Preliminary Studies in Human Cells
Introduction
The results presented in this thesis clearly highlight the importance of dMyc regula-
tion in lgl -induced tumourigenesis, even in the context of the oncogenic cooperation
with activated Ras.
Given the high degree of conservation of the signalling pathways involved in these
events (see Chapter 1), it is likely that similar genetic interactions also take place
in mammalian cells. To test this hypothesis I aimed to analyse the relationship
between Lgl-1/2, Myc and Ras in a human epithelial cell line: MCF10A.
MCF10A are immortalised, non-transformed mammary epithelial cells that, if
cultured in reconstituted basement membrane (3D culture), recapitulate many fea-
tures of mammary epithelium in vivo such as the formation of acini with a hollow
lumen and an evident apical-basal polarisation [198]. These organotypic cultures
are therefore a system of election for the analysis of the effect of tumour-inducing
mutations on epithelial architecture.
Indeed, Scrib knockdown (ScribKD) was shown to cooperate with both Ras and
c-Myc in 3D cultured MCF10A [71, 199]. As reported in Section 1.2.2, ScribKD;
RasV12 acini display an invasive behaviour with the projection of protrusions in the
basement membrane [71]. On the other hand, ScribKD seems to suppress the high
levels of cell death induced by c-Myc in the same cell system [199].
Overexpression of Scrib is able to suppress most of RasV12 induced phenotypes
both in 2D and 3D cultured MCF10A [71]. Interestingly, knockdown of Lgl-1 or
Lgl-2 is able to bypass Scrib-mediated suppression of RasV12 transforming capabili-
ties in these acini (Patrick Humbert, personal communication). This demonstrates
that Lgl-1/2 can cooperate with oncogenic Ras also in human epithelial cells.
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To test whether c-Myc plays a role in this oncogenic cooperation, as it does in
Drosophila imaginal wing disc epithelium, I decided to employ the commercially-
available low molecular weight Myc inhibitor 10058-F4. 10058-F4 is a cell-permeable
thioxothiazolidinone compound that specifically inhibits the c-Myc-Max interaction,
thereby preventing the transactivation of c-Myc target genes [200]. Treatment of
Lgl-1/2KD; RasV12-expressing acini could help clarify whether c-Myc is necessary to
promote tumourigenesis downstream of Lgl-1/2 loss in human cells.
I thus tested the efficacy of c-Myc inhibitor in 2D and 3D cultured MCF10A and
found that, while 10058-F4 efficiently blocks proliferation and c-Myc target genes
expression in monolayer-grown MCF10A, even in a c-Myc-overexpressing context,
its effects are ambiguous on acini grown on Matrigel. It will therefore be necessary
to better characterise 10058-F4 activity on MCF10A acini or to device alternative
strategies in order to test this hypothesis.
Results
Lgl1-2 KD Affects Myc Levels in MCF10A
To investigate if Lgl-1 and/or Lgl-2 knockdown affects c-Myc (hereafter referred
as Myc) levels in MCF10 cultured as a monolayer (2D) I transiently transfected
them with a pool of siRNAs (short interfering RNAs) against Lgl-1, Lgl-2 or both.
Transfection of siRNAs against GFP was used as a control.
qRT-PCR showed that while Lgl-1 mRNA was reduced by 64% relative to the
transfection control (Fig IA), knockdown of Lgl-2 was less efficient and mRNA levels
were reduced by 24% only (Fig IB). Interestingly some compensatory mechanisms
might occur since silencing of one gene induced increased mRNA levels of the other
(Fig. IA-B). Simultaneous knockdown of Lgl-1 and Lgl-2 led to a significant re-
duction of Lgl-1 mRNA abundance and abrogated the compensatory effect of Lgl-1
knockdown on Lgl-2 mRNA which levels were brought back to control levels (Fig
IA-B).
As can be observed in Fig IC, in Lgl-1 depleted cells Myc mRNA levels are
significantly higher than in control transfected cells and this increase is even more
pronounced upon Lgl-2 knockdown. This effect does not seem to be due to the
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reciprocal compensatory effect since higher Myc mRNA levels are also observed
upon simultaneous Lgl-1 and Lgl-2 silencing where mRNA levels of both genes are
equal to or lower than in control transfected cells.
The effect of Lgl-1 and/or Lgl-2 depletion on Myc is also observed at protein
level. As essayed by western blot on whole cell lysates of siRNA transfected cells,
Myc is significantly upregulated with respect to the control (see Fig. ID).
Since Myc mRNA and protein levels were assayed in asynchronously cycling cells,
the effect is likely to be underestimated.
This data indicate that perturbation of Lgl-1 and Lgl-2 expression levels, even
to a low extent as for Lgl-2, affects Myc mRNA and protein abundance. It is thus
possible that the genetic interactions between lgl and dMyc in Drosophila reported
in this thesis are conserved in MCF10A. It will be interesting to test whether these
effects are mediated by similar pathways.
10058-F4 Efficiently Inhibits Myc Activity in 2D Cultures
To test whether 10058-F4 is able to knockdown Myc activity in MCF10A, I
treated 2D cultured cells with increasing concentrations of the inhibitor and 24
hours post treatment I assayed proliferation levels by staining for the mitotic marker
KI67. As can be observed in Fig. IIA treatment with 10058-F4 led to a severe
concentration-dependent inhibition of proliferation. Representative stainings are
reported in Fig IIB. Cells treated with 120µM inhibitor present pycnotic nuclei
indicating at this concentration 10058-F4 might have a toxic effect. 60-120µM is
the widely reported effective concentration range in literature [200–202] and 60µM
was thus chosen as the starting point. It indeed reduced KI67-positive nuclei of over
60%; it is however possible that lower concentrations could still be effective in this
context.
10058-F4 efficacy was confirmed by qRT-PCR of Myc target genes (Fig. IIC).
In 2D cultured MCF10A, 24 hours post treatment with 60µM and 80µM 10058-
F4, Myc target genes are specifically downregulated in a concentration dependent
manner. B2M (β2 microglobulin), a house keeping gene, was used as a control and
its mRNA levels did not vary upon inhibitor treatment. Consistently with other
reports [201, 203], Myc mRNA also was found to be affected by 10058-F4.
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To further asses 10058-F4 specificity I generated a cell line stably expressing an
inducible form of Myc, Myc:ER. Myc:ER is a fusion of Myc and the oestrogen re-
ceptor ligand-binding domain. Upon induction with 4-hydroxytamoxifen (4-OHT)
MYC:ER fusion protein can transactivate Myc target genes [204, 205]. The cell line
produced expresses the fusion protein (not shown) and this latter is functional as
treatment with 4-OHT can promote cell cycle re-entry and proliferation of Myc:ER
expressing cells following 48 hours of starvation to a similar extent as serum/EGF
stimulation does to starved control cells (Fig. IIIA-C). This is achieved at a con-
centration of 200nM 4-OHT and for higher concentrations no further effect is ob-
served (Fig. IIIA). Noticeably, the percentage of KI67 nuclei in starved non-induced
Myc:ER-expressing cells (EtOH treated) is higher than that of starved control cells
indicating that some basal activity of the fusion protein is present even in the ab-
sence of 4-OHT induction (Fig. IIIA). Consistently with Myc:ER being functional,
Myc transcriptional targets are specifically upregulated upon treatment with 200nM
or 500nM 4-OHT (Fig. IVC).
Increasing concentrations of 10058-F4 drastically reduced proliferative rates of
Myc:ER cells induced with 200nM 4-OHT (Fig. IVA-B) as well as mRNA levels
of Myc transcription targets while it did not affect B2M expression (Fig. IVC). In
this case no differences in Myc mRNA abundance can be detected as the mRNA
highly transcribed downstream of Myc:ER heterologous promoter possibly masks
differences in endogenous levels (Fig. IVC).
All together, these data demonstrate that 10058-F4 can efficiently and specifi-
cally interfere with Myc function in monolayer-grown MCF10A.
10058-F4 does not have specific effects in 3D cultures
Since 10058-F4 proved to be effective in inhibiting Myc activity in 2D-cultured
MCF10A I tested its effects on differentiated acini grown on Matrigel. Differently
from what was observed for monolayer-grown MCF10A, 10058-F4 at concentration
of 60µM was toxic and completely inhibited acini formation (Fig.VA) indicating that
cells grown in 3D are more sensitive to this chemical inhibitor.
I then performed a 10058-F4 titration on MCF10 acini. As can be observed in
Fig.VA at day 4 of Matrigel culture treatment with 10µM and, more prominently,
20µM Myc inhibitor caused the formation of acini reduced in size. Similar obser-
vations where made at day 6 of culture (Fig. VA, lower panel). To investigate
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whether this effect was specifically due to inhibition of Myc activity I analysed its
target genes expression (Fig. VB). mRNA levels of Myc target genes did not seem
to change in accordance to the phenotype observed. While BRCA-1 and BRCA-2
mRNA levels showed a significant decrease following 100nM and 500nM inhibitor
treatment, they raised back to control levels for higher concentrations. CycD2 was
not significantly affected at any inhibitor concentration. This might indicate that,
at low concentrations, 10058-F4 is able to specifically interfere with the transcrip-
tion of only some Myc targets without affecting overall acini size or morphology.
On the other hand B2M and Myc mRNA levels show inconsistent fluctuations at
the different concentrations of 10058-F4 and the reduction in size observed upon
treatment with 10-20µM inhibitor does not seem to depend on a decrease of target
genes mRNA, or at least of those tested, and thus might be a non-specific effect.
This data highlight the different sensitivity that MCF10A cells show towards
treatment with 10058-F4 Myc inhibitor when cultured as a monolayer or as three-
dimensional differentiated acini. Further analysis will be required to characterise
the effect of this inhibitor on Matrigel-grown cells in order to be able to use it to
specifically knockdown Myc activity in Lgl-1/2KD; RasV12 organotypic cultures. Al-
ternatively stable cell lines simultaneously expressing Lgl-1/2KD; RasV12 and MycKD
constructs could be generated for this purpose.
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Figure I: A-C: qRT-PCR of Lgl-1 (A), Lgl-2 (B) and c-Myc (C) mRNA 72 hours post Lgl-1 and/or
Lgl-2 specific siRNA pools transfection. mRNA levels are represented as the fold change relative
to the appropriate control. Error bars represent the standard deviation of the mean for three
independent experiments performed in triplicate. ***= p<0.001; **= p<0.01 (Student T-test).
D: Western Blot analysis on whole cell lysates harvested 72 hours post Lgl-1 and/or Lgl-2 specific
siRNA pools transfection. The results of two independent experiments are shown. α-Tubulin
(Tubulin) was used as a loading control.
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Figure II: A: Percentage of KI67-positive nuclei following 24 hours treatment with the indicated
concentrations of 10058-F4 in 2D-cultured MCF10A. Error bars represent the standard deviation
of the mean for two independent experiments performed in triplicate. ***= p<0.001 (Student
T-test) relative to the carrier-only control (DMSO). B: Representative images of KI67 staining
quantified in A, all nuclei are counterstained with DAPI. C: qRT-PCR of c-Myc target genes
(http://www.myccancergene.org) upon 24 hours treatment with the indicated concentrations of
10058-F4. Error bars represent the standard deviation of the mean for two independent experiments
performed in triplicate. ***= p<0.001; **= p<0.01; *= p<0.05 (Student T-test) relative to the
carrier-only control (DMSO).
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Figure III: A: Percentage of KI67-positive nuclei in 2D-cultured Myc:ER-expressing MCF10A
upon 24 hours treatment with the indicated concentrations of 4-OHT in serum/EGF-deprived
medium. Treatment of empty vector-expressing (control) cells with full medium after 48 hours
starvation was used as a control. Error bars represent the standard deviation of the mean for
two independent experiments performed in triplicate. ***= p<0.001; **= p<0.01; *= p<0.05
(Student T-test) relative to the carrier-only control (EtOH). B-C: Representative images of KI67
staining quantified in A of control (B) and Myc:ER-expressing (C) cells following the indicated
treatment. All nuclei are counterstained with DAPI.
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Figure IV: A: Percentage of KI67-positive nuclei in 2D-cultured Myc:ER-expressing MCF10A
induced with 200nM 4-OHT and treated with the indicated concentrations of 10058-F4. Error
bars represent the standard deviation of the mean for two independent experiments performed
in triplicate. Statistical significance of 10058-F4 effect was calculated for the 200nM 4-OHT-
treated samples only ***= p<0.001 (Student T-test) relative to the carrier-only control (DMSO).
B: Representative images of KI67 staining quantified in A of Myc:ER-expressing cells induced with
200nM 4-OHT following treatment with the indicated concentrations of 10058-F4. All nuclei are
counterstained with DAPI. C: qRT-PCR of c-Myc target genes (http://www.myccancergene.org)
in Myc:ER expressing cells induced with 200 or 500nM 4-OHT upon 24 hours treatment with 60µM
10058-F4. Error bars represent the standard deviation of the mean for an experiment performed
in triplicate.
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Figure V: A: Bright field images of acini cultured with the indicated concentrations of
10058-F4 for 4 (upper panel) and 6 (lower panel) days. B: qRT-PCR of c-Myc target genes
(http://www.myccancergene.org) upon 7 days of culture in presence of 10058-F4. Error bars
represent the standard deviation of the mean for two independent experiments performed in
duplicate. **= p<0.01; *= p<0.05 (Student T-test) relative to the carrier-only control (DMSO).
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Materials and Methods
Cell Maintenance MCF10A were cultured in DMEM:F12 (Dulbecco’s Mod-
ified Eagle Medium:F12) supplemented with 5% Donor Horse Serum (Invitrogen),
10µg/ml Insulin (Novo Nordisk), 100ng/ml Cholera Toxin (Sapphire Bioscience),
0.5µg/ml Hydrocortisone (Sigma Aldrich), 20ng/ml EGF (Australian Laboratory
Services), 100U/ml Penicillin and 100U/ml Streptomycin (Invitrogen). HEK-293T
cells were cultured in DMEM with 10% Foetal Bovine Serum (JRH Biosciences),
100U/ml Penicillin and 100U/ml Streptomycin (Invitrogen). All cultures were main-
tained at 37°C in 5% CO2.
Generation of Stable Cell Lines Myc:ER- or empty vector- MCF10A cells
were generated by retroviral infection. HEK-293T were used as packaging cells for
virus production. 1x106 cells were plated in a 10 cm dish and 24 hours later were co-
transfected with either MSCVCherry-empty (Patrick Humbert Lab) or MSCVCherry-
c-Myc:ER (Gretchen Poortinga, G. McArthur Lab) vector and the RD114 am-
photrophic packaging vector using the calcium phosphate technique. 1 ml of CaCl2
0.24M solution containing 10µg of packaging vector and 10µg of DNA vector was
added dropwise to 1ml of HEBS (0.3M NaCl, 0.06M Hepes, 0.45mM Na2HPO4,
pH 7.09-7.12), gently mixing. The mixture was then distributed evenly across
the plate. 18 hours post transfection HEK-293T cells were washed with PBS and
fresh MCF10A medium was applied. Virus-containing supernatant was collected
three/four times, at 8-12 hours intervals, and filtered using 0.22µm filters. 20ng/ml
EGF and 1µ/ml Polybrene (Sigma Aldrich) were added each time. For transduction,
7.5x104 early passage MCF10A were plated in 6-well plates and allowed to settle
for 24 hours. Freshly collected viral supernatant was applied three/four times at
8-12 hours intervals and cells were allowed to recover in fresh medium for 48 hours
after the last viral hit. Infected cells were then selected with a Vantage SE DiVa
cell sorter for Cherry expression.
siRNA Transfections MCF10A were plated in antibiotic free medium at a
density of 1.1x105 per well in six-well plates 24 hours prior transfection. Dharma-
fect SMARTpool siRNA pools (ThermoScientific) specific for hLgl-1 or hLgl-2 were
used at a final concentration of 25nM; when used in combination, the total final
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concentration was 50nM. GFP-directed siRNA pools were used as a control at a
final concentration of 25nM or 50nM respectively. Transfections were performed
as follows: siRNA and Dharmafect lipid (0.15% final concentration) were diluted
in OPTImem, mixed, allowed to complex for 20 minutes at room temperature and
added dropwise to the plate. Transfection solution was replaced after 24 hours
with fresh medium and cells were harvested for RNA or protein extraction 72 hours
post transfection. Knockdown efficiency was assessed by quantitative real-time PCR
(qRT-PCR).
3D Organotypic Cultures 3D organotypic cultures were performed using
the overlay method described in [198]. 40µl of Growth Factor Reduced (GFR) Ma-
trigel (Becton Dickinson) was dispensed to each well of an 8-well chamber slide and
allowed to gel for 30 minutes at 37°C. Subconfluent MCF10A were resuspended
in 3D culture medium (2% GFR Matrigel, 2% Donor Horse Serum, 5ng/ml EGF,
10µg/ml Insulin, 0.5µg/ml Hydrocortisone, 100ng/ml Cholera Toxin, 100U/ml Peni-
cillin and 100U/ml Streptomycin) and plated over Matrigel at a density of 3000 cells
per well. Medium was replaced every 4 days for the duration of the culture period.
Images were taken with a Leica DMIRB inverted microscope and RNA extraction
was performed using the TRizol reagent (Invitrogen).
RNA Extraction, Reverse Transcription and qRT-PCR RNA was har-
vested using TRizol reagent (Invitrogen). Cells grown on plates were scraped directly
into TRizol whilst cells grown in 3D were lysed by dissolving the matrigel in Trizol.
RNA was purified using chloroform extraction and ethanol precipitation following
the manufacturer’s instructions (Invitrogen). Isolated, dried RNA was resuspended
in RNase-free H2O and the concentration and purity of RNA was determined using a
Nanodrop ND-1000 spectrophotometer (Labtech). cDNA was made from 1µg RNA
using 1µg Random Primers (Promega). RNA-Random Primers solution was heated
at 70°C for 5 minutes, cooled on ice for 5 minutes. A mix containing 200U M-MLV
Reverse Transcriptase, M-MMV Buffer and dNTP (0.5mM final concentration) was
added, mixing well. The reaction was carried out at 40°C for 50 minutes after
having sat 10 minutes at room temperature. cDNA samples were amplified in tripli-
cate reactions using the SYBER Green dye detection method (Applied Biosystems).
qRT-PCR reactions were run on a StepOnePlus Real-Time PCR System (Applied
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Biosystems) with the following programme: 95°C for 10 minutes (denaturation), 40
cycles of 95 °C for 15 seconds (denaturation), 60°C for 1 minute (annealing and
extension). Samples were normalised to GAPDH control and relative differences be-
tween samples were calculated (2∆CT , where CT, Cycle Threshold, is the number of
cycles required for the fluorescent signal to cross an arbitrary threshold). Statistical
significance was calculated using the Student T-test with GraphPad Prism software.
The following primers have been used:
Lgl-1 (Patrick Humbert Lab)
Fw: TGCCATCCTGATCAAATGAGG
Rv: CAGTGGAGCCTACAGGTTAGCA
Lgl-2 (Patrick Humbert Lab)
Fw: GAGACCCCAACCAGATCCTGAT
Rv: GATGTTCTCCAGTTGCTGGCTG
c-Myc (Gretchen Poortinga, G. McArthur Lab)
Fw: GGAGACGAGACCTTCATCAA
Rv: CCAGCTTCTCTGAGACGAGCTT
B2M (Gretchen Poortinga, G. McArthur Lab)
Fw: TCACCCCCACTGAAAAAGATGAGTA
Rv: GAATTCTCTGCTCCCCACCTCTAAG
GAPDH (Patrick Humbert Lab)
Fw: AAGGTGAAGGTCGGAGTCAAC
Rv: GAGTTAAAAGCAGCCCTGGTG
ODC (Gretchen Poortinga, G. McArthur Lab)
Fw: TGAGGTTGGTTTCAGCATGTATCT
Rv: GGTTGATTACGCCGGTGATCT
CycD2 (Patrick Humbert Lab)
Fw: CTGTGTGCCACCGACTTTAAGTT
Rv: GATGGCTGCTCCCACACTTC
BRCA-1 (Patrick Humbert Lab)
Fw: GGTGGTACATGCACAGTTGC
Rv: ACTCTGGGGCTCTGTCTTCA
BRCA-2 (Christine Hauser, R. Hannan Lab)
Fw: CCACAGCCAGGCAGTCTGTAT
Rv: AGAACACGCAGAGGGAACTTG
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Protein Extraction, SDS PAGE and Western Blotting Cells were lysed
in SDS Sample Buffer (250mM Tris-HCl pH 6.8, 30% Glycerol, 10% SDS) supple-
mented with the phosphatase inhibitor sodium vanadate (100µM) and Complete
Mini Protease Inhibitor cocktail (Roche Diagnostics). Quantitation of protein con-
centrations was carried out using Lowry Protein Assay (BioRad). Lysates were
resolved on pre-cast acrylamide gradient gels (Invitrogen) and trasferred to PVDF
membrane (Millipore). Membranes were blocked in 5% skim milk in PBST (0.5%
Tween PBS) in agitation for 1 hour at room temperature. Incubation with the
primary antibody was performed overnight at 4°C in agitation. Membranes were
then washed four times in PBST over a period of 1 hour and incubated with the ap-
propriate HRP-conjugated secondary antibody (1:5000, Biorad) in 5% skim milk in
PBST for 1 hour at room temperature, in agitation. Membranes were then washed
four times over a period of 1 hour and developed with LumiLight (Roche) following
manufacturer’s instructions.
The following antibodies were used:
Mouse monoclonal α c-Myc (1:500, 9E11 clone - Invitrogen)
Mouse monoclonal α α-Tubulin (1:40000, B512 clone - Sigma Aldrich)
Drug Treatments MCF10A were plated in 6-well, 12-well or 96-well plate
at a density of 5x104, 3x104 or 4.5x103 cells per well respectively and allowed to
settle for 24 hours. 10058-F4 was then applied at the indicated concentration with
fresh medium. Cells were treated for RNA harvesting or fixed for immunofluores-
cence staining 24 hours post drug treatment. In case of starvation, 24 hours post
seeding, cells were rinsed in PBS and serum/EGF-deprived medium (1% Donor
Horse Serum, 10µg/ml Insulin, 0.5µg/ml Hydrocortisone, 100ng/ml Cholera Toxin,
100U/ml Penicillin and 100U/ml Streptomycin) was added. Cells were cultured
in starving conditions for 48 hours before serum/EGF-deprived medium containing
4-OHT (Sigma) and/or 10058-F4 (Sigma) at the indicated concentrations or full
medium was added. Cells were treated for RNA harvesting or fixed for immunoflu-
orescence staining 24 hours post drug treatment. 4-OHT is solubilised in ethanol
(EtOH) whilst 10058-F4 in dimethyl-sulphoxide (DMSO). For 10058-F4 treatment
in 3D cultured MCF10A, the indicated concentration of the inhibitor was added to
the cell suspension before plating on Matrigel and it was freshly applied at every
medium change.
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KI67 Staining After drug treatments, MCF10A cultured on black immunoflu-
orescence 96-well plates were rinsed with PBS, fixed with 4% paraformaldehyde for
15 minutes and washed three times with PBS. Cells were then permeabilised in 0.3%
Triton-PBS for 10 minutes, washed with PBS again and blocked for 1 hour in 2%
BSA-PBS. Primary antibody (rabbit polyclonal α KI67, Abcam, 1:500) incubation
was performed over night at 4°C in 2% BSA-PBS. Subsequently, cells were washed
three times with PBS and incubated with the secondary antibody (α rabbit Alex-
aFluor 647, Invitrogen, 1:1000) in 2% BSA-PBS for 1 hour at room temperature in
dark. Cells were washed three times with PBS and nuclei were stained with DAPI
(1:1000, Molecular Probes). Imaging was performed with a Cellomics Arrayscan
VTi microscope. KI67 positive nuclei were manually counted (at least 500 nuclei
per well were scored) and the average value of triplicate wells was calculated.
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Abstract
Background: Neoplastic overgrowth depends on the cooperation of several mutations ultimately leading to major 
rearrangements in cellular behaviour. Precancerous cells are often removed by cell death from normal tissues in the 
early steps of the tumourigenic process, but the molecules responsible for such a fundamental safeguard process 
remain in part elusive. With the aim to investigate the molecular crosstalk occurring between precancerous and 
normal cells in vivo, we took advantage of the clonal analysis methods that are available in Drosophila for studying the 
phenotypes due to lethal giant larvae (lgl) neoplastic mutation induced in different backgrounds and tissues.
Results: We observed that lgl mutant cells growing in wild-type imaginal wing discs show poor viability and are 
eliminated by Jun N-terminal Kinase (JNK)-dependent cell death. Furthermore, they express very low levels of dMyc 
oncoprotein compared with those found in the surrounding normal tissue. Evidence that this is a cause of lgl mutant 
cells elimination was obtained by increasing dMyc levels in lgl mutant clones: their overgrowth potential was indeed 
re-established, with mutant cells overwhelming the neighbouring tissue and forming tumourous masses displaying 
several cancer hallmarks. Moreover, when lgl mutant clones were induced in backgrounds of slow-dividing cells, they 
upregulated dMyc, lost apical-basal cell polarity and were able to overgrow. Those phenotypes were abolished by 
reducing dMyc levels in the mutant clones, thereby confirming its key role in lgl-induced tumourigenesis. Furthermore, 
we show that the eiger-dependent Intrinsic Tumour Suppressor pathway plays only a minor role in eliminating lgl 
mutant cells in the wing pouch; lgl-/- clonal death in this region is instead driven mainly by dMyc-induced Cell 
Competition.
Conclusions: Our results provide the first evidence that dMyc oncoprotein is required in lgl tumour suppressor mutant 
tissue to promote invasive overgrowth in larval and adult epithelial tissues. Moreover, we show that dMyc abundance 
inside versus outside the mutant clones plays a key role in driving neoplastic overgrowth.
Background
In Drosophila, the tumour suppressor gene lethal giant
larvae (lgl) functions together with scribble (scrib) and
discs large (dlg) to link apical-basal cell polarity regulation
to cell proliferation control in epithelial tissues [1,2]. Lgl,
Dlg and Scrib are scaffold proteins associated with sep-
tate junctions at the lateral membrane, where they func-
tion in establishing basolateral domain identity by
antagonising the activity of two other complexes: the
Bazooka (Baz/Par3)/Par6/atypical Protein Kinase C
(aPKC) and the Crumbs (Crb)/Stardust (Sdt)/PATJ com-
plexes, which define the apical membrane domain [3].
Alterations to this process compromise apical-basal and
cytoskeletal structure and eventually disrupt epithelial
integrity [2]. When the whole individual is mutant for lgl,
loss of cell structure and neoplastic overgrowth indeed
occur, despite a low proliferation rate, in larval imaginal
epithelia, monolayered diploid organs which give rise to
the adult appendages. These epithelia grow as highly dis-
organised, multistratified masses in which cell differenti-
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Page 2 of 16ation does not occur and the animal dies after a
prolonged larval stage [1,2]. Furthermore, when these
tumourous tissues are transplanted into wild-type recipi-
ents, they overgrow and cells migrate to distant sites
where they are able to form secondary tumours [4], thus
showing some of the properties of mammalian metastatic
cancers. The function of lgl as a tumour suppressor is
evolutionarily conserved, since the human orthologue,
Hugl-1, can rescue Drosophila lgl mutants, and downreg-
ulation of its activity in human cells results in cell polarity
and proliferation defects and is associated with cancer
[5,6]. Despite the malignant behaviour (increased tumour
growth and survival and invasive properties) of lgl mutant
tissues, adult wings from lgl+/- individuals in which lgl-/-
clones had been generated at the larval stage by X-rays
did not display tumourous growth [7], raising the possi-
bility that lgl mutant cells could be eliminated through a
mechanism induced by the surrounding tissue.
There are two mechanisms described in the literature
that may act to prevent lgl-/- clones from developing into
tumours. First, it has been recently shown that the
growth of polarity-deficient scrib or dlg mutant clones is
counteracted by the so-called Intrinsic Tumour Suppres-
sion (ITS) mechanism, which functions by triggering in
the mutant cells both endocytic uptake and endosomal
activation of the Eiger protein (homologue of the mam-
malian Tumour Necrosis Factor), which in turn leads to
activation of pro-apoptotic JNK signaling [8,9]. However,
when normal tissue surrounding the mutant clones is
removed, mutant cells are no longer eliminated and grow
into tumours [8]. ITS can be thus classified as a non-
autonomous process, in which an as yet unknown signal
from the normal tissue acts to induce the mutant cells to
undergo apoptosis. Second, it has long been known that
relatively slow-growing cells are eliminated from devel-
oping tissues by a phenomenon termed Cell Competition
(CC), where slow-dividing cells are killed and replaced by
the surrounding faster-growing populations, eventually
giving rise to an organ of proper size [10]. CC was first
described by analysing Minute (M) mutations in Droso-
phila [11], a group of dominant, homozygous-lethal
mutations of various ribosomal genes. M/+ cells are via-
ble in a homotypic context (that is, all the cells composing
the tissue are of the same genotype) though showing a
reduced rate of cell proliferation; however, when juxta-
posed to wild-type cells, they are eliminated by apoptosis
and the wild-type cells overtake the M/+ cells so that the
organ eventually reaches normal size. It has been recently
speculated that these competitive interactions could have
evolved as a mechanism ensuring that viable but unfit,
damaged or potentially harmful cells do not accumulate
within a growing tissue, and this could be the case in nor-
mal development as well as in tumourigenesis [12,13].
During recent years it has become evident that different
levels of dMyc protein in adjacent cell populations can
trigger competitive interactions; cells with higher dMyc
levels are able to out-compete those showing lower levels
by inducing apoptotic death [14,15]. Both Minute and
dMyc-induced CC are assumed to depend on a local dif-
ference in ribosome biogenesis or function that affects
cell growth and proliferation [13]. Clonal alterations in
dMyc expression are indeed detrimental due to its key
role in cell growth, proliferation and biosynthesis [16]
and upregulation of this protein is associated with almost
all human cancers [17], among which carcinomas show in
addition alterations in apical-basal cell polarity [18,19]. lgl
mutant cells have both abnormal polarity and a reduced
proliferation rate, so both ITS and CC may be involved in
their elimination. In Drosophila epithelia, two main path-
ways are known to trigger apoptosis upon polarity altera-
tion: the JNK signalling and the Hid/dIAP1 pathways
[20]. JNK signalling has been clearly associated to ITS,
while its involvement in dMyc-induced CC is still contro-
versial [14,15].
In order to identify possible molecules and mechanisms
associated with the phenotype of lgl mutant cells, we
induced lgl-/- clones in diverse backgrounds and tissues.
We show that lgl-/- clonal phenotype strictly depends on
dMyc oncoprotein levels: when lgl-/- cells have lower lev-
els of dMyc with respect to the surrounding tissue, their
clonal growth is restricted by JNK-mediated apoptosis,
whereas when lgl-/- cells have high levels of dMyc, mutant
clones survive and proliferate to form invasive tumours.
Results and Discussion
lgl mutant clones die by caspase-dependent apoptosis 
when induced in an lgl+/- background
In order to investigate the proliferation and polarity phe-
notypes of lgl mutant cells during development, we
induced clones of two different lgl null mutations in Dros-
ophila wild-type wing discs, larval proliferating epithelia
where competitive mechanisms between genetically dif-
ferent cell populations have been extensively character-
ised [14,15]. As can be observed in Figure 1A and Figure
S1A, B in Additional File 1, lgl4 [21] or lgl27S3 [22] mutant
clones grew preferentially in the proximal-distal direc-
tion, in a pattern similar to that of wild-type clones [23].
At two days after induction lgl-/- clones and their twin
lgl+/+ clones were similar in size (Figure S1A in Additional
file 1), while at three days lgl-/- clones were about one half
the size of their twins (bright white, compare Figure S1B
and Figure S1A in Additional file 1, n = 40 each) and
many of them (37%, n = 287) disappeared by the end of
larval development, leaving only the twin clone (Figure
S1B in Additional file 1, arrow). However, some persisted
to the end of development, resulting in scarring of the
adult wing (Figure S1C in Additional file 1).
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Figure 1 lgl-/- clones induced in lgl+/- imaginal wing discs die by apoptosis and the surrounding tissue grows at their expense. A, B: lgl-/- 
clones (GFP-) induced in a w, hs-Flp/+; l(2)gl4, FRT40A/Ubi>GFPnls, FRT40A background (GFP+). Wild-type twin clones are GFP2+. A: active-Caspase 3 
staining; in A*, a magnification of the region outlined is shown. B: dIAP1 staining; its expression within the mutant clone (arrow) is visibly lower. C: lgl-
/- clones (GFP2+) induced in a w, hs-Flp/+; l(2)gl4, Ubi>GFPnls, FRT40A/FRT40A background (GFP+). Wild-type twin clones are GFP-. pJNK staining shows 
that the JNK pathway is activated inside the lgl mutant clone (arrow). Wing discs are outlined in A and C. Scale bars are 35 μm. Mutant clone genotypes 
are indicated. D: lgl-/- (left panel) and wild-type (right panel) clone profile from a twin analysis of l(2)gl4 or wild-type clones sampled in the wing pouch 
region induced in a w, hs-Flp/+; l(2)gl4, FRT40A or FRT40A/Ubi>GFPnls, FRT40A background. Black bars indicate lgl4 (n = 40) and wild-type (n = 40) 
clones and white bars indicate the respective twins. For this experiment, freshly hatched larvae were collected in a one-hour time window and staged 
on cornmeal medium to 90 hours after hatching before collecting tissues.
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by apoptosis (Figure 1A) and in basal sections many pyc-
notic nuclei were visible within lgl-/- clones (Figure S1E in
Additional file 1), confirming the presence of dying cells.
Caspase activation occurred mostly in mutant cells at
clonal boundaries, where mutant and normal tissues were
in close contact (outlined, magnified in Figure 1A*). The
anti-apoptotic protein Drosophila Inhibitor of Apoptosis
1 (dIAP1), ubiquitously expressed in imaginal tissues
[24], was downregulated in lgl-/- cells (Figure 1B, arrow),
whereas the JNK pathway was activated (as detected by
phospho-JNK staining) in the mutant clones (Figure 1C,
arrow). Possible crosstalk among these pathways in
inducing cell death in lgl mutant clones will be discussed
in detail in Section 5.
lgl mutant clones showed slight defects in disc folding,
as revealed by F-actin staining (Figure S1D in Additional
file 1, arrow); however, mutant cells did not seem to be
strongly compromised in apical-basal polarity (as
detected by aPKC and Scribble staining), at least up to 72
hrs after clone induction (Figures 2C and S1F, G in Addi-
tional file 1), and no discontinuities in basement mem-
brane were visible (not shown), in agreement with
previous observations [22,25].
lgl mutant cells express low levels of dMyc oncoprotein 
compared with the adjacent epithelium, and the latter 
grows at the expense of the lgl-/- clones
To test whether competitive interactions were involved in
the elimination of lgl-/- cells from the normal tissue, we
performed a double clonal assay in which lgl-/- clones
were induced in an lgl+/- background in parallel to wild-
type clones induced in a wild-type background (Figure
1D). As expected, while no differences were observed
between wild-type control clones and their twins (right
panel, black and white bars respectively, P = 0.86), lgl
mutant clones were smaller than their wild-type twins
(left panel, black and white bars respectively, P < 0.001),
as well as smaller than wild-type clones induced in con-
trol discs (right panel, black bars, P < 0.001). The wild-
type twins of lgl-/- clones (left panel, white bars) were
instead much larger than the wild-type twins from con-
trol discs (right panel, white bars, P < 0.001). Since no
dominant effects on cellular growth rate have been
reported for lgl null mutations, and developmental stages
of lgl+/- animals are of the same duration as those of lgl+/+
individuals, even in clonal assays, this result suggests that
some non-autonomous mechanisms are at work in lgl-/-
clone elimination and that mutant cells are being
replaced by the normal surrounding tissue.
Since it is known that differences in dMyc abundance
among adjacent cells can trigger competitive behaviour
[14,15], we next analysed dMyc protein levels and found
that dMyc was weakly expressed within lgl mutant clones
with respect to the surrounding lgl+/- tissue (Figure 2). We
therefore speculated that cells bearing precancerous
lesions that do not confer a survival or proliferative
advantage relative to neighbouring cells, as with lgl-/- cells
that lack dMyc protein, can be eliminated by apoptosis. In
the wing disc, dMyc protein accumulates mainly in the
distal region, the wing pouch, and is expressed only
weakly in the proximal regions, hinge and pleura (see Fig-
ure S2A in Additional File 1). In these proximal regions,
no differences in dMyc levels were visible between lgl-/-
clones and the adjacent cells; such clones were larger than
those in the wing pouch, although they never formed
tumours (Figure S1G in Additional File 1. Proximal: 3,254
± 1,129 pixels vs distal: 2,197 ± 756 pixels, n = 35 each; P <
0.001) and showed low levels of cell death (not shown).
Thus, low dMyc levels in lgl-/- cells seem to affect growth
and viability of these cells mainly in the distal region
(wing pouch), where the surrounding tissue expresses
high levels of dMyc.
Figure 2 lgl mutant clones show low levels of dMyc oncoprotein 
with respect to the surrounding tissue. A, B: lgl-/- clones (GFP-) in-
duced in a w, hs-Flp/+; l(2)gl4, FRT40A/Ubi>GFPnls, FRT40A background 
(GFP+). Wild-type twin clones are GFP2+. A: dMyc and aPKC staining; 
clone is outlined and the projection along the Z axis shows that dMyc 
expression within the mutant clone is low all along the disc thickness 
(enclosed between two white bars) and does not show strong defects 
in apical-basal cell polarity (asterisk). The apical-basal axis of the disc 
proper is also shown. Another lgl-/- clone showing low dMyc levels (ar-
row) can be observed in B at higher magnification. C: To show mutant 
nuclei, lgl-/- clones (GFP2+, arrow) were also induced in a w, hs-Flp/+; 
l(2)gl4, Ubi>GFPnls, FRT40A/FRT40A background (GFP+). Wild-type twin 
clones are GFP-. In the projection along the Z axis it can be seen that 
lgl-/- cells are being basally extruded from the epithelium. Wing disc is 
outlined in A. Scale bars are 35 μm. Mutant clone genotypes are indi-
cated.
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their neoplastic potential
To investigate if the reduced level of dMyc protein in lgl
mutant cells could be a cause of their elimination from
the epithelium, we took advantage of the MARCM sys-
tem [26] to express the UAS-dmyc construct [27] in lgl-/-
clones. As can be observed in Figure 3A, lgl-/-; UAS-dmyc
(dmycover) clones were round in shape and massively
overgrown, with the largest clones located in the proxi-
mal regions of the disc. A 10-fold increase in clone area
was observed with respect to lgl-/- control clones induced
through the same genetic system (average area of clones
sampled in the hinge/pleura: 24,518 ± 4,237 pixels vs
2,725 ± 1,146 pixels respectively, n = 68 each). A gain in
cell size has been reported for dmycover cells [28], raising
the question of whether this could contribute in a signifi-
cant way to lgl-/-; dmycover clone area. Our analysis con-
firmed that cells in lgl-/-; dmycover clones were larger than
in lgl-/- control clones (83 ± 41 pixels vs 67 ± 32, n = 80
each), but this gain in cell size accounts only for a small
fraction of clone expansion, indicating that the massive
Figure 3 dMyc expression in lgl-/- clones induced in an lgl+/- background promotes overgrowth and invasive behaviour. A-E: lgl-/-; UAS-dmyc 
clones (GFP+) in a yw, hs-Flp, tub>Gal4, UAS-GFP/+; l(2)gl4, FRT40A/tub>Gal80, FRT40A; UAS-dmyc/+ background (GFP-). A: clone morphology. B: active-
Caspase 3 and dIAP1 staining; the arrows indicate groups of mutant cells undergoing autonomous apoptosis and the arrowheads indicate lgl+/- cells 
dying outside a mutant clone. C: distribution of the ratios 'clone area/active Caspase 3 fluorescence intensity' (red squares) and 'clone area/GFP fluo-
rescence intensity' (green circles) as a control (n = 40); D: dMyc and aPKC staining; the projection along the Z axis shows the multilayered nature of 
the epithelium inside the mutant clone. The apical-basal axis of the disc proper is also indicated. The arrows indicate clones in the wing pouch that 
show low levels of dMyc protein. E: Laminin A staining; the arrows indicate regions of discontinuity. Wing disc is outlined in D. Scale bars are 35 μm. 
Mutant clone genotypes are indicated.
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substantial increase in cell number.
dMyc ectopic expression is associated with an autono-
mous increase in apoptosis [29], so we expected to find
high levels of cell death within lgl-/-; dmycover clones.
However, while small clones showed many active-Cas-
pase 3 positive cells (Figure 3B, arrows), the majority of
the large clones showed little or no active-Caspase 3
staining (Figure 3B, clone outlined). We indeed found a
significant negative correlation between clone size and
active-Caspase 3 staining (Figure 3C, Spearman's rank
correlation coefficient 0.716, P < 0.001). Furthermore,
active-Caspase 3 staining was evident immediately out-
side the overgrown clones (Figure 3B, arrowheads), indi-
cating that dMyc overexpression conferred lgl-/- cells the
ability to out-compete neighbouring cells. dIAP1 protein
was expressed in the overgrowing mutant clones (Figure
3B), but was undetectable in the smallest clones, where
the active-Caspase 3 signal is the strongest (Figure 3B,
arrows).
dmyc overexpression in lgl-/- cells therefore had a differ-
ent outcome depending on the region of the disc where
clones were located. In the proximal regions (hinge and
pleura), where the endogenous dMyc levels are very low
and competitive interactions between lgl-/- and wild-type
cells are relaxed, some lgl-/-; dmycover cells survived and
formed clonal progeny that expressed dIAP1 and was
therefore able to take advantage of dMyc's role in pro-
moting biosynthesis and proliferation to out-compete
surrounding cells (Figure 3B, arrowheads; see also the
large clone in the hinge region in Figure 3D). lgl-/-; dmy-
cover clones located in the distal region (pouch) instead
grew poorly, did not express dIAP1 protein and under-
went untimely cell death (Figure 3B, arrows); the explana-
tion for this behaviour could be because endogenous
dMyc is expressed at high levels here, which is likely to
prevent these lgl-/-; dmycover clones from acquiring a com-
petitive advantage. Other mechanisms could also be
involved in generating such regional diversity in clonal
growth, and further work is required to address this com-
plex issue.
A staining for the apical marker aPKC indicated that lgl-
/-; dmycover cells displayed impaired apical-basal polarity
(Figure 3D, see in particular the Z projection), a typical
hallmark of epithelial neoplasias [30]. Staining for Lami-
nin A, a major component of the basement membrane in
both Drosophila and mammalian epithelia, revealed signs
of discontinuity across the mutant clones (Figure 3E,
arrows), suggesting that lgl-/-; dmycover cells can acquire
invasive properties, as has been demonstrated with other
cooperative oncogenic models in Drosophila [25,31,32].
No pharate adults were recovered from larvae carrying
lgl-/-; dmycover clones (not shown), indicating that the dif-
ferentiation of adult structures was impaired.
As discussed above, lgl-/-; dmycover clones in the wing
pouch behave differently from those in the wing hinge/
pleura. In Figure 3D, the arrow indicates a clone in the
wing pouch that does not exhibit tumourous properties.
Notably, despite expression of UAS-dmyc transgene,
clones do not show the high levels of dMyc protein
observable in the clone located in the hinge. Since dmyc
expression was induced using a heterologous promoter,
the fact that dMyc protein is low in the lgl mutant clones
in the wing pouch suggests that in this region an lgl-
dependent regulation of dmyc at a post-transcriptional
level is at work. Moreover, this result suggests that dMyc
protein must be stably upregulated in lgl mutant clones in
order to trigger overgrowth. This observation is similar to
that of many human cancers, where Myc protein is highly
and stably overexpressed [33]. Altogether, these data
highlight a key role for dmyc in cooperating with the loss
of a tumour suppressor to promote proliferation and to
unleash the invasive potential of mutant cells.
dp110 kinase expression fails to rescue the defective 
growth of lgl mutant cells
To understand whether dMyc could be substituted in res-
cuing the defective growth of lgl-/- cells in an lgl+/- back-
ground by other growth-promoting molecules, we
expressed in lgl-/- clones an activated form of the catalytic
subunit of the Phosphoinositide-3 Kinase, dp110CAAX
[34], whose well-known role in cell growth and prolifera-
tion does not involve CC [14]. As can be observed in Fig-
ure S3B in Additional File 1, dp110 is not able to rescue
the defective growth of lgl-/- cells. Indeed, UAS-
dp110CAAX; lgl-/- clones are comparable in size to lgl-/-
clones induced through the same technique (average area
1,974 ± 753 pixels vs 1,894 ± 916 pixels respectively, n =
40 each, P = 0.67); moreover, no significant impairments
in cell polarity were observed (see Figure S3B in addi-
tional file 1, Z projection). As a control, a disc bearing
dp110CAAX clones is shown (Figure S3A in Additional file
1). Since it has been demonstrated that the ectopic
expression of genes in the Insulin pathway, such as dp110,
has no effect on ribosome biogenesis in Drosophila [35],
it is plausible that the competitive properties of dMyc are
due mainly to an increase in ribosome biogenesis [13,15];
its effect in increasing growth, proliferation and survival
of lgl mutant cells could be due to the boosting of their
biosynthetic rates.
Inhibition of cell death is not sufficient for driving 
tumourous growth of lgl mutant clones in the wing pouch 
region
Since several molecules associated with cell death were
found to be deregulated in lgl mutant clones generated in
an lgl+/- background (see Figure 1), we tried to rescue lgl
mutant clones viability by co-expressing dIAP1 or a dom-
Froldi et al. BMC Biology 2010, 8:33
http://www.biomedcentral.com/1741-7007/8/33
Page 7 of 16inant negative form of the Drosophila JNK, basket (bsk).
As can be seen in Figure 4A, lgl-/-; UAS-dIAP1 clones in
the wing pouch still showed active-Caspase 3 signals
(arrow). A statistical analysis performed on clones found
in the wing pouch indeed demonstrated that they are
smaller than their wild-type twins (average area 7,721 ±
944 pixels vs 11,583 ± 1,248 pixels respectively, n = 28; P <
0.001). Since the JNK pathway is activated in lgl mutant
clones in the wing pouch (Figure 1C, arrow), it could sig-
nificantly contribute to their death. It has however previ-
ously been reported that JNK activation also occurs in
response to dIAP1 inactivation [36,37]; therefore if the
reverse interaction occurred it may be expected that JNK
signalling would be absent in lgl-/-; UAS-dIAP1 cells but,
as shown in Figure 4B, there is strong upregulation of
active JNK, as detected by pJNK staining (arrow), indicat-
ing that it contributes to the elimination of lgl mutant
clones independently of dIAP1. Both pJNK and active-
Caspase 3 were also visible in the mutant clones in the
proximal regions of the wing disc (Figure 4A, B, hinge
and pleura respectively, white arrowheads), but their phe-
notype was quite different from that of clones in the wing
pouch; they were large, round-shaped and, as can be seen
in Figure 4A, active-Caspase 3 signal was also present in
several cells surrounding the mutant clone (grey arrow-
heads). A statistical analysis showed that such clones
were larger than their wild-type twins (average area
15,243 ± 1,228 pixels vs 9,855 ± 1,991 pixels respectively,
n = 22; P < 0.01) These phenotypes were associated with
high dMyc levels, as shown in Figure 4C (arrow); thus
JNK signalling may here be subverted from a pro-apop-
totic to a pro-growth function, as has been demonstrated
to occur in genetic contexts in which alterations in the
polarity genes lgl, scrib and dlg are accompanied by an
ectopic expression of activated (oncogenic) Ras or Notch
[32,38,39].
We then blocked the JNK pathway inside the lgl-/-
clones by using a bskDN transgene [39] and found that the
active-Caspase 3 signal was no longer observable in lgl-/-
clones, regardless of the region in which they were
located (not shown), indicating that JNK signalling-
induced cell death is the main pathway by which lgl
mutant cells die. As can be seen in Figure 4D, UAS-bskDN;
lgl-/- clones in the wing pouch (outlined) expressed low
levels of dMyc and did not form tumours; statistical anal-
ysis performed in this region showed that, despite the fact
that UAS-bskDN; lgl-/- clones no longer died, their size was
smaller than that of their wild-type twins (average area
12,697 ± 8,491 pixels vs 21,957 ± 8,372 pixels respectively,
n = 15, P < 0.001), demonstrating that even when cell
death is blocked UAS-bskDN; lgl-/- cells have a proliferative
disadvantage with respect to the wild-type tissue.
In contrast to the wing pouch, UAS-bskDN; lgl-/- clones
in the proximal regions (hinge and pleura) showed high
dMyc protein levels, lost polarity and overgrew (Figure
4E), indicating that the pro-growth role of the JNK path-
way observed in polarity-compromised clones overex-
pressing activated Ras or Notch [32,38,39] appears not to
be necessary in the wing disc for the tumourous growth
induced by the cooperation between lgl mutation and
dMyc oncoprotein. Altogether, these data show that the
Figure 4 Inhibition of cell death is not sufficient to unveil the ma-
lignant potential of the lgl-/- clones in the wing pouch region. A-C: 
lgl-/-; UAS-dIAP clones (GFP2+) induced in a yw, hs-Flp, tub>Gal4/+; 
l(2)gl4, Ubi>GFPnls, FRT40A/tub>Gal80, FRT40A; UAS-dIAP/+ back-
ground (GFP+). Wild-type twin clones are GFP-. Active-Caspase 3 (A) 
and pJNK (B) signals are both visible inside lgl mutant clones (arrows). 
Arrowheads indicate clones in the proximal regions and grey arrow-
heads point to active-Caspase 3 signals in lgl+/- cells surrounding the 
mutant clone (outlined). In C, an lgl-/- clone expressing high levels of 
dMyc protein is shown (arrow). D, E: UAS-bskDN; lgl-/- clones (GFP2+) in-
duced in a yw, hs-Flp, tub>Gal4/UAS-bskDN; l(2)gl4, Ubi>GFPnls, FRT40A/
tub>Gal80, FRT40 background (GFP+). Wild-type twin clones are GFP-. 
dMyc protein is low in the mutant clone in the wing pouch (D) but is 
high in the clone in the pleura (E). Clone boundaries are indicated by 
the white dotted line. Wing discs are outlined in A and B. Scale bars are 
35 μm. Mutant clone genotypes are indicated.
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cells in the wing pouch versus the hinge/pleura regions
also occurs for lgl-/- clones in which cell death has been
inhibited and is also associated with the different levels of
dMyc protein in the mutant versus the adjacent normal
tissue.
The Intrinsic Tumour Suppressor pathway does not appear 
to be involved in lgl-/- cells elimination in the wing pouch 
region
A recent study demonstrated that clones of scrib and dlg
tumour suppressor mutants generated in wild-type ima-
ginal discs are eliminated by the Intrinsic Tumour Sup-
pressor (ITS) pathway, involving JNK-dependent
apoptosis induced by an endocytic accumulation of the
TNF homologue, Eiger (Egr) [8]. Since scrib and dlg are
well-known lgl partners in regulating apical-basal cell
polarity and proliferation and show similar neoplastic
phenotypes in a homotypic background [2], it could be
expected that lgl-/- clones could be eliminated by a similar
mechanism. To investigate this, we first looked for altera-
tions in endocytosis in the lgl mutant clones by using an
early-endosome reporter, Rab5, since it was observed by
Igaki et al. [8] that Rab5-positive endosomes accumulated
in scrib mutant clones in the eye disc correlating with
pJNK staining. However, in the wing pouch region we did
not observe changes in Rab5 levels within lgl-/- clones
with respect to the neighbours (see Figure 5A, arrow-
head, and respective magnification), whereas outside the
wing pouch a moderate increase in Rab5 levels in lgl-/-
clones was observed (see Figure 5A, arrow, and respective
magnification). Since Igaki et al. [8] demonstrated that
ITS depends on an autocrine TNF signalling, we then
silenced the TNF homologue, egr, in lgl mutant cells by
expressing a UAS-egrRNAi construct (for validation see
Figure S4A, B in Additional File 1) and scored for changes
in clone morphology, but no alterations were observed
relative to the lgl-/- clonal phenotype (Figure 5B-B"). lgl-/-;
UAS-egrRNAi clones in the wing pouch were comparable
in size to lgl-/- clones induced through the same system
(average area pixels 2,954 ± 876 vs 3,177 ± 1,028 pixels
respectively, n = 19 each; P = 0,58). Similar effects were
seen in lgl mutant clones in discs in which the UAS-
egrRNAi construct was expressed under the control of
the hedgehog promoter in the whole posterior compart-
ment, thereby also removing Egr protein in the lgl+/- back-
ground (not shown). In Figure 5B and 5B', the apical and
basal sections of a wing pouch are shown in which an lgl
mutant clone is being basally extruded (in Figure 5B the
position of the mutant clone is outlined), which also
showed increased pJNK staining (Figure 5B"). The fact
that JNK signalling is increased here suggests that, in this
case, JNK pathway activation is not triggered by egr-
mediated ITS. We next expressed in lgl mutant clones a
dominant negative form of Rab5 [40] to block endocyto-
sis, since in the Igaki et al. study [8] it was shown that
blocking endocytosis decreased JNK signalling and cell
death of scrib mutant clones. Indeed, we found that some
lgl-/- mutant clones expressing Rab5DN in the proximal
regions overgrew (13 out of 27 scored, Figure 5C), while
clones in the wing pouch never did. Again, lgl-/-; UAS-
Rab5DN clones (arrows) in the wing pouch were much
smaller than the wild-type twins (see Figure S4C in Addi-
tional File 1) and expressed both active-Caspase 3 (Figure
5D, arrow) and pJNK (Figure 5E, arrow), distinct from
what has been observed for scrib mutant clones in the eye
disc, where Rab5DN expression increased their growth [8].
Notably, all the overgrowing clones observed in the prox-
imal regions of the wing disc were characterised by high
dMyc protein levels (Figure 5C). Taken together, these
data exclude egr-mediated ITS as the main mechanism
responsible for lgl mutant clones elimination, at least in
the wing pouch.
lgl-/- cells grown in a Minute background overexpress dMyc, 
display a competitive behaviour and form malignant 
tumours
As we showed in section 5, lgl-/- cells grew slower than
wild-type cells in a clonal context, which is possibly the
main reason why they are eliminated from the epithe-
lium. To confirm the hypothesis for an active role of CC
in restraining lgl-/- clonal growth, we induced lgl mutant
clones in the slow-dividing Minute background, to give
them a proliferative advantage. As can be seen in Figure
6A-C"' and in the Additional File 2, lgl mutant clones in
these larvae were able to overgrow (average area of clones
sampled all across the wing disc: 12,974 ± 3,427 pixels vs
2,648 ± 1,211 pixels of lgl mutant clones in a wild-type
background, n = 40 each) and cells became rounded, indi-
cating that apical-basal polarity was lost, as can be seen in
the Z projection where aPKC apical determinant spreads
cortically. lgl-/- clones showed high levels of dMyc protein
(Figure 6A, arrow), which accumulated mainly in those
outside of the wing pouch (see also Figure S5 in Addi-
tional File 1). dMyc upregulation is attributable to lgl loss
of function because wild-type cells did not show any
changes in dMyc levels when growing in a M/+ back-
ground (Figure S6 in Additional file 1; in particular, no
dMyc accumulation was visible in a large clone in the
hinge region, S6A, arrow). lgl-/- clones in the wing pouch
did not overgrow, showed a level of dMyc similar to that
found in the M/+, lgl+/- adjacent cells (Figure S5A in
Additional File 1, clone outlined) and did not undergo
apoptosis (not shown). In that region, dMyc endogenous
expression is high (see Figure S5A in Additional File 1), so
it is plausible that its upregulation by the loss of function
of lgl was not sufficient to trigger the cell growth advan-
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of the adjacent tissue.
In contrast, in regions where dMyc abundance is very
low, such as the hinge and the pleura, dMyc upregulation
by lgl mutation might be sufficient for clone overgrowth.
In large lgl-/- clones in the hinge or pleura, dIAP1 was also
expressed (Figure 6B') and active-Caspase 3 signal was
evident in few cells in the mutant clones, but marked
mainly groups of surrounding cells (Figure 6B, B',
arrows), which were deficient in dIAP1 (Figure 6B, B',
arrowheads). Moreover, cells lost polarity (Figure S5 in
Additional file 1) and the basement membrane showed
signs of discontinuity (arrows in Figure 6C'-C"', com-
pared with the wild-type disc shown in C), indicating
invasive behaviour. No pharate adults were recovered
from mosaic larvae (not shown). Altogether, these data
show that lgl-/- cells grown in a M/+, lgl+/- background can
acquire a competitive advantage, which correlates with
high dMyc expression and polarity loss. The upregulation
of dMyc protein inside lgl-/- clones induced in the M/+
background may be a consequence of an increase in dmyc
transcript levels, since an upregulation of dmyc transcrip-
tion, assayed by a dm>LacZ construct [41] (dm stands for
diminutive, the gene encoding dMyc protein) was
observed (Figure S7B in Additional File 1). In contrast,
there was no correlation between dmyc transcription and
protein abundance in lgl-/- clones grown in the lgl+/- back-
ground; the reduced levels of dMyc protein observed
(Figure 2) did not result from a decrease in dmyc tran-
scription (Figure S7A in Additional File 1), therefore
post-transcriptional mechanisms must be at work in this
case.
To determine the functional importance of dMyc
upregulation in lgl-/- clones induced in the M/+, lgl+/-
background, we silenced dmyc inside lgl-/- clones using a
UAS-dmRNAi construct (for validation, see Figure S2C in
Additional File 1). Knockdown of dmyc expression in lgl-/-
clones prevented the cell polarity defects observed with
lgl-/- clones alone (Figure 6D, compared with Figure 6A-C,
Z projections), even when the lgl mutant tissue occupied
a larger proportion of the disc (Figure 6D'); no degrada-
tion of basement membrane occurred (not shown) and
clones did not form tumourous masses, regardless of the
region in which they were located. Adults were indeed
recovered at the expected frequency (not shown). Con-
cerning the cell death pattern in these clones, it ranged
from a complete absence of active-Caspase 3 signal in the
majority of discs analysed (Figure 6E) to scattered signals,
either in lgl-/- cells, surrounding cells, or in regions distant
from mutant clones (Figure 6E', arrows). These results
indicate that lgl-/-; UAS-dmRNAi and M/+, lgl+/- cells
coexist in the same tissue without undertaking competi-
Figure 5 Intrinsic Tumour Suppression is not responsible for lgl-/- clonal death in the wing pouch region. A: Lgl antibody staining (red) of lgl-/
- clones (black) induced in a yw, hs-Flp, tub>Gal4/+; l(2)gl4, FRT40A/tub>Gal80, FRT40; tub>YFP::Rab5/+background (red+). The wild-type twin clones 
are red2+. The arrow indicates an lgl mutant clone in the notum where the YFP::Rab5 signal is slightly increased and the arrowhead indicates an lgl 
mutant clone in the pouch where the YFP::Rab5 signal is comparable to that found in the surrounding lgl+/- tissue. Magnifications of the mutant clones 
are shown on the right. B-B": lgl-/-;UAS-egrRNAi clones (GFP2+) induced in a yw, hs-Flp, tub>Gal4/+; l(2)gl4, Ubi>GFPnls, FRT40A/tub>Gal80, FRT40A; UAS-
egrRNA i/+ background (GFP+). Wild-type twin clones are GFP-. B and B' show the apical and basal sections of the same disc; in the basal section a 
mutant clone contains cells that are basally excluded from the epithelium (arrow) and shows pJNK staining (B", arrow). The clone contour is outlined 
in B. C:, lgl-/-; UAS-YFP::Rab5DN clones (GFP+) induced in a yw, hs-Flp, tub>Gal4, UAS-GFP/+; l(2)gl4, FRT40A/tub>Gal80, FRT40A; UAS-YFP::Rab5DN/+ back-
ground (GFP-), stained with aPKC and dMyc. Due to high staining intensity inside the mutant clones, dMyc signal has been kept very low to avoid 
overexposure, so its endogenous expression is barely visible. D, E: lgl-/-; UAS-YFP::Rab5DN clones (GFP2+) induced in a yw, hs-Flp, tub>Gal4/+; l(2)gl4, 
Ubi>GFPnls, FRT40A/tub>Gal80, FRT40A; UAS-YFP::Rab5DN/+ background (GFP+). Wild-type twin clones are GFP-. D: active-Caspase 3; E: pJNK. Wing 
discs are outlined in B", D and E. Scale bars are 35 μm. Mutant clone genotypes are indicated.
Froldi et al. BMC Biology 2010, 8:33
http://www.biomedcentral.com/1741-7007/8/33
Page 10 of 16tive interactions, possibly because both populations show
a similar impairment in cell proliferation. Similar results
were obtained by Wu and Johnston upon the induction of
dm loss-of-function clones in a M/+ background [42]. M/
+ tissue could also intrinsically possess a low level of
dMyc protein, but we were not able to detect differences
in dMyc protein levels between wild-type and M/+ clones
throughout the wing disc (see Figure S6 in Additional File
1). Thus, the silencing of dmyc in lgl-/- clones and the
reduced ribosomal pool in the M/+, lgl+/- background
may make their levels of biosynthesis comparable. The
ability of lgl mutant patches to grow despite dMyc depri-
vation might be due to the upregulation of other growth-
promoting factors in the M/+, lgl+/- context, which are
however per se unable to provide lgl-/- cells with tumouri-
genic features.
Figure 6 lgl-/- malignant behaviour in a Minute background depends on dMyc protein levels. A-C"': lgl-/- clones (GFP-) in a w, hs-Flp/+;l(2)gl4, 
FRT40A/M(2)24F, Ubi>GFPnls, FRT40A background (GFP+). A: dMyc and aPKC staining. A strong dMyc accumulation is visible in the part of the mutant 
clone located in the hinge region (arrows). A Z projection of the mutant clone shows that loss of cell polarity accompanies the dramatic overgrowth; 
the apical-basal axis of the disc proper is shown. A Z projection of a region of the disc without mutant clones is shown on the right as a control. B: 
Activated Caspase 3 and dIAP1 staining. Arrows indicate M/+, lgl+/- cells dying around the mutant clones; the Z projection confirms that dying cells 
are outside the lgl-/- tissue. Arrowheads indicate that dying cells are deprived of dIAP1. C: Surface and cross sections of a wild-type disc stained with 
Laminin A. C'-C"': Laminin A staining of lgl-/- clones in a M/+, lgl+/- background; arrows indicate several points in which basement membrane integrity 
is lost. D-E': lgl-/-; UAS-dmRNAi clones (GFP+) in a yw, hs-Flp, tub>Gal4, UAS-GFP/+;l(2)gl4, FRT40A/M(2)24F, tub>Gal80, FRT40A; UAS-dmRNAi/+ back-
ground (GFP-). D, D': aPKC staining reveals that lgl-/-; UAS-dmRNAi mutant cells in a M/+, lgl+/- background do not lose apical-basal polarity (compare 
with 6A). Heat shock pulses were 20 minutes (D) and 1 hour duration (D'). E, E': Caspase staining shows that apoptosis is either absent (E) or scattered 
throughout the disc (E', arrows). Scale bars are 35 μm. Mutant clone genotypes are indicated.
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dMyc protein is not tissue-specific
With the aim of assessing whether the oncogenic cooper-
ation between lgl mutation and dMyc protein could be
conserved in other Drosophila tissues, we investigated lgl-
/- clonal behaviour in the ovarian follicular epithelium, a
monolayered adult tissue of somatic origin that sur-
rounds the germ line of the egg chamber. Interestingly,
the phenotype of lgl-/- clones in the follicular epithelium
appeared to be rather different from that observed in the
wing imaginal epithelia, but similar to that previously
reported in the whole mutant animal; in females bearing
a homozygous temperature-sensitive lgl mutation, egg
chambers invariantly show hyperproliferation of follicu-
lar cells that display loss of apical-basal polarity and
migrate between the nurse cells [43]. We found that lgl
mutant clones overproliferated and formed multilayers
near the chamber poles (Figure 7A), consistent with pre-
vious studies [2,44]. Active-Caspase 3 staining revealed
that apoptosis was occasionally observable in egg cham-
bers from Stage 8 onward in lgl+/- cells at the clone border
(Figure 7B). This cell death pattern is reminiscent of a
mechanism of dMyc-induced CC. CC, however, has
never been described in the follicular epithelium, so we
induced dmycover Flp-out clones [45] in adult females and
observed the cell death pattern in their egg chambers. As
can be seen in Figure S8 in Additional File 1, the wild-
type tissue underwent massive cell death, particularly
when it was completely surrounded by dmycover cells
(arrows), suggesting that dmyc is able to induce apoptosis
in the surrounding cells also in this tissue. Indeed, lgl-/-
clones expressed dMyc protein in early egg chambers
(Figure 7C) as well as at later stages (Figure 7C'), where
endogenous protein is normally absent (see Figure S2B in
Additional file 1). dmyc was also transcriptionally acti-
vated, as can be seen from dm>LacZ expression in Figure
S7C in Additional file 1. Thus, lgl-/- clonal behaviour in
the follicular epithelium positively correlates with dmyc
expression. dIAP1 levels in lgl-/- follicular clones were
similar to those seen in the lgl+/- adjacent tissue (see Fig-
ure 7E), and no autonomous apoptosis was visible in lgl-/-
follicular cells (not shown). Further, we allowed clones to
grow for four additional days in order to obtain stronger
phenotypes. As can be seen in Figure 7D-D", dMyc pro-
tein was detectable in all lgl-/- cells; clonal phenotype var-
ied from larger areas of multilayered tissue (Figure 7D),
which sometimes extended away from the poles (Figure
7D'), to clones that invaded into the nurse cells territory
(Figure 7D", arrow). To determine the contribution of
dmyc to the lgl mutant phenotype in this tissue, we low-
ered dMyc levels inside lgl-/- cells using the UAS-dmRNAi
construct. We observed a pronounced decrease both in
clone size and number (visible clone area: 44% decrease
in 60 clones at chamber poles analysed for each genotype;
clone number: 74% decrease on a total of 20 pairs of ova-
ries for each genotype) and no multilayered tissue was
seen, demonstrating that also in this epithelium dMyc
protein is required for lgl mutant clones to grow as malig-
nant tumours.
Conclusions
Deciphering the molecular crosstalk occurring between
genetically different cell populations growing within a tis-
sue is relevant to both developmental and cancer biology.
In Drosophila, lgl mutant larvae show neoplastic over-
growth of the epithelial tissues, whereas lgl- cells growing
in mosaic larvae are usually eliminated by cell death; thus
this opposite phenotype results from mechanisms trig-
gered by the confrontation of lgl- and lgl+ cells. In the lit-
erature, two main processes have been described to
mediate the elimination of unfit/polarity-deficient cells
from Drosophila imaginal epithelia: Cell Competition
(CC) and Intrinsic Tumour Suppression (ITS) [9]. Both
mechanisms work by the induction of cell death in the
mutant population; in addition, normal tissue grows at
the expense of the unfit cells in CC [15], while this has not
been shown for ITS [8]. There is suggestive evidence in
the literature regarding the relevance of CC to cancer
biology [12,13,46], however a clear connection between
CC and tumour development is yet to be made.
dMyc oncoprotein has been shown to play a leading
role in CC, in the sense that cells bearing low levels of this
protein die by apoptosis if growing in a high dMyc-
expressing context [14,15]. In ITS, cell death is instead
triggered in the presence of cells with impaired polarity in
an otherwise normal epithelium [8]. Here we found that
JNK-mediated apoptosis is the main process through
which lgl mutant clones are eliminated from imaginal
wing epithelia (Figures 1C and 4D). Clonal phenotype is
however different in the distal (wing pouch) and proximal
(hinge/pleura) regions of the wing disc: lgl mutant clones
located in the wing pouch showed massive cell death and
were rapidly extruded from the epithelium (Figures 1 and
S1E-F in Additional file 1), while clones located in the
hinge/pleura grew to a larger extent, although they never
formed tumours (Figure S1G in Additional file 1). This
regional difference in clonal behaviour could depend on
dMyc protein pattern in the wing disc; the protein is
highly expressed in the wing pouch and very low in the
hinge/pleura (Figure S2A in Additional file 1). We indeed
found that lgl- clones in the wing pouch expressed very
low levels of dMyc protein relative to the background
(Figure 2); such clones died and were replaced by the sur-
rounding wild-type tissue (Figure 1D). Moreover, lgl-
clonal behaviour in the slow-dividing Minute background
(Figure 6) or in the follicular epithelium (Figure 7)
switched from out-competed to overgrown and invasive,
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Figure 7 lgl-/- clonal overgrowth is sustained by dMyc expression also in the follicular epithelium. A-E: Twin-clone analysis of lgl-/- clones (GFP-
) induced in a w, hs-Flp/+; l(2)gl4, FRT40A/Ubi>GFPnls, FRT40A background (GFP+). Wild-type twin clones are GFP2+. A: lgl-/- clones (bordered by white 
bars) stained for Scrib are shown in early and late egg chambers. Scrib distribution spreads from lateral to cortical as mutant cells become round. B: 
active-Caspase 3 staining of Stage 8 to 9 egg chambers; arrows indicate wild-type cells undergoing apoptosis. C: dMyc staining of early (C) and late 
(C') egg chambers. Bars mark clone boundaries and arrows indicate dMyc expression inside the mutant clones. D-D": dMyc staining in older lgl-/- clones; 
in D" the arrow indicates mutant cells migrating into the nurse cell territory. E: dIAP1 staining of early and late egg chambers. The arrows indicate high 
dIAP1 expression in the lgl-/- clones. Mutant clone genotypes are indicated.
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high dMyc levels relative to the neighbouring tissue. Low-
ering dMyc abundance inside those clones prevented the
tumourous phenotype (Figure 6D and data not shown),
whereas dMyc overexpression in lgl- mutant clones in a
wild-type background was able to confer increased prolif-
eration, survival and invasive properties (Figure 3), clearly
demonstrating that dMyc plays a key role in lgl- cells
behaviour. In all the cases analysed, clonal overgrowth of
lgl- dmycover tissue was observed in the proximal regions
of the wing disc, where endogenous dMyc is poorly
expressed, underlining the importance of a favourable
dMyc gradient between the mutant clone and the sur-
rounding tissue in triggering lgl-induced malignancy. We
also showed that ITS is not responsible for lgl mutant
cells elimination in the wing pouch, in contrast to what
was observed for the other two neoplastic tumour sup-
pressor mutants scrib and dlg [8]; lgl- clones located in the
distal regions still died even upon egr silencing or endo-
cytosis inhibition (Figure 5B-D). In the pouch, where
dMyc protein is highly expressed, lgl- cells instead under-
went apoptosis due to low levels of dMyc protein relative
to their neighbours, since when dMyc levels were
restored in the mutant clones, as happens in a slow-grow-
ing Minute background, lgl mutant cells no longer died.
This is first evidence that dMyc-induced CC protects tis-
sues from tumourous growth. On the other hand, block-
ade of endocytosis in lgl mutant tissue located outside of
the wing pouch resulted in clonal overgrowth, indicating
that ITS is likely to be involved in the elimination of lgl
mutant cells in this region. Also in this case, dMyc upreg-
ulation was observed in the overgrown mutant tissue
(Figure 5C).
The main conclusion of our work is that dMyc protein
levels dictate the behaviour of lgl- tissue: when dMyc is
highly expressed it cooperates with lgl mutations in a cell-
autonomous manner, driving malignant growth in differ-
ent contexts and organs, whereas when dMyc is downreg-
ulated in lgl- tissue relative to the wild-type surrounding
cells, the lgl mutant cells are eliminated by CC. Moreover,
it appears that CC and ITS play an important role in epi-
thelial integrity, eliminating potentially harmful cells in
complementary regions of the wing disc.
How does Lgl depletion lead to dMyc upregulation in
particular tissues? Recent analysis [47] has revealed that
depletion of Lgl in the eye disc leads to deregulation of
the Salvador-Warts-Hippo (SWH) tumour suppressor
pathway, an evolutionarily conserved signalling pathway
that controls organ size and prevents hyperplastic dis-
eases from flies to humans by restricting the activity of
the transcriptional coactivator Yorkie [48]. Further to
this, we found that dmyc is a transcriptional target of the
SWH pathway, and dMyc protein is strongly upregulated
in mutant clones of many members of the pathway
(unpublished data). Consistent with the SWH pathway
being deregulated, the bona fide Yorkie target, dIAP1
[49,50] was upregulated in larger lgl- clones that overgrew
and expressed dMyc (Figure 6B' and data not shown),
although further analysis of this in wing disc clones using
other SWH targets is required to confirm this. We also
note that the upregulation of dMyc in lgl- tissue correlates
with a loss in apico-basal polarity (Figures 6A and S5B in
Additional file 1, arrow). Although in the eye disc lgl-
clones deregulate the SWH pathway without polarity loss
[47], this does not seem to be the case in the wing, since
the SWH target dIAP1 was only upregulated in lgl- tissue
where polarity is lost. The results of our study suggest
that upon Lgl depletion, to the extent that apical-basal
cell polarity is compromised, that is, in a Minute context
in the wing disc or in the ovarian follicular cells, deregu-
lation of the SWH pathway occurs and, as a consequence,
upregulates dIAP1 and dmyc. The activity of the dmyc
promoter is indeed increased in lgl- clones induced in a
Minute background and in follicular cells (Figure S7B, C
in Additional file 1). In lgl- clones induced in a wild-type
context, where lgl mutant cells do not lose polarity (Fig-
ure S1F, G in Additional file 1), dmyc transcription is not
altered (Figure S7A In Additional file 1). In these clones,
dMyc protein is downregulated, which could occur by
post-transcriptional mechanisms affecting protein stabil-
ity [51].
Examples of these complex behaviours are also present
in the literature describing mammalian carcinogenesis, in
which the role of polarity proteins is still not well under-
stood. It has been recently shown that c-myc cooperates
with scribble tumour suppressor to induce the neoplastic
progression observed during mammary tumourigenesis
[52]. On the other hand, in a murine model of FAP, APC-
cells deprived of c-myc were out-competed by surround-
ing, c-myc-expressing wild-type cells, thereby reverting
the malignant phenotype, suggesting that CC could play a
role in mammalian carcinogenesis [53].
Complex molecular interactions among genetically dif-
ferent cells growing in an organ emerge from our study,
which in turn activate several safeguard mechanisms to
restrict overgrowth and preserve epithelial integrity. Due
to the conservation of signalling pathways, cell prolifera-
tion, and cell death pathway genes between fly and
humans, Drosophila represents an ideal system for
analysing the early events occurring in tumourigenesis
upon the confrontation of different cell populations, and
further analysis will help dissect these mechanisms.
Methods
Mosaic analyses
For the list of mutant and transgenic flies utilised, please
see Additional File 1.
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expression of UAS-lgl transgenes, resulting in normal lar-
val and adult structures [22,5].
For mosaic analyses, either the Flp-FRT [54] or
MARCM [26] systems were used. For larval staging,
freshly hatched larvae were collected in a one-to-four
hour time window. For the twin analysis, larvae were heat
shocked 48 hours After Egg Laying (AEL) for one hour at
37°C and adult females were heat shocked one to two
days after eclosion for one hour at 37°C. For the MARCM
system, larvae were heat shocked 48 hours After Egg Lay-
ing (AEL) for 20 minutes at 37°C. Minute individuals
were always heat shocked at 72 hours AEL to compensate
for developmental delay. For the Flp-out system [45],
adult females were heat shocked one to two days after
eclosion for eight minutes at 37°C. For all the systems
used, tissues were collected 72 hours after the heat shock
both for larvae and adults, unless otherwise specified. All
crosses were kept at 25°C.
Immunofluorescence
Imaginal discs and ovaries were fixed and stained accord-
ing to standard protocols. The following antibodies and
dilutions were used: rabbit anti-active-Caspase 3 (1:200,
(9664S) Cell Signaling Technology, Inc., Danvers, MA,
USA); mouse anti-dIAP1 (1:100, BA Hay); rabbit anti-
Laminin A (1:200, Y Kitagawa); rabbit anti-Scribble
(1:100, CQ Doe); mouse anti-dMyc (1:5) [55]; mouse anti-
βGal (1:25, [40-1a] DSHB, University of Iowa, Iowa City,
IA, USA); rabbit anti-βGal (1:50, F Graziani); rabbit anti-
aPKCζ (1:200, [sc-216] Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA, USA); mouse anti-phospho-JNK (1:100,
[G9 clone] Cell Signaling Technology Inc., Danvers, MA,
USA); rabbit a-Egr (1:500, M Miura). Alexa Fluor 555 or
568 goat anti-mouse and anti-rabbit (1:200, Invitrogen
Corporation, Carlsbad, CA, USA) and Cy5-conjugated
goat anti-mouse and anti-rabbit (1:100, Jackson Immu-
noResearch Laboratories, Inc., West Grove, PA, USA)
were used as secondary antibodies. DAPI and TOPRO
staining were used to detect DNA and phalloidin staining
to detect F-actin. Samples were analysed by laser confocal
microscopy (Leica TSC SP2, Leica Microsystems SpA,
Milan, Italy) and entire images were processed with
Adobe Photoshop software. ImageJ free software from
NIH, Bethesda, MD, USA was used for rebuilding the
projections along the Z axis starting from 25-45 Z stacks.
Measurements and statistical analysis
To measure clone area (in pixel2) and fluorescence inten-
sity (in calibrated units), ImageJ free software from NIH,
Bethesda, MD, USA, was used. Fluorescence intensity
(signal intensity) was calculated as the average gray value
within the selection. The average and the standard devia-
tion alone or the t-Student test P value are given in the
text. For the correlation between clone size and active-
Caspase 3 staining in Figure 3, the Spearman's rank corre-
lation coefficients were calculated using the software
XLSTAT (available at http://www.xlstat.com). To mea-
sure average cell area in wing disc clones, TOPRO stained
nuclei and clone area were scored in confocal series and
the relative cell area (in pixels2) was calculated.
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